
<html lang="en"     class="pb-page"  data-request-id="b0d10d00-0fb4-4fb3-b7ef-c870c5522146"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2010.53.issue-22;requestedJournal:journal:jmcmar;article:article:10.1021/jm101010n;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis and Discovery of Water-Soluble Microtubule Targeting Agents that Bind to the Colchicine Site on Tubulin and Circumvent Pgp Mediated Resistance" /></meta><meta name="dc.Creator" content="Aleem  Gangjee" /></meta><meta name="dc.Creator" content="Ying  Zhao" /></meta><meta name="dc.Creator" content="Lu  Lin" /></meta><meta name="dc.Creator" content="Sudhir  Raghavan" /></meta><meta name="dc.Creator" content="Elizabeth G.  Roberts" /></meta><meta name="dc.Creator" content="April L.  Risinger" /></meta><meta name="dc.Creator" content="Ernest  Hamel" /></meta><meta name="dc.Creator" content="Susan L.  Mooberry" /></meta><meta name="dc.Description" content="Two classes of molecules were designed and synthesized based on a 6-CH3 cyclopenta[d]pyrimidine scaffold and a pyrrolo[2,3-d]pyrimidine scaffold. The pyrrolo[2,3-d]pyrimidines were synthesized by r..." /></meta><meta name="Description" content="Two classes of molecules were designed and synthesized based on a 6-CH3 cyclopenta[d]pyrimidine scaffold and a pyrrolo[2,3-d]pyrimidine scaffold. The pyrrolo[2,3-d]pyrimidines were synthesized by r..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 25, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm101010n" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm101010n" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm101010n" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm101010n" /></link>
        
    
    

<title>Synthesis and Discovery of Water-Soluble Microtubule Targeting Agents that Bind to the Colchicine Site on Tubulin and Circumvent Pgp Mediated Resistance | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm101010n" /></meta><meta property="og:title" content="Synthesis and Discovery of Water-Soluble Microtubule Targeting Agents that Bind to the Colchicine Site on Tubulin and Circumvent Pgp Mediated Resistance" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0012.jpeg" /></meta><meta property="og:description" content="Two classes of molecules were designed and synthesized based on a 6-CH3 cyclopenta[d]pyrimidine scaffold and a pyrrolo[2,3-d]pyrimidine scaffold. The pyrrolo[2,3-d]pyrimidines were synthesized by reacting ethyl 2-cyano-4,4-diethoxybutanoate and acetamidine, which in turn was chlorinated and reacted with the appropriate anilines to afford 1 and 2. The cyclopenta[d]pyrimidines were obtained from 3-methyladapic acid, followed by reaction with acetamidine to afford the cyclopenta[d]pyrimidine scaffold. Chlorination and reaction with appropriate anilines afforded (±)-3·HCl−(±)-7·HCl. Compounds 1 and (±)-3·HCl had potent antiproliferative activities in the nanomolar range. Compound (±)-3·HCl is significantly more potent than 1. Mechanistic studies showed that 1 and (±)-3·HCl cause loss of cellular microtubules, inhibit the polymerization of purified tubulin, and inhibit colchicine binding. Modeling studies show interactions of these compounds within the colchicine site. The identification of these new inhibitors that can also overcome clinically relevant mechanisms of drug resistance provides new scaffolds for colchicine site agents. " /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm101010n"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm101010n">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm101010n&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm101010n&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm101010n&amp;href=/doi/10.1021/jm101010n" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 8116-8128</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm100971t" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm101024j" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/jm101533s"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Discovery of Water-Soluble Microtubule Targeting Agents that Bind to the Colchicine Site on Tubulin and Circumvent Pgp Mediated Resistance</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aleem++Gangjee">Aleem Gangjee</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ying++Zhao">Ying Zhao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lu++Lin">Lu Lin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sudhir++Raghavan">Sudhir Raghavan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth+G.++Roberts">Elizabeth G. Roberts</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=April+L.++Risinger">April L. Risinger</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ernest++Hamel">Ernest Hamel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan+L.++Mooberry">Susan L. Mooberry</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Division of Medicinal Chemistry, Graduate School of Pharmaceutical Sciences, Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Pharmacology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, Texas 78229, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702, United States</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. (A.G.) Telephone: 412-396-6070. Fax 412-396-5593. E-mail <a href="/cdn-cgi/l/email-protection#3e595f5059545b5b7e5a4b4f105b5a4b"><span class="__cf_email__" data-cfemail="caadaba4ada0afaf8aaebfbbe4afaebf">[email protected]</span></a>. (S.L.M.) Telephone 210-567-4788. Fax 210-567-4300. E-mail <a href="/cdn-cgi/l/email-protection#04696b6b666176767d4471706c776777652a616071"><span class="__cf_email__" data-cfemail="eb868484898e999992ab9e9f839888988ac58e8f9e">[email protected]</span></a></div><div class="corresp-fn" id="fn1">∥These authors contributed equally to this work</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm101010n&amp;href=/doi/10.1021%2Fjm101010n" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 8116–8128</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 25, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 August 2010</li><li><span class="item_label"><b>Published</b> online</span>25 October 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 November 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm101010n" title="DOI URL">https://doi.org/10.1021/jm101010n</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8116%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAleem%2BGangjee%252C%2BYing%2BZhao%252C%2BLu%2BLin%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D22%26contentID%3Djm101010n%26title%3DSynthesis%2Band%2BDiscovery%2Bof%2BWater-Soluble%2BMicrotubule%2BTargeting%2BAgents%2Bthat%2BBind%2Bto%2Bthe%2BColchicine%2BSite%2Bon%2BTubulin%2Band%2BCircumvent%2BPgp%2BMediated%2BResistance%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8128%26publicationDate%3DNovember%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm101010n"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2811</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">50</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm101010n" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Discovery of Water-Soluble Microtubule Targeting Agents that Bind to the Colchicine Site on Tubulin and Circumvent Pgp Mediated Resistance&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Aleem&quot;,&quot;last_name&quot;:&quot;Gangjee&quot;},{&quot;first_name&quot;:&quot;Ying&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Lu&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;Sudhir&quot;,&quot;last_name&quot;:&quot;Raghavan&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;G. Roberts&quot;},{&quot;first_name&quot;:&quot;April&quot;,&quot;last_name&quot;:&quot;L. Risinger&quot;},{&quot;first_name&quot;:&quot;Ernest&quot;,&quot;last_name&quot;:&quot;Hamel&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;L. Mooberry&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;25&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;8116-8128&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm101010n&quot;},&quot;abstract&quot;:&quot;Two classes of molecules were designed and synthesized based on a 6-CH3 cyclopenta[d]pyrimidine scaffold and a pyrrolo[2,3-d]pyrimidine scaffold. The pyrrolo[2,3-d]pyrimidines were synthesized by reacting ethyl 2-cyano-4,4-diethoxybutanoate and acetamidine, which in turn was chlorinated and reacted with the appropriate anilines to afford 1 and 2. The cyclopenta[d]pyrimidines were obtained from 3-methyladapic acid, followed by reaction with acetamidine to afford the cyclopenta[d]pyrimidine scaffold. Chlorination and reaction with appropriate anilines afforded (±)-3·HCl−(±)-7·HCl. Compounds 1 and (±)-3·HCl had potent antiproliferative activities in the nanomolar range. Compound (±)-3·HCl is significantly more potent than 1. Mechanistic studies showed that 1 and (±)-3·HCl cause loss of cellular microtubules, inhibit the polymerization of purified tubulin, and inhibit colchicine binding. Modeling studies show interactions of these compounds within the colchicine site. The identification of these new inhibitors th&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm101010n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101010n" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm101010n&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101010n" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm101010n&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101010n" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm101010n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101010n&amp;href=/doi/10.1021/jm101010n" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm101010n" /></input><a href="/doi/pdf/10.1021/jm101010n" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm101010n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm101010n%26sid%3Dliteratum%253Aachs%26pmid%3D20973488%26genre%3Darticle%26aulast%3DGangjee%26date%3D2010%26atitle%3DSynthesis%2Band%2BDiscovery%2Bof%2BWater-Soluble%2BMicrotubule%2BTargeting%2BAgents%2Bthat%2BBind%2Bto%2Bthe%2BColchicine%2BSite%2Bon%2BTubulin%2Band%2BCircumvent%2BPgp%2BMediated%2BResistance%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D22%26spage%3D8116%26epage%3D8128%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292227" title="Drug resistance">Drug resistance</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291917" title="Pyrimidine">Pyrimidine</a>,</li><li><a href="/action/doSearch?ConceptID=290768" title="Antineoplastic agents">Antineoplastic agents</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jmcmar.2010.53.issue-22/production/jmcmar.2010.53.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/medium/jm-2010-01010n_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101010n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Two classes of molecules were designed and synthesized based on a 6-CH<sub>3</sub> cyclopenta[<i>d</i>]pyrimidine scaffold and a pyrrolo[2,3-<i>d</i>]pyrimidine scaffold. The pyrrolo[2,3-<i>d</i>]pyrimidines were synthesized by reacting ethyl 2-cyano-4,4-diethoxybutanoate and acetamidine, which in turn was chlorinated and reacted with the appropriate anilines to afford <b>1</b> and <b>2</b>. The cyclopenta[<i>d</i>]pyrimidines were obtained from 3-methyladapic acid, followed by reaction with acetamidine to afford the cyclopenta[<i>d</i>]pyrimidine scaffold. Chlorination and reaction with appropriate anilines afforded (±)-<b>3</b>·HCl−(±)-<b>7</b>·HCl. Compounds <b>1</b> and (±)-<b>3</b>·HCl had potent antiproliferative activities in the nanomolar range. Compound (±)-<b>3</b>·HCl is significantly more potent than <b>1</b>. Mechanistic studies showed that <b>1</b> and (±)-<b>3</b>·HCl cause loss of cellular microtubules, inhibit the polymerization of purified tubulin, and inhibit colchicine binding. Modeling studies show interactions of these compounds within the colchicine site. The identification of these new inhibitors that can also overcome clinically relevant mechanisms of drug resistance provides new scaffolds for colchicine site agents.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51547" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51547" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Three major classes of microtubule active agents have been identified (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> The vinca alkaloids vincristine, vinblastine, vindesine, and vinorelbine are β-tubulin binding agents that are important in the treatment of leukemias, lymphomas, non-small-cell lung cancer, and other cancers. These are microtubule polymerization inhibitors. The second group includes the taxoids, paclitaxel (Taxol) and docetaxel (Taxotere), as well as the epothilones. The binding site for paclitaxel is also in the β-subunit but is distinct from that of the vinca alkaloids. Paclitaxel and other taxoids (and the epothilones) bind to the interior of the microtubule,<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> and these are designated microtubule-stabilizing agents becuase they stimulate tubulin polymerization. The taxoids are useful in the treatment of breast, lung, ovarian, head and neck, and prostate carcinomas among others. The third class, typified by colchicine, is composed of a diverse collection of small molecules that bind to the colchicine site on β-tubulin at its interface with α-tubulin, distinct from the vinca site. Colchicine site agents also inhibit tubulin polymerization. Combretastatins, as exemplified by combretastatin A-4 (CA4<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>) and its phosphorylated prodrug combretastatin A-4 phosphate (CA4P), are a class of drugs that are in clinical trials as antitumor agents that bind to the colchicine site.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Colchicine itself is not used as an antitumor agent but is used in the treatment of gout and familial Mediterranean fever. There are no clinically approved antitumor agents that bind to the colchicine site. However, several of these agents are currrently in clinical trials,<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> demonstrating the importance of developing colchicine site agents both for use alone and in combination chemotherapy protocols.<div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: Combretastatin A-4, CA4; multiple drug resistance, MDR; P-glycoprotein, Pgp; multidrug resistance protein 1, MRP1; receptor tyrosine kinase, RTK; epidermal growth factor receptor, EGFR; platelet-derived growth factor receptor, PDGFR; vascular endothelial growth factor receptor, VEGFR; relative resistance, Rr; <i>N</i>-deacetyl-<i>N</i>-(2-mercaptoacetyl)colchicine, DAMA colchicine; 2-methoxyestradiol, 2ME2.</p></div></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/medium/jm-2010-01010n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of microtubule targeting agents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101010n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Half of all human tumors have mutations in the p53 gene, and the most effective drugs in p53 mutant cell lines are tubulin-binding agents.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> This further emphasizes the importance of developing new tubulin-binding drugs that are active against resistant tumors. Comprehensive reviews of structures and activities for these agents are available in the literature.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13">(9-13)</a></div><div class="NLM_p">Despite the unprecedented success of microtubule disrupting agents in cancer chemotherapy, multidrug resistance (MDR) is a major limitation of cancer chemotherapy, and MDR tumors are usually resistant to tubulin-binding drugs. Overexpression of P-glycoprotein (Pgp) has been reported in the clinical setting in a number of tumor types, particularly after patients have received chemotherapy.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> In addition, it has also been reported that Pgp expression may be a prognostic indicator in certain cancers and is associated with poor response to chemotherapy,<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> demonstrating the clinical importance of this mechanism of tumor resistance. Overexpression of Pgp appears to be more relevant in the clinical setting than elevation of MRP1 levels.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The overwhelming lack of success of Pgp inhibitors in the clinic indicates that the ability to overcome to Pgp-mediated resistance is an important property for new microtubule targeting agents.<a onclick="showRef(event, 'ref12 ref16'); return false;" href="javascript:void(0);" class="ref ref12 ref16">(12, 16)</a> Such agents will fill an unmet need in the clinic for patients that develop resistance due to Pgp overexpression.</div><div class="NLM_p">The other clinical mechanism of resistance to microtubule targeted agents involves the expression of specific isotypes of β-tubulin, of which the βIII-tubulin isotype is of paramount concern. There is unequivocal clinical evidence that βIII-tubulin expression is involved in resistance to taxoids and vinca alkaloids in multiple tumor types including non-small cell lung,<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17-19)</a> breast,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and ovarian cancers.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> Excellent reviews of the importance of βIII-tubulin in tumor resistance to microtubule targeted agents are available.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> In a recent study, Stengel et al.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and Lee et al.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> have shown that colchicine site agents circumvent βIII-tubulin resistance and highlight the critical importance of developing new agents that bind to the colchicine site as an alternative to the taxoids for the treatment of refractory cancers. The ability to overcome resistance due to Pgp and βIII-tubulin expression was part of the impetus for the recent FDA approval of ixabepilone as an antitumor agent and further attests to the importance of developing agents that overcome these resistance mechanisms.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_p">An additional serious problem with several of the currently used antitubulin agents, particularly the taxoids, is their poor water solubility. This necessitates their formulation in polyoxyethylated castor oil or polysorbate, which can cause hypersensitivity reactions and require long administration times. This is a problem, too, with ixabepilone, which also needs to be dissolved in polyoxyethylated castor oil. Thus water-soluble microtubule targeted agents are highly coveted, and an enormous effort continues to chemically modify and/or formulate analogues of these agents to increase their water solubility.</div><div class="NLM_p last">Synergistic or additive effects of microtubule targeted agents used in combination occurs, in part, due to the different target sites of the agents on tubulin. Estramustine and paclitaxel, which bind to different sites on tubulin, can act synergistically or additively in combination.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Combinations including paclitaxel or docetaxel plus vinorelbine are more efficacious in combination than as single agents.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> CA4P is currently in clinical trials in combination with paclitaxel (<a href="http://www.clinicaltrials.gov" class="extLink">www.clinicaltrials.gov</a>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> As noted above, no colchicine site agent is FDA approved for cancer chemotherapy. There are however several colchicine site agents in clinical trials, and approval of such a drug would allow evaluation of whether enhanced activity could be obtained by combining it with a taxoid or vinca alkaloid. Thus, new tubulin-binding agents that do not act at the taxoid or vinca alkaloid site on tubulin are of considerable interest, both as single agents and to combine with these established drugs.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Synthesis of Water-Soluble Microtubule Targeting Agents</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12776" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12776" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We had previously synthesized 2-amino-4-anilino-6-substituted pyrrolo[2,3-<i>d</i>]pyrimidines as receptor tyrosine kinase (RTK) inhibitors of general structure <b>A</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Three possible binding modes to RTK were suggested from molecular modeling. To define the mode(s) of binding, we synthesized the aniline N-methylated analogue (<b>A</b>; R<sub>1</sub> = CH<sub>3</sub>; R<sub>2</sub> = H), the N7-methylated analogue (<b>A</b>; R<sub>1</sub> = H; R<sub>2</sub> = CH<sub>3</sub>), and the aniline N- and N7-dimethylated analogue (<b>A</b>; R<sub>1</sub> = CH<sub>3</sub>; R<sub>2</sub> = CH<sub>3</sub>). These results were first reported in 2005.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> Further, analogue design from these lead compounds afforded the pyrrolo[2,3-<i>d</i>]pyrimidines <b>1</b>−<b>2</b> and the cyclopenta[<i>d</i>]pyrimidine (±)-<b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) as the free base, and <b>1</b>−(±)-<b>3</b> as the HCl, water-soluble salts as well. Compounds <b>1</b>−(±)-<b>3</b> were not RTK inhibitors (evaluated against EGFR, VEGFR-1, VEGFR-2, and PDGFR-β), but in the preclinical screening program of the National Cancer Institute in its 60 tumor cell line panel <b>1</b> inhibited the proliferation of most of the 60 cancer cell lines with a GI<sub>50</sub> of less than 500 nM (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) and (±)-<b>3</b>·HCl inhibited the proliferation of the majority of the 60 cell lines with a potent GI<sub>50</sub> of less than 30 nM (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/medium/jm-2010-01010n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Lead compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101010n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Tumor Cell Growth Inhibitory Activity GI<sub>50</sub> (nM) of <b>1</b> and (±)-<b>3</b>·HCl in NCI 60 Cell Line Panel</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="right" /></col><col align="left" /></col><col align="char" char="." /></col><col align="right" /></col><col align="left" /></col><col align="char" char="." /></col><col align="right" /></col><col align="left" /></col><col align="char" char="." /></col><col align="right" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">panel/cell line</th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">GI<sub>50</sub> (nM) compound</th><th class="colsep0 rowsep0" align="center">panel/cell line</th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">GI<sub>50</sub> (nM) compound</th><th class="colsep0 rowsep0" align="center">panel/cell line</th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">GI<sub>50</sub> (nM) compound</th><th class="colsep0 rowsep0" align="center">panel/cell line</th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">GI<sub>50</sub> (nM) compound</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Leukemia</b></td><td class="colsep0 rowsep0" align="center" char="."><b>1</b></td><td class="colsep0 rowsep0" align="center">(±)-<b>3</b>·HCl</td><td class="colsep0 rowsep0" align="left"><b>Colon Cancer</b></td><td class="colsep0 rowsep0" align="center" char="."><b>1</b></td><td class="colsep0 rowsep0" align="center">(±)-<b>3</b>·HCl</td><td class="colsep0 rowsep0" align="left"><b>Melanoma</b></td><td class="colsep0 rowsep0" align="center" char="."><b>1</b></td><td class="colsep0 rowsep0" align="center">(±)-<b>3</b>·HCl</td><td class="colsep0 rowsep0" align="left"><b>Renal Cancer</b></td><td class="colsep0 rowsep0" align="center" char="."><b>1</b></td><td class="colsep0 rowsep0" align="center">(±)-<b>3</b>·HCl</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CCRF-CEM</td><td class="colsep0 rowsep0" align="char" char=".">315</td><td class="colsep0 rowsep0" align="right">16.3</td><td class="colsep0 rowsep0" align="left">COLO 205</td><td class="colsep0 rowsep0" align="char" char=".">243</td><td class="colsep0 rowsep0" align="right">18.3</td><td class="colsep0 rowsep0" align="left">LOX IMVI</td><td class="colsep0 rowsep0" align="char" char=".">407</td><td class="colsep0 rowsep0" align="right">22.7</td><td class="colsep0 rowsep0" align="left">786 - 0</td><td class="colsep0 rowsep0" align="char" char=".">433</td><td class="colsep0 rowsep0" align="right">34.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HL-60(TB)</td><td class="colsep0 rowsep0" align="char" char=".">190</td><td class="colsep0 rowsep0" align="right"><10</td><td class="colsep0 rowsep0" align="left">HCC-2998</td><td class="colsep0 rowsep0" align="char" char=".">271</td><td class="colsep0 rowsep0" align="right">24.0</td><td class="colsep0 rowsep0" align="left">M14</td><td class="colsep0 rowsep0" align="char" char=".">218</td><td class="colsep0 rowsep0" align="right">10.2</td><td class="colsep0 rowsep0" align="left">A498</td><td class="colsep0 rowsep0" align="char" char=".">198</td><td class="colsep0 rowsep0" align="right"><10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">K-562</td><td class="colsep0 rowsep0" align="char" char=".">179</td><td class="colsep0 rowsep0" align="right"><10</td><td class="colsep0 rowsep0" align="left">HCT-116</td><td class="colsep0 rowsep0" align="char" char=".">344</td><td class="colsep0 rowsep0" align="right">15.1</td><td class="colsep0 rowsep0" align="left">MDA-MB-435</td><td class="colsep0 rowsep0" align="char" char=".">44.2</td><td class="colsep0 rowsep0" align="right"><10</td><td class="colsep0 rowsep0" align="left">ACHN</td><td class="colsep0 rowsep0" align="char" char=".">556</td><td class="colsep0 rowsep0" align="right">14.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MOLT-4</td><td class="colsep0 rowsep0" align="char" char=".">503</td><td class="colsep0 rowsep0" align="right">31.8</td><td class="colsep0 rowsep0" align="left">HCT-15</td><td class="colsep0 rowsep0" align="char" char=".">275</td><td class="colsep0 rowsep0" align="right"><10</td><td class="colsep0 rowsep0" align="left">SK-MEL-2</td><td class="colsep0 rowsep0" align="char" char=".">251</td><td class="colsep0 rowsep0" align="right">33.1</td><td class="colsep0 rowsep0" align="left">CAKI-1</td><td class="colsep0 rowsep0" align="char" char=".">339</td><td class="colsep0 rowsep0" align="right"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RPMI-8226</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="right">15.7</td><td class="colsep0 rowsep0" align="left">HT29</td><td class="colsep0 rowsep0" align="char" char=".">279</td><td class="colsep0 rowsep0" align="right">11.8</td><td class="colsep0 rowsep0" align="left">SK-MEL-28</td><td class="colsep0 rowsep0" align="char" char=".">603</td><td class="colsep0 rowsep0" align="right"><10</td><td class="colsep0 rowsep0" align="left">RXF 393</td><td class="colsep0 rowsep0" align="char" char=".">226</td><td class="colsep0 rowsep0" align="right"><10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SR</td><td class="colsep0 rowsep0" align="char" char=".">87.6</td><td class="colsep0 rowsep0" align="right"><10</td><td class="colsep0 rowsep0" align="left">KM12</td><td class="colsep0 rowsep0" align="char" char=".">181</td><td class="colsep0 rowsep0" align="right"><10</td><td class="colsep0 rowsep0" align="left">SK-MEL-5</td><td class="colsep0 rowsep0" align="char" char=".">177</td><td class="colsep0 rowsep0" align="right"><10</td><td class="colsep0 rowsep0" align="left">SN12C</td><td class="colsep0 rowsep0" align="char" char=".">854</td><td class="colsep0 rowsep0" align="right">31.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NSCLC</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="right"> </td><td class="colsep0 rowsep0" align="left">SW-620</td><td class="colsep0 rowsep0" align="char" char=".">246</td><td class="colsep0 rowsep0" align="right"><10</td><td class="colsep0 rowsep0" align="left">UACC-62</td><td class="colsep0 rowsep0" align="char" char=".">625</td><td class="colsep0 rowsep0" align="right"><10</td><td class="colsep0 rowsep0" align="left">TK10</td><td class="colsep0 rowsep0" align="char" char=".">390</td><td class="colsep0 rowsep0" align="right">292</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A549/ATCC</td><td class="colsep0 rowsep0" align="char" char=".">723</td><td class="colsep0 rowsep0" align="right">24.4</td><td class="colsep0 rowsep0" align="left"><b>CNS Cancer</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="right"> </td><td class="colsep0 rowsep0" align="left"><b>Ovarian Cancer</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="right"> </td><td class="colsep0 rowsep0" align="left">UO-31</td><td class="colsep0 rowsep0" align="char" char=".">307</td><td class="colsep0 rowsep0" align="right">13.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EKVX</td><td class="colsep0 rowsep0" align="char" char=".">875</td><td class="colsep0 rowsep0" align="right">19.6</td><td class="colsep0 rowsep0" align="left">SF-268</td><td class="colsep0 rowsep0" align="char" char=".">449</td><td class="colsep0 rowsep0" align="right">15.2</td><td class="colsep0 rowsep0" align="left">IGROVI</td><td class="colsep0 rowsep0" align="char" char=".">340</td><td class="colsep0 rowsep0" align="right">11.0</td><td class="colsep0 rowsep0" align="left"><b>Prostate Cancer</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="right"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HOP-62</td><td class="colsep0 rowsep0" align="char" char=".">291</td><td class="colsep0 rowsep0" align="right">19.4</td><td class="colsep0 rowsep0" align="left">SF-295</td><td class="colsep0 rowsep0" align="char" char=".">269</td><td class="colsep0 rowsep0" align="right"><10</td><td class="colsep0 rowsep0" align="left">OVCAR-3</td><td class="colsep0 rowsep0" align="char" char=".">192</td><td class="colsep0 rowsep0" align="right"><10</td><td class="colsep0 rowsep0" align="left">PC-3</td><td class="colsep0 rowsep0" align="char" char=".">509</td><td class="colsep0 rowsep0" align="right">14.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HOP-92</td><td class="colsep0 rowsep0" align="char" char=".">4800</td><td class="colsep0 rowsep0" align="right">55.4</td><td class="colsep0 rowsep0" align="left">SF-539</td><td class="colsep0 rowsep0" align="char" char=".">288</td><td class="colsep0 rowsep0" align="right">11.4</td><td class="colsep0 rowsep0" align="left">OVCAR-4</td><td class="colsep0 rowsep0" align="char" char=".">7730</td><td class="colsep0 rowsep0" align="right">26.8</td><td class="colsep0 rowsep0" align="left">DU-145</td><td class="colsep0 rowsep0" align="char" char=".">269</td><td class="colsep0 rowsep0" align="right">21.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NCI-H226</td><td class="colsep0 rowsep0" align="char" char=".">623</td><td class="colsep0 rowsep0" align="right">31.5</td><td class="colsep0 rowsep0" align="left">SNB-19</td><td class="colsep0 rowsep0" align="char" char=".">612</td><td class="colsep0 rowsep0" align="right">36.9</td><td class="colsep0 rowsep0" align="left">OVCAR-5</td><td class="colsep0 rowsep0" align="char" char=".">1670</td><td class="colsep0 rowsep0" align="right">38.5</td><td class="colsep0 rowsep0" align="left"><b>Breast Cancer</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="right"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NCI-H23</td><td class="colsep0 rowsep0" align="char" char=".">438</td><td class="colsep0 rowsep0" align="right">16.4</td><td class="colsep0 rowsep0" align="left">SNB-75</td><td class="colsep0 rowsep0" align="char" char=".">185</td><td class="colsep0 rowsep0" align="right"><10</td><td class="colsep0 rowsep0" align="left">OVCAR-8</td><td class="colsep0 rowsep0" align="char" char=".">639</td><td class="colsep0 rowsep0" align="right">32.8</td><td class="colsep0 rowsep0" align="left">MCF7</td><td class="colsep0 rowsep0" align="char" char=".">314</td><td class="colsep0 rowsep0" align="right"><10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NCI-H322M</td><td class="colsep0 rowsep0" align="char" char=".">428</td><td class="colsep0 rowsep0" align="right">59.0</td><td class="colsep0 rowsep0" align="left">U251</td><td class="colsep0 rowsep0" align="char" char=".">440</td><td class="colsep0 rowsep0" align="right">12.5</td><td class="colsep0 rowsep0" align="left">NCI/ADR-RES</td><td class="colsep0 rowsep0" align="char" char=".">164</td><td class="colsep0 rowsep0" align="right"><10</td><td class="colsep0 rowsep0" align="left">MDA-MB-231/ATCC</td><td class="colsep0 rowsep0" align="char" char=".">1260</td><td class="colsep0 rowsep0" align="right">24.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NCI-H460</td><td class="colsep0 rowsep0" align="char" char=".">351</td><td class="colsep0 rowsep0" align="right">23.4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="right"> </td><td class="colsep0 rowsep0" align="left">SK-OV-3</td><td class="colsep0 rowsep0" align="char" char=".">248</td><td class="colsep0 rowsep0" align="right">27.5</td><td class="colsep0 rowsep0" align="left">HS 578T</td><td class="colsep0 rowsep0" align="char" char=".">249</td><td class="colsep0 rowsep0" align="right"><10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NCI-H522</td><td class="colsep0 rowsep0" align="char" char=".">40.2</td><td class="colsep0 rowsep0" align="right"><10</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="right"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="right"> </td><td class="colsep0 rowsep0" align="left">BT-549</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="right">21.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="right"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="right"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="right"> </td><td class="colsep0 rowsep0" align="left">MDA-MB-468</td><td class="colsep0 rowsep0" align="char" char=".">208</td><td class="colsep0 rowsep0" align="right"><10</td></tr></tbody></table></div></div><div class="NLM_p last">The potent activities of these compounds prompted a COMPARE analysis,<a onclick="showRef(event, 'ref32 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref34">(32, 34)</a> which showed vincristine sulfate to have the closest Pearsons correlation coefficient with <b>1</b> and (±)-<b>3</b>·HCl. Other compounds, such as vinblastine sulfate and maytansine, also tubulin binding agents, were ranked as the next closest correlation. This clearly warranted the evaluation of <b>1</b> and (±)-<b>3</b>·HCl as tubulin binding agents. It was also of interest to synthesize and evaluate <b>2</b>, the desmethyl analogue of <b>1</b>, and (±)<b>-4</b>, the desmethyl analogue of (±)-<b>3</b>. In addition, due to the more potent activity of (±)-<b>3</b>·HCl in the NCI preclinical panel as compared to <b>1</b>, compounds (±)-<b>5</b>·HCl−(±)-<b>7</b>·HCl (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) were also synthesized to determine the position and importance of the 4′-OMe moiety to the biological activity of (±)-<b>3</b>·HCl.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56527" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56527" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compound <b>1</b> was synthesized as shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Ethyl 2-cyano-4,4-diethoxybutanoate <b>8</b> and acetamidine·HCl, <b>9</b>, were reacted at reflux for 5 h and cooled to 0 °C, and then the precipitate was collected and treated with conc. H<sub>2</sub>SO<sub>4</sub> in ethanol at reflux for 2 h to afford 2-methyl-4-oxo-pyrrolo[2,3-<i>d</i>]pyrimidine <b>10</b> in 64% yield. Chlorination with POCl<sub>3</sub> afforded <b>11</b> (83% yield).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Treatment of <b>11</b> with the appropriate anilines <b>12</b> afforded <b>1</b> (R = CH<sub>3</sub>) (80% yield) and <b>2</b> (R = H) (41%). The water-soluble hydrochloride salt of <b>1</b> was obtained as a white precipitate (∼100%) by dissolving <b>1</b> in anhydrous ether followed by bubbling anhydrous HCl gas.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/medium/jm-2010-01010n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0003.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Pyrrolo[2,3-<i>d</i>]pyrimidines <b>1</b> and <b>2</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101010n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) 2-bromo-1,1-diethoxyethane, NaOMe, anhyd. DMF, 90 °C, 4 h; (ii) acetamidine·HCl, NaOEt, EtOH, reflux, 3 h; (iii) conc. H<sub>2</sub>SO<sub>4</sub>, EtOH, reflux, 2 h. (b) POCl<sub>3</sub>, reflux, 3 h. (c) <i>i</i>-PrOH, HCl (1 drop), reflux, 4 h. (d) Anhyd. HCl gas, anhyd. ether.</p></p></figure><div class="NLM_p">Target compounds (±)-<b>3</b>−(±)-<b>7</b> were prepared as shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. 2,6-Dimethyl-6,7-dihydro-3<i>H</i>-cyclopenta[<i>d</i>]pyrimidin-4(5<i>H</i>)-one (±)-<b>14</b> was prepared via the reaction of commercially available 3-methyladipic acid (±)-<b>13</b> and conc. H<sub>2</sub>SO<sub>4</sub> at reflux in ethanol and a Dieckmann condensation in the presence of elemental sodium in toluene, followed by treatment with acetamidine·HCl <b>9</b> (21% over three steps). Chlorination of (±)-<b>14</b> with POCl<sub>3</sub> for 3 h at reflux afforded (±)-<b>15</b> (69%).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Compound (±)-<b>15</b> was unstable and easily decomposed to (±)-<b>14</b> if not used immediately. Reaction of (±)-<b>15</b> with the appropriate anilines in <i>i</i>-PrOH in the presence of 2−3 drops of conc. HCl afforded (±)-<b>3</b>−(±)-<b>7</b>. Anhydrous HCl gas was bubbled through an anhydrous ether solution of (±)-<b>3</b>, (±)-<b>5</b>−(±)-<b>7</b> to afford the corresponding HCl salts as white solids.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/medium/jm-2010-01010n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0004.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Cyclopenta[<i>d</i>]pyrimidines (±)-3 − (±)-7 and Their HCl Salts<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101010n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) conc. H<sub>2</sub>SO<sub>4</sub>, EtOH, reflux, 8 h; (ii) Na, toluene, reflux, 3 h; (iii) acetamidine·HCl <b>9</b>, <i>t-</i>BuOK, <i>t</i>-BuOH. (b) POCl<sub>3</sub>, reflux, 3 h. (c) <i>i</i>-PrOH, HCl (2−3 drops), reflux, 3−6 h. (d) Anhyd. HCl gas, anhyd. ether.</p></p></figure></div><div id="sec2_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Biological Evaluations</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72887" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72887" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> NCI Cytotoxicity Studies and Antimicrotubule Effects in Cells</h3><div class="NLM_p">Compounds <b>1</b> and (±)-<b>3</b>·HCl showed potent GI<sub>50</sub>'s in most of the NCI 60 cancer cell lines (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The microtubule disrupting effects of <b>1</b> and (±)-<b>3</b>·HCl were observed (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) in a cell-based phenotypic screen. Compounds <b>1</b> and (±)-<b>3</b>·HCl caused dramatic reorganization of the interphase microtubule network, similar to the effects of colchicine and CA4P. The EC<sub>50</sub> (concentration required to cause 50% loss of cellular microtubules) (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) was calculated to be 7 nM for CA4P,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> 56 nM for (±)-<b>3</b>·HCl, and 5.8 μM for <b>1</b>. Consistent with effects on cellular microtubules, <b>1</b> and (±)-<b>3</b>·HCl caused the formation of aberrant mitotic spindles and mitotic accumulation when measured by flow cytometry (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Compounds <b>1</b> and (±)-<b>3</b>·HCl are potent microtubule depolymerizers in cells, confirming the COMPARE analysis results.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/medium/jm-2010-01010n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0005.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of CA4P, <b>1</b>, and (±)-<b>3</b>·HCl on interphase microtubules. A-10 cells were treated with vehicle or compounds as indicated for 18 h, and then the cells were fixed and microtubules visualized by indirect immunofluorescence techniques.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101010n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> Values for Inhibition of Proliferation of MDA-MB-435 Cells and EC<sub>50</sub>s for Cellular Microtubule Loss</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="right" /></col><col align="right" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> ± SD (MDA-MB-435)</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> for microtubule depolymerization</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="right">183 ± 3.4 nM</td><td class="colsep0 rowsep0" align="right">5.8 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="right">>10 μM</td><td class="colsep0 rowsep0" align="right">>40 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>3</b>·HCl</td><td class="colsep0 rowsep0" align="right">17.0 ± 0.7 nM</td><td class="colsep0 rowsep0" align="right">56 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>4</b></td><td class="colsep0 rowsep0" align="right">>10 μM</td><td class="colsep0 rowsep0" align="right">>40 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>5</b>·HCl</td><td class="colsep0 rowsep0" align="right">153 ± 11.1 nM</td><td class="colsep0 rowsep0" align="right">3.0 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>6</b>·HCl</td><td class="colsep0 rowsep0" align="right">ND<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="right">>40 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>7</b>·HCl</td><td class="colsep0 rowsep0" align="right">2.7 ± 0.3 μM</td><td class="colsep0 rowsep0" align="right">>40 μM</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">ND: Not determined.</p></div></div></div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/medium/jm-2010-01010n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0006.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cell cycle distribution. MBA-MB-435 cells were treated with vehicle (A), 12.5 nM paclitaxel (B), 45 nM (±)-<b>3</b>·HCl (C), or 850 nM <b>1</b> (D) for 24 h. The cells were then harvested, stained with propidium iodide, and evaluated by flow cytometry.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101010n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Antiproliferative Effects</h3><div class="NLM_p">Compounds <b>1</b> and (±)-<b>3</b>·HCl were tested for antiproliferative effects against the drug sensitive MDA-MB-435 cell line using the sulforhodamine B assay (SRB assay).<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> The data (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) indicate that (±)-<b>3</b>·HCl has potent antiproliferative effects with an IC<sub>50</sub> (concentration required to cause 50% inhibition of proliferation) of 17.0 ± 0.7 nM. Compound <b>1</b> is less potent, consistent with its effects in the phenotypic assay and by flow cytometry, with an IC<sub>50</sub> of 183 ± 3.4 nM.</div><div class="NLM_p">The ability of <b>1</b> and (±)-<b>3</b>·HCl to circumvent Pgp-mediated drug resistance was evaluated by using an SK-OV-3 isogenic cell line pair (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). In this cell line pair, the relative resistance (Rr) of paclitaxel, a well-known Pgp substrate, is greater than 800 while Rr values of 1.2 and 1.6 were obtained with <b>1</b> and (±)-<b>3</b>·HCl, respectively, consistent with the Rr values obtained with other colchicine site agents, CA4P and 2ME2 of 1.5−2.6. These data suggest that both <b>1</b> and (±)-<b>3</b>·HCl are poor substrates for transport by Pgp and thus have advantages over some clinically useful tubulin-targeting drugs such as paclitaxel.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. <b>1</b> and (±)-<b>3</b>·HCl Circumvent Pgp and βIII-Tubulin Mediated Resistance<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="3" align="center" char="±">effect of Pgp on drug sensitivity<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" colspan="3" align="center" char="±">effect of βIII-tubulin on drug sensitivity<a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="2" align="center" char="±">IC<sub>50</sub> ± SD (nM)</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" colspan="2" align="center" char="±">IC<sub>50</sub> ± SD (nM)</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">drug</th><th class="colsep0 rowsep0" align="center" char="±">SK-OV-3</th><th class="colsep0 rowsep0" align="center" char="±">SK-OV-3 MDR-1-6/6</th><th class="colsep0 rowsep0" align="center" char=".">Rr</th><th class="colsep0 rowsep0" align="center" char="±">HeLa</th><th class="colsep0 rowsep0" align="center" char="±">WT βIII</th><th class="colsep0 rowsep0" align="center" char=".">Rr</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">paclitaxel</td><td class="colsep0 rowsep0" align="char" char="±">3.0 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">2600 ± 270</td><td class="colsep0 rowsep0" align="char" char=".">864</td><td class="colsep0 rowsep0" align="char" char="±">1.6 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">7.7 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CA4P</td><td class="colsep0 rowsep0" align="char" char="±">4.5 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">6.6 ± 1.3</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char="±">4.7 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">5.7 ± 0.4</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2ME2</td><td class="colsep0 rowsep0" align="char" char="±">867 ± 36</td><td class="colsep0 rowsep0" align="char" char="±">2268 ± 235</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char="±">608 ± 55</td><td class="colsep0 rowsep0" align="char" char="±">586 ± 37</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="±">278 ± 19</td><td class="colsep0 rowsep0" align="char" char="±">435 ± 33</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char="±">270 ± 21</td><td class="colsep0 rowsep0" align="char" char="±">186 ± 17</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>3</b>·HCl</td><td class="colsep0 rowsep0" align="char" char="±">38.6 ± 3.1</td><td class="colsep0 rowsep0" align="char" char="±">44.4 ± 3.2</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char="±">37.3 ± 4.1</td><td class="colsep0 rowsep0" align="char" char="±">23.9 ± 1.7</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Rr: Relative resistance.</p></div><div class="footnote" id="t3fn1"><sup>b</sup><p class="last">Antiproliferative effects of (±)-<b>3</b>·HCl and <b>1</b> in parental and <i>MDR-1</i>-transducted cell lines in comparison with other microtubule disrupting agents. The IC<sub>50</sub> values were determined using the SRB assay (<i>n</i> = 3 ± SD). The Rr was calculated by dividing the IC<sub>50</sub> of the Pgp overexpressing cell line by the IC<sub>50</sub> of the parental cell line.</p></div><div class="footnote" id="t3fn2"><sup>c</sup><p class="last">Effects of the expression of βIII-tubulin on the sensitivity of cell lines to microtubule-targeting agents. The Rr was calculated by dividing the IC<sub>50</sub> of the WT βIII cell line by the IC<sub>50</sub> of the parental HeLa cells.</p></div></div></div><div class="NLM_p last">A second mechanism of drug resistance that can lead to treatment failure with tubulin-targeting drugs is the expression of the βIII isotype of tubulin as discussed above. An isogenic HeLa cell line pair was used to evaluate the effect of βIII tubulin expression on the activities of <b>1</b> and (±)-<b>3</b>·HCl.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Compounds <b>1</b> and (±)-<b>3</b>·HCl have Rr values of 0.6−0.7 (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) in this cell line pair, suggesting that they overcome drug resistance mediated by βIII tubulin as compared with paclitaxel, which has a Rr of 4.7. Thus, both <b>1</b> and (±)-<b>3</b>·HCl inhibit tumor cells with equal potency without regard to their expression of Pgp or βIII-tubulin.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Further Mechanistic Studies</h3><div class="NLM_p">Studies were conducted to determine if <b>1</b> and (±)-<b>3</b>·HCl inhibited the polymerization of purified bovine brain tubulin, as would be predicted from the effects in cells. These biochemical studies provide an indication of a direct interaction of the compounds with tubulin. An initial study, shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, indicates that both <b>1</b> and (±)-<b>3</b>·HCl are potent inhibitors of purified tubulin assembly. Both compounds were therefore compared with CA4P as inhibitors of assembly in a quantitative study (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). In this assay, both <b>1</b> and (±)-<b>3</b>·HCl inhibited tubulin assembly about as well as CA4 (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). The data in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> also show that <b>1</b> and (±)-<b>3</b>·HCl bind at the colchicine site on tubulin, since they inhibited [<sup>3</sup>H]colchicine binding to the protein, although not as potently as CA4.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/medium/jm-2010-01010n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0007.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of microtubule disrupting agents on tubulin polymerization. Paclitaxel represents a positive control for a microtubule stabilizer and colchicine the control for a microtubule depolymerizer. The assays were conducted using purified bovine brain tubulin from Cytoskeleton Inc. in the presence of 10% glycerol, 3 mg/mL purified tubulin, and 10 mM GTP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101010n&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibition of Tubulin Assembly and Inhibition of Colchicine Binding</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±"> </th><th class="colsep0 rowsep0" colspan="2" align="center">inhibition of colchicine binding</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±">inhibition of tubulin assembly</th><th class="colsep0 rowsep0" colspan="2" align="center">% Inhibition ± SD</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub> ± SD (nM)</th><th class="colsep0 rowsep0" align="center">1 μM</th><th class="colsep0 rowsep0" align="center" char="±">5 μM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CA4</td><td class="colsep0 rowsep0" align="char" char="±">1.0 ± 0.09</td><td class="colsep0 rowsep0" align="left">88 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">99 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char="±">2.6 ± 0.05</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="±">70 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>3</b>·HCl</td><td class="colsep0 rowsep0" align="char" char="±">1.9 ± 0.01</td><td class="colsep0 rowsep0" align="left">60 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">84 ± 3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">ND: Not determined.</p></div></div></div><div class="NLM_p last">To determine the structural requirements for the 4′-OCH<sub>3</sub> and N4-CH<sub>3</sub> moieties for activity, compounds <b>2</b> and (±)-<b>4</b>−(±)-<b>7</b> were synthesized. The superior activity of (±)-<b>3</b>·HCl suggests that the pyrrole NH of <b>1</b> is not important for activity. Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> indicates that the methylation of the aniline N is crucial for activity in both scaffolds (compare <b>1</b> with <b>2</b> and (±)-<b>3</b>·HCl with (±)-<b>4</b>). In addition, the 4′-OCH<sub>3</sub> moiety is important for potent activity (compare (±)-<b>3</b>·HCl with (±)-<b>7</b>·HCl), and the optimum location for the methoxyl group is at the 4′-position since (±)-<b>5</b>·HCl, which has a 3′-OCH<sub>3</sub>, was about 9-fold less potent than (±)-<b>3</b>·HCl, which has a 4′-OCH<sub>3</sub>. Finally, (±)-<b>6</b>·HCl, the analogue with a 2′-OCH<sub>3</sub>, was inactive.</div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Molecular Modeling</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41451" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41451" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In an attempt to explain the molecular basis of the potent activity of the <i>N</i>-Me analogues <b>1</b> and (±)-<b>3</b>·HCl and the inactivity of the N-desmethyl analogues <b>2</b> and (±)-<b>4</b>, we modeled compounds <b>1</b>−<b>7</b> into the colchicine site. The X-ray crystal structure of tubulin at 3.58 Å resolution was obtained from the protein database (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SA0">1SA0</a><a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a>). This crystal structure contains the αβ dimers of tubulin complexed with <i>N</i>-deacetyl-<i>N</i>-(2-mercaptoacetyl)colchicine (DAMA colchicine), a close structural analogue of colchicine. The binding of colchicine to the tubulin dimer has been described in the literature.<a onclick="showRef(event, 'ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42">(40-42)</a> Colchicine binds to β-tubulin at its interface with α-tubulin. The colchicine site has dimensions of ∼10 Å × ∼10 Å × ∼4−5 Å and is composed of strands S8 and S9, loop T7, and helices H7 and H8 (nomenclature and amino acid residue positions as described in ref <a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">40</a>) from the β subunit and loop T5 from the α subunit of tubulin. Thrα179 and Valα181 in the α-tubulin subunit form hydrogen bonds with colchicine. Additionally, Cysβ241 forms a hydrogen bond with the oxygen atom of the 3-OCH<sub>3</sub> in the A-ring of colchicine. Further hydrophobic stabilization is afforded by side chain atoms of Valα181 and Metβ259. In addition, the carbonyl group of the A-ring H-bonds with Lysβ352.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Docking of (<i>R</i>)-3</h3><div class="NLM_p">Docking studies were performed using the docking suite of Molecular Operating Environment software (MOE 2008.10).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Details of the docking protocol used are provided in the <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>. Multiple low-energy conformations (within 1 kcal/mol of the best pose) were obtained on docking (<i>R</i>)-<b>3</b> and other analogues. The multiple docked poses can be explained by the large volume of the active site (10 Å × 10 Å × 4−5 Å).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a> shows the docked conformation of (<i>R</i>)-<b>3</b> which was arbitrarily selected as a working model for the docking of compounds <b>1</b>−<b>7</b> on the basis of their structural similarity to the bound conformation of DAMA colchicine. The pose in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a> for (<i>R</i>)-<b>3</b> had a score (−6.8379 kcal/mol) within 1 kcal/mol of the best scored pose. Comparison of the docked conformation of (<i>R</i>)-<b>3</b> with the crystal structure conformation of DAMA colchicine shows overlap of the 4′-OCH<sub>3</sub> phenyl group of (<i>R</i>)-<b>3</b> with the trimethoxybenzene A-ring of DAMA colchicine (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). In this pose, the 4′-OCH<sub>3</sub> of (<i>R</i>)-<b>3</b> overlaps with the 3′-OCH<sub>3</sub> group in the A ring of DAMA colchicine. Similar interactions of the −OCH<sub>3</sub> groups with Cysβ241 have been reported in the literature.<a onclick="showRef(event, 'ref41 ref44'); return false;" href="javascript:void(0);" class="ref ref41 ref44">(41, 44)</a> The conformation of (<i>R</i>)-<b>3</b> depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a> permits the formation of a hydrogen bond between Cysβ241 and the oxygen atom of the 4′-OCH<sub>3</sub> of (<i>R</i>)-<b>3</b> as is observed between Cysβ241 and the 3′-OCH<sub>3</sub> group of DAMA colchicine in its X-ray crystal structure with tubulin. The phenyl ring of (<i>R</i>)-<b>3</b> mimics the A ring of colchicine and is involved in hydrophobic interactions with amino acids from β-tubulin (Leuβ248, Alaβ250, Leuβ255, and Alaβ316). Additionally, the methyl group of the 4′-OCH<sub>3</sub> moiety could interact with the side chain of Ileβ378 and/or with the side chain of Valβ318.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/medium/jm-2010-01010n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0008.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Stereo view. Docked pose of (<i>R</i>)-<b>3</b> (white) overlaid with DAMA colchicine (red) in the colchicine site of tubulin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101010n&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We<a onclick="showRef(event, 'ref45 ref46 ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47 ref48 ref49">(45-49)</a> and others<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> have previously demonstrated that similar CH<sub>3</sub> moieties dictate the biological activities predicated on hydrophobic interactions and/or conformational restriction. It was of interest to extend these findings to provide a rationale for the high potency of the <i>N</i>-CH<sub>3</sub> analogues of the present study compared with the <i>N</i>-desmethyl analogues.</div><div class="NLM_p">The <i>N-</i>CH<sub>3</sub> group of (<i>R</i>)-<b>3</b> occupies a region in space in proximity to the C5 and C6 atoms of the B-ring of DAMA colchicine. In this orientation, the <i>N-</i>CH<sub>3</sub> group is involved in hydrophobic interactions with the side chain C atoms of Lysβ254 and Alaβ250. An additional hydrophobic interaction between the <i>N-</i>CH<sub>3</sub> moiety of (<i>R</i>)-<b>3</b> and the side chain C-atom of Leuβ248 also occurs due to the flexible nature of the protein (measured distance between <i>N-</i>CH<sub>3</sub> and side chain C of Leuβ248 is 4.21 Å). These interactions could assist in stabilization of the docked conformation of (<i>R</i>)-<b>3</b> and could explain, in part, the observed difference in activity of the <i>N</i>-desmethyl analogue, (<i>R</i>)-<b>4</b>, which would lack these additional interactions (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). The <i>N-</i>CH<sub>3</sub> also aids in maintaining the relative conformations of the cyclopenta[<i>d</i>]pyrimidine and the phenyl ring. While similar docked poses were observed for (<i>R</i>)-<b>4</b>, the docked poses of compounds with the <i>N-</i>CH<sub>3</sub> group consistently scored higher (∼1 kcal/mol) than those of compounds that lack the <i>N-</i>CH<sub>3</sub> group.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/medium/jm-2010-01010n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0009.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Stereo view. Superimposition of the docked poses of (<i>R</i>)-<b>3</b> (white) and (<i>R</i>)-<b>4</b> (magenta) in the colchicine site of tubulin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101010n&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A systematic conformational search carried out using Sybyl X 1.1<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> for energy minimized structures of (<i>R</i>)-<b>3</b> and (<i>R</i>)-<b>4</b> returned a lower number of conformers for the <i>N</i>-CH<sub>3</sub> compound (<i>R</i>)-<b>3</b> compared with the NH compound (<i>R</i>)-<b>4</b> using the same settings. This is indicative of restrictions on the rotational freedom of the 4′-OCH<sub>3</sub> phenyl ring of (<i>R</i>)-<b>3</b> in the presence of the <i>N</i>-CH<sub>3</sub> moiety and decreases the number of low energy conformations of the 4′-OCH<sub>3</sub> phenyl ring relative to the cyclopenta[<i>d</i>]pyrimidine scaffold of (<i>R</i>)-<b>3</b>. Similar results were obtained for the conformational search of <b>1</b> and <b>2</b>.</div><div class="NLM_p">The cyclopenta[<i>d</i>]pyrimidine of (<i>R</i>)-<b>3</b> ring partially overlaps with the C-ring of DAMA colchicine and is stabilized by hydrophobic interactions with side chain C atoms of Leuβ255, Asnβ258, and Lysβ252. The C7 of (<i>R</i>)-<b>3</b> overlaps the C9 carbonyl C of DAMA colchicine. The C2-CH<sub>3</sub> moiety of (<i>R</i>)-<b>3</b> is involved in a hydrophobic interaction with Alaα180 (4.35 Å), while the C6-CH<sub>3</sub> group of (<i>R</i>)-<b>3</b> is involved in hydrophobic interactions with Valα181 and Alaβ316. We did not observe a significant difference in the binding poses and docked scores of (<i>R</i>)-<b>3</b> (−6.8379 kcal/mol) and (<i>S</i>)-<b>3</b> (−6.9454 kcal/mol) due to the chirality of the C6-CH<sub>3</sub> group (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). Whether this slight predicted difference between the two isomers is reflected in the biological activities can only be determined once the two isomers are individually synthesized and evaluated.</div><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/medium/jm-2010-01010n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0010.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Stereo view. Superimposition of the docked poses of (<i>R</i>)-<b>3</b> (white), (<i>S</i>)-<b>3</b> (cyan), and DAMA colchicine (red) in the colchicine site of tubulin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101010n&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While this work was in progress, studies describing a series of quinazolines<a onclick="showRef(event, 'ref51 ref52 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref51 ref52 ref53 ref54">(51-54)</a> and thieno[3,2-<i>d</i>]pyrimidines<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> as potent apoptosis inducers were published. These reports suggest a similar function for the <i>N-</i>CH<sub>3</sub> moiety, but do not provide molecular details about the binding modes of the quinazolines and/or thieno[3,2-<i>d</i>]pyrimidines to tubulin.</div><div class="NLM_p">Molecular modeling suggests that the binding interactions afforded by the 4′-OCH<sub>3</sub> group on the anilino ring play an important part and dictate the potency of these compounds against tubulin, since deletion or moving the 4′-OCH<sub>3</sub> moiety results in a significant loss of activity. However, molecular modeling does not provide a reason(s) for the loss of potency of (±)-<b>6</b> (2′-OCH<sub>3</sub>) compared with (±)-<b>3</b>. We speculate that the loss of potency could be explained by the loss of interactions of the 4′-OCH<sub>3</sub> moiety of (±)-<b>3</b> and/or the additional conformational restriction of the anilino ring by a combination of <i>N</i>-methylation and the 2′-OCH<sub>3</sub> moiety on the phenyl ring or both.</div><div class="NLM_p">The docking mode of <b>1</b> (not shown) was strikingly similar to the docking mode of (<i>R</i>)-<b>3</b>. The pyrrole NH of <b>1</b> was not involved in a hydrogen bond with the amino acid residues of the tubulin binding site. Additionally, <b>1</b> lacks the 6-CH<sub>3</sub> substitution in (<i>R</i>)-<b>3</b> and could thus lack the additional bonding afforded by the substituent at C6. The docked pose of <b>1</b> had a score of −6.0330 kcal/mol, somewhat less but comparable to that of (<i>R</i>)- and (<i>S</i>)-<b>3</b>.</div><div class="NLM_p">We also compared the binding mode of compounds <b>1</b>−<b>7</b> to the proposed binding modes<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> of 15 known tubulin inhibitors. As an example, (<i>R</i>)-<b>3</b> retains the key binding interactions exhibited by the known tubulin inhibitors and is in a conformation consistent with those for the reported compounds<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>). Similar docked poses were observed in this study for compounds <b>1</b>−<b>7</b>.</div><figure id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/medium/jm-2010-01010n_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0011.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Stereo view. Docking mode of (<i>R</i>)-<b>3</b> (white) overlaid with docked poses of 15 ligands<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (blue) in the colchicine site of tubulin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101010n&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In summary, we report the synthesis and identification of the mechanism of action of water-soluble, colchicine site microtubule depolymerizing agents <b>1</b> and (±)-<b>3</b>·HCl. These compounds inhibit the growth of tumor cells with GI<sub>50</sub> values in the nanomolar range and overcome two clinically important tumor resistance mechanisms that limit activity of microtubule targeting agents, expression of Pgp and βIII tubulin. For these analogues, the 6-CH<sub>3</sub> cyclopenta[<i>d</i>]pyrimidine scaffold is better than the pyrrolo[2,3-<i>d</i>]pyrimidine scaffold, and both the 4-<i>N</i>-methyl and 4′-OCH<sub>3</sub> groups on the aniline ring are required for optimal potency. We have also provided an explanation of the importance of the <i>N</i>-CH<sub>3</sub> moiety of <b>1</b> and (±)-<b>3</b>·HCl for biological activity via molecular modeling. Compounds <b>1</b> and (±)-<b>3</b>·HCl are important lead analogues for the development of further compounds for in vivo evaluation and possible advancement into clinical trials.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43084" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43084" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Analytical samples were dried in vacuo (0.2 mmHg) in a CHEM-DRY drying apparatus over P<sub>2</sub>O<sub>5</sub> at 50 °C. Melting points were determined on a digital MEL-TEMP II melting point apparatus with a FLUKE 51 K/J electronic thermometer, and are uncorrected. Nuclear magnetic resonance spectra for proton (<sup>1</sup>H NMR) were recorded on Bruker Avance II 400 (400 MHz) and 500 (500 MHz) NMR systems. The chemical shift values are expressed in ppm (parts per million) relative to tetramethylsilane as an internal standard: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad singlet. Thin-layer chromatography (TLC) was performed on Whatman Sil G/UV254 silica gel plates with a fluorescent indicator, and the spots were visualized under 254 and 366 nm illumination. Proportions of solvents used for TLC are by volume. Column chromatography was performed on a 230−400 mesh silica gel (Fisher Scientific) column. Elemental analyses were performed by Atlantic Microlab, Inc., Norcross, GA. Element compositions are within ±0.4% of the calculated values and indicate >95% purity. Fractional moles of water or organic solvents frequently found in some analytical samples could not be prevented despite 24−48 h of drying in vacuo and were confirmed where possible by their presence in the <sup>1</sup>H NMR spectra. Mass spectrum data were acquired on the Agilent G6220AA TOF LC/MS system using the nano ESI (Agilent chip tube system with infusion chip). All solvents and chemicals were purchased from Sigma-Aldrich Co. or Fisher Scientific Inc. and were used as received.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 2-Methyl-3<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4(7<i>H</i>)-one (10)</h3><div class="NLM_p last">The synthesis of <b>10</b> utilized a reported method.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> To a solution of ethyl 2-cyanoacetate <b>8</b> (10 mmol, 1.13 g) in anhydrous dimethylformamide (DMF, 20 mL) was added sodium methoxide (10 mmol, 0.54 g). After stirring for 30 min, 2-bromo-1,1-diethoxyethane (10 mmol, 1.97 g) was added, and the reaction was heated at 90 °C for 4 h. After cooling to room temperature, the reaction solution was extracted with diethyl ether (2 × 20 mL). The ether layer was collected, dried over sodium sulfate, and evaporated to give a pale yellow liquid. The liquid was added to a solution of acetamidine hydrochloride <b>9</b> (10 mmol, 0.94 g) and sodium ethoxide (10 mmol, 0.68 g) in ethanol (20 mL) and refluxed for 3 h. The solution was evaporated to dryness and extracted with ethyl acetate and water. The organic layer was collected and evaporated to afford a solid. Concentrated sulfuric acid (2 mL) in ethanol (10 mL) was added to the solid, and the mixture was kept at reflux for 2 h. At the end of the reaction, water (10 mL) was added and the pH was adjusted to 8 using ammonium hydroxide. The precipitate obtained was collected and dried to give <b>10</b> as an off-white powder (0.85 g). Compound <b>10</b> was used without further purification.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 4-Chloro-2-methyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (11)</h3><div class="NLM_p last">Compound <b>10</b> (5 mmol, 0.75 g) was treated with POCl<sub>3</sub> (10 mL) and heated under reflux for 3 h, and the remaining POCl<sub>3</sub> was removed in vacuo. Ammonium hydroxide was carefully added to the resulting slurry, followed by extraction with ethyl acetate. After combining the organic phases and evaporation, compound <b>11</b> was obtained as a pale yellow powder (0.67 g, 81%) and used without further purification. <i>R</i><sub>f</sub> 0.45 (CH<sub>3</sub>OH:CHCl<sub>3</sub> = 1:5). An analytical sample was purified for <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 2.28 (s, 3 H, 2-CH<sub>3</sub>), 6.35 (d, 1 H, 5-H, <i>J</i> = 3.28 Hz), 6.93 (d, 1 H, 6-H, <i>J</i> = 3.28 Hz), 11.67 (s, 1 H, 7H, D<sub>2</sub>O exchanged).</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> <i>N</i>-(4-Methoxyphenyl)-<i>N</i>,2-dimethyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-amine (1)</h3><div class="NLM_p last">To a solution of compound <b>11</b> (5 mmol, 0.84 g) in isopropanol (4 mL) was added 4-methoxy-<i>N</i>-methylaniline <b>12</b> (5.5 mmol, 0.75 g) and a drop of conc. HCl. The reaction mixture was refluxed for 4 h. After evaporation of the solvents, a silica gel plug (2 g) was made and loaded to a silica gel column. The column was eluted sequentially with 0% and 1% methanol in chloroform. Fractions containing the product (TLC) were pooled and evaporated to afford <b>1</b> as a white solid (1.14 g, 85%). <i>R</i><sub>f</sub> 0.60 (CH<sub>3</sub>OH:CHCl<sub>3</sub> = 1:5); mp, 229.3−229.5 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 2.45 (s, 3 H, 2-CH<sub>3</sub>), 3.45 (s, 3 H, NCH<sub>3</sub>), 3.82 (s, 3 H, OCH<sub>3</sub>), 4.52 (d, 1 H, 5-H, <i>J</i> = 3.50 Hz), 6.73 (d, 1 H, 6-H, <i>J</i> = 3.55 Hz), 7.04 (d, 2 H, phenyl, <i>J</i> = 8.85 Hz), 7.27 (d, 2 H, phenyl, <i>J</i> = 8.85 Hz), 11.27 (s, 1 H, 7-H, D<sub>2</sub>O exchanged). HRMS <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>17</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 269.1397; found, 269.1385 [M + H]<sup>+</sup>. Anal. (C<sub>15</sub>H<sub>16</sub>N<sub>4</sub>O) C, H, N.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>N</i>-(4-Methoxyphenyl)-<i>N</i>,2-dimethyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-amine·HCl (1·HCl)</h3><div class="NLM_p last">The HCl salt of <b>1</b> was obtained by treating its ether/ethyl acetate solution with HCl gas in an ice bath for 5 min. The white salt as it formed precipitated from the solution. The salt was collected and dried to give a white solid; mp 247.5−249.7 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 2.64 (s, 3 H, 2-CH<sub>3</sub>), 3.62 (s, 3 H, NCH<sub>3</sub>), 3.81 (s, 3 H, OCH<sub>3</sub>), 4.59 (s, 1 H, 5-H), 7.00 (s, 1 H, 6-H), 7.12 (d, 2 H, phenyl, <i>J</i> = 8.45 Hz), 7.41 (d, 2 H, phenyl, <i>J</i> = 8.30), 12.32 (s, 1 H, 7-H, D<sub>2</sub>O exchanged). Anal. (C<sub>15</sub>H<sub>16</sub>N<sub>4</sub>O) C, H, N.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> <i>N</i>-(4-Methoxyphenyl)-2-methyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-amine (2)</h3><div class="NLM_p last">The synthesis of <b>2</b> followed the same method as for <b>1</b> using <b>11</b> (5 mmol, 0.84 g) and 4-methoxy-<i>N</i>-methylaniline <b>12</b> (5.5 mmol, 0.68 g). After column chromatography with 0% and 1% methanol in chloroform, fractions containing the product (TLC) were pooled and evaporated to afford <b>2</b> as a white solid (0.95 g, 75%). <i>R</i><sub>f</sub> 0.42 (CH<sub>3</sub>OH:CHCl<sub>3</sub> = 1:5); mp, 258.7−259.9 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 2.42 (s, 3 H, 2-CH<sub>3</sub>), 3.73 (s, 3 H, OCH<sub>3</sub>), 6.55 (d, 1 H, 5-H, <i>J</i> = 3.24 Hz), 6.91 (d, 2 H, phenyl, <i>J</i> = 8.96 Hz), 7.05 (d, 1 H, 6-H, <i>J</i> = 3.44 Hz), 7.74 (d, 2 H, phenyl, <i>J</i> = 8.92 Hz), 9.02 (s, 1H, N−H), 11.41 (s, 1 H, 7-H, D<sub>2</sub>O exchanged). HRMS <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>15</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 255.1240; found, 255.1234 [M + H]<sup>+</sup>. Anal. (C<sub>14</sub>H<sub>14</sub>N<sub>4</sub>O) C, H, N.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2,6-Dimethyl-6,7-dihydro-3<i>H</i>-cyclopenta[<i>d</i>]pyrimidin-4(5<i>H</i>)-one ((±)-14)</h3><div class="NLM_p last">3-Methyladipic acid (±)-<b>13</b> (1.60 g, 10 mmol) was heated at reflux in ethanol/conc. sulfuric acid solution (35 mL, v/v = 2.5/1) for 8 h. The solution was neutralized with ammonium hydroxide to pH = 7 and then diluted with ethyl acetate (100 mL) and washed with water. The organic phase was dried with anhydrous sodium sulfate and evaporated to afford a light yellow liquid which was used in the next step without further purification. The yellow liquid was dissolved in anhydrous toluene (100 mL), and sodium (0.23 g) was added to the solution. The mixture was heated at reflux for 3 h and cooled, neutralized with 1 N hydrochloric acid solution, and washed with water. After drying with anhydrous sodium sulfate, the organic phase was separated and evaporated to afford a light brown liquid. The liquid was used in the next step without further purification. The light brown liquid was diluted with <i>t</i>-BuOH. Acetamidine hydrochloride (1.13 g, 12 mmol) and potassium <i>tert</i>-butoxide (1.34 g, 12 mmol) were added, and the mixture was heated at reflux overnight. The reaction mixture was cooled, and the precipitate was collected by filtration. The residue was washed with warm methanol twice (30 mL × 1, 15 mL × 1). The filtrate and washings were combined, and then 3 g of silica gel was added and removed the solvent in vacuo to afford a dry plug. This plug was placed on the top of a silica gel column and eluted with 1% methanol in chloroform. Fractions containing the product were pooled and evaporated to afford 0.35 g of (±)-<b>14</b> (21% yield total for three steps) as a white solid. TLC <i>R</i><sub>f</sub> 0.30 (CHCl<sub>3</sub>/CH<sub>3</sub>OH, 10:1); mp 173.9−175.4 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.05−1.07 (d, 3 H, CH<sub>3</sub>, <i>J</i> = 6.8 Hz), 2.24 (s, 3 H, CH<sub>3</sub>), 2.13−2.34, 2.73−2.90 (m, 5 H, CH<sub>2</sub>CHCH<sub>2</sub>), 12.16 (br, 1 H, OH, exchanged). Anal. (C<sub>9</sub>H<sub>12</sub>N<sub>2</sub>O) C, H, N.</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 4-Chloro-2,6-dimethyl-6,7-dihydro-5<i>H</i>-cyclopenta[<i>d</i>]pyrimidine ((±)-15)</h3><div class="NLM_p last">A mixture of (±)-<b>14</b> (0.25 g, 1.5 mmol) and POCl<sub>3</sub> (10 mL) was heated at reflux for 3 h. The reaction mixture was cooled and evaporated at reduced pressure. The residue was diluted with chloroform (50 mL) and neutralized with ammonium hydroxide slowly in an ice bath. The organic portion was washed with water (3 × 30 mL) and dried with anhydrous sodium sulfate. Concentration of the organic solvent with 1 g of silica gel afforded a dry plug. This plug was placed on the top of a silica gel column and eluted with 20% hexane in chloroform. Fractions containing the product were pooled and evaporated to afford 0.14 g of (±)-<b>15</b> as a colorless liquid (69%). Compound (±)-<b>15</b> was unstable and was used for the next step without further characterization.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Procedure for (±)-3−(±)-7</h3><div class="NLM_p last">Compound (±)-<b>15</b> and aniline or the appropriate substituted <i>N</i>-methyl anilines were dissolved in isopropanol (5 mL). To this solution was added 37% hydrochloric acid (2−3 drops). The mixture was heated at reflux for 3−6 h. Then the reaction was cooled and evaporated at reduced pressure. The residue was diluted with chloroform, neutralized with ammonium hydroxide, and then washed with water (2 × 30 mL). After drying with anhydrous sodium sulfate, organic solvent with 1 g of silica gel was evaporated under reduced pressure to give a dry plug. This plug was placed on the top of a silica gel column and eluted with chloroform. Fractions containing the product were pooled and evaporated to afford pure compounds (±)-<b>3</b>−(±)-<b>7</b>. Compounds were dissolved in anhydrous ether (10 mL), and then anhydrous hydrochloric acid gas was bubbled into the solution until no more solid precipitated out. The white solid was collected by filtration and dried over P<sub>2</sub>O<sub>5</sub> to afford (±)-<b>3</b>·HCl, (±)-<b>5</b>·HCl−(±)-<b>7</b>·HCl.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>-(4-Methoxyphenyl)-<i>N</i>,2,6-trimethyl-6,7-dihydro-5<i>H</i>-cyclopenta[<i>d</i>]pyrimidin-4-aminium chloride ((±)-3·HCl)</h3><div class="NLM_p last">Compound (±)-<b>3</b> was synthesized from (±)-<b>15</b> (0.19 g, 1.01 mmol) and 4-methoxy-<i>N</i>-methyl aniline (0.17 mg, 1.22 mmol) using the general procedure described above to afford after purification 0.18 g (61%) as a light yellow liquid. TLC <i>R</i><sub>f</sub> 0.24 (CHCl<sub>3</sub>/CH<sub>3</sub>OH, 10:1). Compound (±)-<b>3</b>·HCl was synthesized from (±)-<b>3</b> as a white solid (0.16 g, 79%); mp 196−198 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 0.85−0.86 (d, 3 H, CH<sub>3</sub>, <i>J</i> = 6.8 Hz), 1.37−1.47 (m, 1 H, CH), 1.89−1.99 (m, 1 H, CH), 2.26−2.35 (m, 1 H, CH), 2.43−2.44 (m, 1 H, CH), 2.98−3.05 (m, 1 H, CH), 2.60 (s, 3 H, 2-CH<sub>3</sub>), 3.51 (s, 3 H, NCH<sub>3</sub>), 3.80 (s, 3 H, OCH<sub>3</sub>), 7.01−7.03 (d, 2 H, Ph-H, <i>J</i> = 8.8 Hz), 7.33−7.35 (d, 2 H, Ph-H, <i>J</i> = 8.8 Hz), 14.88 (br, 1 H, HCl, exch). Anal. (C<sub>17</sub>H<sub>22</sub>N<sub>3</sub>OCl) C, H, N, Cl.</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>N</i>-(4-Methoxyphenyl)-2,6-dimethyl-6,7-dihydro-5<i>H</i>-cyclopenta[<i>d</i>]pyrimidin-4-amine ((±)-4)</h3><div class="NLM_p last">Compound (±)-<b>4</b> was synthesized from (±)-<b>15</b> (0.17 g, 0.94 mmol) and 4-methoxyaniline (0.14 g, 1.13 mmol) using the general procedure described above to afford after purification 0.16 g (61%) as a white solid. TLC <i>R</i><sub>f</sub> 0.32 (CHCl<sub>3</sub>/CH<sub>3</sub>OH, 10:1); mp 130.5−131.3 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.09−1.12 (d, 3 H, CH<sub>3</sub>, <i>J</i> = 6.8 Hz), 2.35 (s, 3 H, 2-CH<sub>3</sub>), 1.36−1.48 (m, 1 H, CH), 1.88−2.01 (m, 1 H, CH), 2.25−2.35 (m, 1 H, CH), 2.41−2.45 (m, 1 H, CH), 2.98−3.05 (m, 1 H, CH), 3.73 (s, 3 H, OCH<sub>3</sub>), 6.86−6.89 (d, 2 H, Ph-H, <i>J</i> = 8.8 Hz), 7.60−7.63 (d, 2 H, Ph-H, <i>J</i> = 8.8 Hz), 8.41 (br, 1 H, NH, exchanged). Anal. (C<sub>16</sub>H<sub>19</sub>N<sub>3</sub>O) C, H, N.</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>N</i>-(3-Methoxyphenyl)-<i>N</i>,2,6-trimethyl-6,7-dihydro-5<i>H</i>-cyclopenta[<i>d</i>]pyrimidin-4-aminium chloride ((±)-5·HCl)</h3><div class="NLM_p last">Compound (±)-<b>5</b> was synthesized from (±)-<b>15</b> (0.23 g, 1.3 mmol) and 3-methoxy-<i>N</i>-methylaniline (0.20 g, 1.4 mmol) using the general procedure described above to afford after purification as a light yellow liquid. TLC <i>R</i><sub>f</sub> 0.33 (CHCl<sub>3</sub>/CH<sub>3</sub>OH, 10:1). Compound (±)-<b>5</b>·HCl was synthesized from (±)-<b>5</b> as an off white solid (0.27 g, 66% for two steps); mp 209.6−210.7 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 0.85−0.87 (d, 3 H, CH<sub>3</sub>, <i>J</i> = 6.8 Hz), 1.44−1.50 (m, 1 H, CH), 1.95−2.01 (m, 1 H, CH), 2.26−2.35 (m, 1 H, CH), 2.45−2.48 (m, 1 H, CH), 3.00−3.07 (m, 1 H, CH), 2.62 (s, 3 H, 2-CH<sub>3</sub>), 3.55 (s, 3 H, NCH<sub>3</sub>), 3.78 (s, 3 H, OCH<sub>3</sub>), 6.69−7.42 (m, 4 H, Ph-H), 15.21 (br, 1 H, HCl, exchanged). Anal. (C<sub>17</sub>H<sub>22</sub>N<sub>3</sub>OCl· 0.1H<sub>2</sub>O) C, H, N, Cl.</div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>N</i>-(2-Methoxyphenyl)-<i>N</i>,2,6-trimethyl-6,7-dihydro-5<i>H</i>-cyclopenta[<i>d</i>]pyrimidin-4-aminium chloride ((±)-6·HCl)</h3><div class="NLM_p last">Compound (±)-<b>6</b> was synthesized from (±)-<b>15</b> (0.24 g, 1.31 mmol) and 2-methoxy-<i>N</i>-methylaniline (0.18 g, 1.31 mmol) using the general procedure described above to afford after purification as a colorless liquid. <i>R</i><sub><i>f</i></sub> 0.37 (CHCl<sub>3</sub>/CH<sub>3</sub>OH, 10:1). Compound (±)-<b>6</b>·HCl was synthesized from (±)-<b>6</b> as a white solid (0.23 g, 55% for two steps); mp 148−149 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 0.83−0.85 (d, 3 H, CH<sub>3</sub>, <i>J</i> = 6.8 Hz), 1.31−1.39 (m, 1 H, CH), 1.82−1.93 (m, 1 H, CH), 2.26−2.31 (m, 1 H, CH), 2.43−2.46 (m, 1 H, CH), 2.99−3.07 (m, 1 H, CH), 2.62 (s, 3 H, 2-CH<sub>3</sub>), 3.45 (s, 3 H, NCH<sub>3</sub>), 3.79 (s, 3 H, OCH<sub>3</sub>), 7.03−7.51 (m, 4 H, Ph-H), 15.09 (br, 1 H, HCl, exchanged). Anal. (C<sub>17</sub>H<sub>22</sub>N<sub>3</sub>OCl·0.1H<sub>2</sub>O) C, H, N, Cl.</div></div><div id="sec3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-Phenyl-<i>N</i>,2,6-trimethyl-6,7-dihydro-5<i>H</i>-cyclopenta[<i>d</i>]pyrimidin-4-aminium chloride ((±)-7·HCl)</h3><div class="NLM_p last">Compound (±)-<b>7</b> was synthesized from (±)-<b>15</b> (0.18 g, 0.99 mmol) and <i>N</i>-methylaniline (0.11 g, 0.99 mmol) using the general procedure described above to afford after purification 0.21 g (83%) as a white solid. <i>R</i><sub>f</sub> 0.36 (CHCl<sub>3</sub>/CH<sub>3</sub>OH, 10:1); mp 112.6−113.2 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 0.81−0.83 (d, 3 H, CH<sub>3</sub>), 1.40−1.44, 1.86−2.26, 2.74−2.80 (m, 5 H, CH<sub>2</sub>CHCH<sub>2</sub>), 2.41 (s, 3 H, 2-CH<sub>3</sub>), 3.37 (s, 3 H, NCH<sub>3</sub>), 7.18−7.41 (m, 4 H, Ph-H). Anal. (C<sub>16</sub>H<sub>19</sub>N<sub>3</sub>) C, H, N. Compound (±)-<b>7</b>·HCl was synthesized from (±)-<b>7</b> (0.17 g, 0.65 mmol) as a white solid (0.15 g, 79%); mp 263.2−264.6 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 0.83−0.85 (d, 3 H, CH<sub>3</sub>, <i>J</i> = 6.8 Hz), 1.35−1.42 (m, 1 H, CH), 1.81−1.91 (m, 1 H, CH), 2.24−2.32 (m, 1 H, CH), 2.42−2.45 (m, 1 H, CH), 2.99−3.05 (m, 1 H, CH), 2.61 (s, 3 H, 2-CH<sub>3</sub>), 3.55 (s, 3 H, NCH<sub>3</sub>), 7.41−7.53 (m, 4 H, Ph-H), 15.09 (br, 1 H, HCl, exch). Anal. (C<sub>16</sub>H<sub>20</sub>ClN<sub>3</sub>) C, H, N, Cl.</div></div><div id="sec3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Molecular Modeling and Computational Studies</h3><div class="NLM_p last">The X-ray crystal structure of tubulin at 3.58 Å resolution was obtained from the protein database (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SA0">1SA0</a><a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a>). This crystal structure contains the αβ dimers of tubulin complexed with <i>N</i>-deacetyl-<i>N</i>-(2-mercaptoacetyl) colchicine (DAMA colchicine), a close structural analogue of colchicine.</div></div><div id="sec3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Docking Procedure</h3><div class="NLM_p">Docking studies were performed using the docking suite of Molecular Operating Environment software (MOE 2008.10).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The PDB file was downloaded (<a href="http://www.pdb.org" class="extLink">www.pdb.org</a>) and imported into MOE. The A and B subunits of the protein, along with the crystallized ligand, were retained, while the C, D, and E subunits, GTP, GDP, and Mg ions were deleted. After addition of hydrogen atoms, the protein was then “prepared” using the LigX function in MOE. LigX is a graphical interface and collection of procedures for conducting interactive ligand modification and energy minimization in the active site of a flexible receptor. In LigX calculations, the receptor atoms far from the ligand are held fixed (constrained not to move) while receptor atoms near the ligand (in the active site) are allowed to move but are subject to tether restraints that discourage gross movement. The procedure was performed with the default settings.</div><div class="NLM_p">Ligands were built using the molecule builder function in MOE and were energy minimized to its local minima using the MMF94X forcefield to a constant (0.05 kcal/mol).</div><div class="NLM_p">Ligands were docked into the active site of the prepared protein using the docking suite as implemented in MOE. The docking was restricted to the active site pocket residues using the Alpha triangle placement method. Refinement of the docked poses was carried out using the Forcefield refinement scheme and scored using the Affinity dG scoring system. Around 30 poses were returned for each compound at the end of each docking run. The docked poses were manually examined in the binding pocket to ensure quality of docking and to confirm absence of steric clashes with the amino acid residues of the binding pocket.</div><div class="NLM_p">To validate the utility of MOE 2008.10 for docking ligands into the active site, DAMA colchicine, the native ligand in the crystal structure (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SA0">1SA0</a>), was built using the molecule builder, energy minimized, and docked into the active site using the above parameters. The best docked pose of DAMA colchicine displayed an rmsd of 0.9531 Å compared with the crystal structure pose of DAMA colchicine. MOE 2008.10 was thus validated for our docking studies. Docking studies of the lead compounds and selected proposed molecules were performed using the same procedure.</div><div class="NLM_p last">Coordinates of the binding models of the 15 known tubulin inhibitors reported by Nguyen et al.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> were retrieved from the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. The coordinates as well as the docked pose of (<i>R</i>)-<b>3</b> were imported and visualized using MOE 2008.10. A systematic conformational search was carried out using Sybyl X 1.1<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> using 5° increments. Molecules were built using the molecule builder function in MOE 2008.10 and were imported into Sybyl X 1.1 and energy minimized using the Tripos forcefield with a distance-dependent dielecetric and the Powell conjugate gradient with a convergence criterion of 0.01 kcal/mol.</div></div><div id="sec3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Cellular Studies</h3><div id="sec3_16_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Effects of Compounds on Cellular Microtubules</h4><div class="NLM_p last">A-10 cells were used to evaluate the effects of the compounds on interphase and mitotic microtubules using indirect immunofluorescence techniques, and the EC<sub>50</sub> values were calculated from a minimum of three experiments as described previously.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div></div><div id="sec3_16_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Sulforhodamine B (SRB) Assay</h4><div class="NLM_p last">The SRB assay<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> was used to evaluate the antiproliferative and cytotoxic effects of the compounds against cancer cells as previously described.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> MDA-MB-435 cells were obtained from the Lombardi Cancer Institute (Washington D.C.).  SK-OV-3 and HeLa cells were purchased from the American Type Culture Collection (Manassas,  VA). The methods used to generate and characterize the SK-OV-3 MDR-1-6/6 and WTβIII cell lines have been described.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The IC<sub>50</sub> represents the mean of at least three independent experiments using triplicate points in each experiment.</div></div><div id="sec3_16_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> In Vitro Tubulin Polymerization</h4><div class="NLM_p last">Inhibition of tubulin polymerization was measured using the tubulin polymerization assay kit (Cytoskeleton Inc.) according to manufacturer’s directions. Briefly, 300 μg of purified bovine brain tubulin was incubated with tubulin assembly buffer (80 mM Na-Pipes, pH 6.9, 1 mM EGTA, 1 mM MgCl<sub>2</sub>, 10 mM GTP, and 10% glycerol) and the indicated drug in a final volume of 100 μL. The polymerization of purified tubulin into microtubules was monitored by absorbance at 340 nm at 37 °C in a Spectromax Plus 96-well plate spectrophotometer (Molecular Devices).</div></div><div id="sec3_16_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Cell Cycle Analysis</h4><div class="NLM_p last">MDA-MB-435 cells were treated for 24 h with vehicle, <b>1</b>, or (±)-<b>3·HCl</b> or 12.5 nM paclitaxel as a positive control. Following drug treatment, the cells were harvested and stained with Krishan’s reagent and analyzed using a FacsCalibur flow cytometer. The data are plotted as propidium iodide intensity versus the number of events.</div></div><div id="sec3_16_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Quantitative Tubulin Studies</h4><div class="NLM_p last">Bovine brain tubulin was purified as described previously.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The assembly reaction mixtures contained 1.0 mg/mL (10 μM) tubulin, 0.8 M monosodium glutamate (pH of 2 M stock solution adjusted to pH 6.6 with HCl), 4% (v/v) dimethyl sulfoxide as compound solvent, varying compound concentrations, and, after a 15 min preincubation at 30 °C, 0.4 mM GTP. The 0 °C reaction mixtures were transferred to 0 °C cuvettes in a recording spectrophotometer equipped with an electronic temperature controller. After baselines were established, the temperature was jumped to 30 °C over about 30 s, and changes in turbidity were measured over 20 min. The compound concentration that caused a 50% reduction in increase in turbidity, interpolated from the values obtained with defined compound concentrations, was defined as the IC<sub>50</sub> value.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> The assay to measure inhibition of [<sup>3</sup>H]colchicine binding was described in detail previously.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Reaction mixtures contained 0.1 mg/mL (1.0 μM) tubulin, 5.0 μM [<sup>3</sup>H]colchicine, and potential inhibitors at 1.0 or 5.0 μM, as indicated. Incubation was for 10 min at 37 °C, at which point the reaction has reached 40−60% of the maximum colchicine that can be bound in reaction mixtures without inhibitor. The [<sup>3</sup>H]colchicine was a product of Perkin-Elmer. CA4 was a generous gift of Dr. G. R. Pettit, Arizona State University.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39"><a href="/doi/suppl/10.1021/jm101010n">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81142" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81142" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Results from elemental analysis: high resolution mass spectra (HRMS) (EI); high resolution mass spectra (HRMS) (ESI); and representation of cell cycle distribution data (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm101010n/suppl_file/jm101010n_si_001.pdf">jm101010n_si_001.pdf (39.57 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm101010n" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88567" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88567" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aleem Gangjee</span> - <span class="hlFld-Affiliation affiliation">Division of Medicinal Chemistry, Graduate School of Pharmaceutical Sciences, Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c0a7a1aea7aaa5a580a4b5b1eea5a4b5e0adafafa2a5b2b2b980b5b4a8b3a3b3a1eea5a4b5"><span class="__cf_email__" data-cfemail="accbcdc2cbc6c9c9ecc8d9dd82c9c8d9">[email protected]</span> <span class="__cf_email__" data-cfemail="127f7d7d707760606b5267667a617161733c777667">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan L. Mooberry</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, Texas 78229, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#82e5e3ece5e8e7e7c2e6f7f3ace7e6f7a2efedede0e7f0f0fbc2f7f6eaf1e1f1e3ace7e6f7"><span class="__cf_email__" data-cfemail="90f7f1fef7faf5f5d0f4e5e1bef5f4e5">[email protected]</span> <span class="__cf_email__" data-cfemail="d1bcbebeb3b4a3a3a891a4a5b9a2b2a2b0ffb4b5a4">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ying Zhao</span> - <span class="hlFld-Affiliation affiliation">Division of Medicinal Chemistry, Graduate School of Pharmaceutical Sciences, Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lu Lin</span> - <span class="hlFld-Affiliation affiliation">Division of Medicinal Chemistry, Graduate School of Pharmaceutical Sciences, Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sudhir Raghavan</span> - <span class="hlFld-Affiliation affiliation">Division of Medicinal Chemistry, Graduate School of Pharmaceutical Sciences, Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth G. Roberts</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, Texas 78229, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">April L. Risinger</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, Texas 78229, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ernest Hamel</span> - <span class="hlFld-Affiliation affiliation">Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61442" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61442" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported, in part, by the National Institutes of Health and National Cancer Institute Grant CA098850 (AG). We thank Desiree LeBouf and Cara Westbrook for excellent technical assistance. A.L.R. was supported by a Cowles Fellowship, and support from the CTRC Cancer Center Support Grant, CCSG (CA054174) (S.L.M.) is acknowledged.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28667" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28667" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 59 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Jordan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L.</span><span> </span><span class="NLM_article-title">Microtubules as a Target for Anticancer Drugs</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1038%2Fnrc1317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=15057285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1Gmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=253-265&author=M.+A.+Jordanauthor=L.+Wilson&title=Microtubules+as+a+Target+for+Anticancer+Drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubules as a target for anticancer drugs</span></div><div class="casAuthors">Jordan, Mary Ann; Wilson, Leslie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">253-265</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Highly dynamic mitotic-spindle microtubules are among the most successful targets for anticancer therapy.  Microtubule-targeted drugs, including paclitaxel and Vinca alkaloids, were previously considered to work primarily by increasing or decreasing the cellular microtubule mass.  Although these effects might have a role in their chemotherapeutic actions, we now know that at lower concns., microtubule-targeted drugs can suppress microtubule dynamics without changing microtubule mass; this action leads to mitotic block and apoptosis.  In addn. to the expanding array of chem. diverse antimitotic agents, some microtubule-targeted drugs can act as vascular-targeting agents, rapidly depolymg. microtubules of newly formed vasculature to shut down the blood supply to tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRJbrFnzwqjbVg90H21EOLACvtfcHk0lhz7qXDgqrK_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1Gmt74%253D&md5=bbbf212e03ffe6763098fc41f21a8158</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc1317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1317%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DM.%2BA.%26aulast%3DWilson%26aufirst%3DL.%26atitle%3DMicrotubules%2520as%2520a%2520Target%2520for%2520Anticancer%2520Drugs%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D253%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Jordan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, K.</span><span> </span><span class="NLM_article-title">How do Microtubule-Targeted Drugs Work? An Overview</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">730</span><span class="NLM_x">–</span> <span class="NLM_lpage">742</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.2174%2F156800907783220417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=18220533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFOnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=730-742&author=M.+A.+Jordanauthor=K.+Kamath&title=How+do+Microtubule-Targeted+Drugs+Work%3F+An+Overview"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">How do microtubule-targeted drugs work? An overview</span></div><div class="casAuthors">Jordan, Mary Ann; Kamath, Kathy</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">730-742</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The importance of microtubules in mitosis makes them a superb target for a group of highly successful, chem. diverse anticancer drugs.  Knowledge of the mechanistic differences among the many drugs of this class is vital to understanding their tissue and cell specificity, the development of resistance, the design of novel improved drugs, optimal scheduling of treatment, and potential synergistic combinations.  This overview covers microtubule assembly dynamics, the exquisite regulation of microtubule dynamics in cells by endogenous regulators, the important role of microtubule dynamics in mitosis, the diversity and no. of microtubule-targeted drugs undergoing clin. development, the antimitotic mechanisms of microtubule-targeted drugs with emphasis on suppression of microtubule dynamics by vinblastine and taxol, the role of drug uptake and retention in the efficacy of microtubule-targeted drugs, and the anti-angiogenic and vascular-disrupting mechanisms of microtubule targeted drugs.  In view of the success of this class of drugs, it has been argued that microtubules represent the single best cancer target identified to date, and it seems likely that drugs in this class will continue to remain an important chemotherapeutic class of drugs even as more selective chemotherapeutic approaches are developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrblMjKhFIo0rVg90H21EOLACvtfcHk0lj4jXKgsDXb8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFOnsbg%253D&md5=58b841471750af2499f766da0ea5e0d6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F156800907783220417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800907783220417%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DM.%2BA.%26aulast%3DKamath%26aufirst%3DK.%26atitle%3DHow%2520do%2520Microtubule-Targeted%2520Drugs%2520Work%253F%2520An%2520Overview%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2007%26volume%3D7%26spage%3D730%26epage%3D742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Lee, J. F.; Harris, L. N.</span><span> </span><span class="NLM_article-title">Antimicrotubule Agents</span>. In  <span class="citation_source-book">Cancer: Principles & Practice of Oncology</span>, <span class="NLM_edition">8</span>th ed.; <span class="NLM_contrib-group">DeVita, V. T.,  Jr.; Lawrence, T. S.,; Rosenberg, S. A.</span>, Eds.; <span class="NLM_publisher-name">Lippincott Williams & Wilkins</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">447</span>− <span class="NLM_lpage">456</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=447-456&author=J.+F.+Lee&author=L.+N.+Harrisauthor=V.+T.+DeVita&author=T.+S.+Lawrence&author=S.+A.+Rosenberg&title=Cancer%3A+Principles+%26+Practice+of+Oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BF.%26atitle%3DAntimicrotubule%2520Agents%26btitle%3DCancer%253A%2520Principles%2520%2526%2520Practice%2520of%2520Oncology%26aulast%3DDeVita%26aufirst%3DV.%2BT.%26pub%3DLippincott%2520Williams%2520%2526%2520Wilkins%26date%3D2008%26spage%3D447%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Löwe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downing, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nogales, E.</span><span> </span><span class="NLM_article-title">Refined Structure of αβ-Tubulin at 3.5Å Resolution</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">1045</span><span class="NLM_x">–</span> <span class="NLM_lpage">1057</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2001&pages=1045-1057&author=J.+L%C3%B6weauthor=H.+Liauthor=K.+H.+Downingauthor=E.+Nogales&title=Refined+Structure+of+%CE%B1%CE%B2-Tubulin+at+3.5%C3%85+Resolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6we%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DDowning%26aufirst%3DK.%2BH.%26aulast%3DNogales%26aufirst%3DE.%26atitle%3DRefined%2520Structure%2520of%2520%25CE%25B1%25CE%25B2-Tubulin%2520at%25203.5%25C3%2585%2520Resolution%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2001%26volume%3D313%26spage%3D1045%26epage%3D1057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Huey, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barasoain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pineda, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edler, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerezo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderwal, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorensen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreu, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J. F.</span><span> </span><span class="NLM_article-title">Cyclostreptin Binds Covalently to Microtubule Pores and Lumenal Taxoid Binding Sites</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1038%2Fnchembio853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=17206139" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=117-125&author=R.+M.+Hueyauthor=E.+Calvoauthor=I.+Barasoainauthor=O.+Pinedaauthor=M.+C.+Edlerauthor=R.+Matesanzauthor=G.+Cerezoauthor=C.+D.+Vanderwalauthor=B.+W.+Dayauthor=E.+J.+Sorensenauthor=J.+A.+Lopezauthor=J.+M.+Andreuauthor=E.+Hamelauthor=J.+F.+Diaz&title=Cyclostreptin+Binds+Covalently+to+Microtubule+Pores+and+Lumenal+Taxoid+Binding+Sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnchembio853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio853%26sid%3Dliteratum%253Aachs%26aulast%3DHuey%26aufirst%3DR.%2BM.%26aulast%3DCalvo%26aufirst%3DE.%26aulast%3DBarasoain%26aufirst%3DI.%26aulast%3DPineda%26aufirst%3DO.%26aulast%3DEdler%26aufirst%3DM.%2BC.%26aulast%3DMatesanz%26aufirst%3DR.%26aulast%3DCerezo%26aufirst%3DG.%26aulast%3DVanderwal%26aufirst%3DC.%2BD.%26aulast%3DDay%26aufirst%3DB.%2BW.%26aulast%3DSorensen%26aufirst%3DE.%2BJ.%26aulast%3DLopez%26aufirst%3DJ.%2BA.%26aulast%3DAndreu%26aufirst%3DJ.%2BM.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DDiaz%26aufirst%3DJ.%2BF.%26atitle%3DCyclostreptin%2520Binds%2520Covalently%2520to%2520Microtubule%2520Pores%2520and%2520Lumenal%2520Taxoid%2520Binding%2520Sites%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2007%26volume%3D3%26spage%3D117%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Kanthou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozer, M. T.</span><span> </span><span class="NLM_article-title">Microtubule Depolymerizing Vascular Disrupting Agents: Novel Therapeutic Agents for Oncology and Other Pathologies</span> <span class="citation_source-journal">Int. J. Exp. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1111%2Fj.1365-2613.2009.00651.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=19563611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotV2isr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2009&pages=284-294&author=C.+Kanthouauthor=M.+T.+Tozer&title=Microtubule+Depolymerizing+Vascular+Disrupting+Agents%3A+Novel+Therapeutic+Agents+for+Oncology+and+Other+Pathologies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies</span></div><div class="casAuthors">Kanthou, Chryso; Tozer, Gillian M.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Experimental Pathology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">284-294</span>CODEN:
                <span class="NLM_cas:coden">IJEPEI</span>;
        ISSN:<span class="NLM_cas:issn">0959-9673</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Vascular disrupting agents (VDAs) are a relatively new group of "vascular targeting" agents that exhibit selective activity against established tumor vascular networks, causing severe interruption of tumor blood flow and necrosis to the tumor mass.  Microtubule depolymg. agents form by far the largest group of small mol. wt. VDAs many of which, including lead compd. disodium combretastatin A-4 3-O-phosphate (CA-4-P), are under clin. development for cancer.  Although distinct from the angiogenesis inhibitors, VDAs can also interfere with angiogenesis and therefore constitute a potential group of novel drugs for the treatment of pathol. conditions characterized by excessive angiogenesis, in addn. to cancer.  The endothelial cytoskeleton is the primary cellular target of this family of drugs, and some progress in understanding the mol. and signalling mechanisms assocd. with their endothelial disrupting activity has been made in the last few years.  Susceptibility of tumor vessels to VDA damage is ascribed to their immature pericyte-defective nature, although the exact mol. mechanisms involved have not been clearly defined.  Despite causing profound damage to tumors, VDAs fail to halt tumor growth unless used together with conventional treatments.  This failure is attributed to resistance mechanisms, primarily assocd. with cells that remain viable within the tumor rim, and enhanced angiogenesis.  The focus is now to understand mechanisms of susceptibility and resistance to identify novel mol. targets and develop strategies that are more effective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmpN7il32X0rVg90H21EOLACvtfcHk0lj4jXKgsDXb8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotV2isr4%253D&md5=42b728813bf9c53bbc6d32d262639d15</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2613.2009.00651.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2613.2009.00651.x%26sid%3Dliteratum%253Aachs%26aulast%3DKanthou%26aufirst%3DC.%26aulast%3DTozer%26aufirst%3DM.%2BT.%26atitle%3DMicrotubule%2520Depolymerizing%2520Vascular%2520Disrupting%2520Agents%253A%2520Novel%2520Therapeutic%2520Agents%2520for%2520Oncology%2520and%2520Other%2520Pathologies%26jtitle%3DInt.%2520J.%2520Exp.%2520Pathol.%26date%3D2009%26volume%3D90%26spage%3D284%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Carlson, R. O.</span><span> </span><span class="NLM_article-title">New Tubulin Targeting Agents Currently in Clinical Development</span> <span class="citation_source-journal">Expert Opin. Investig. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">707</span><span class="NLM_x">–</span> <span class="NLM_lpage">722</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=707-722&author=R.+O.+Carlson&title=New+Tubulin+Targeting+Agents+Currently+in+Clinical+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarlson%26aufirst%3DR.%2BO.%26atitle%3DNew%2520Tubulin%2520Targeting%2520Agents%2520Currently%2520in%2520Clinical%2520Development%26jtitle%3DExpert%2520Opin.%2520Investig.%2520Drugs%26date%3D2008%26volume%3D17%26spage%3D707%26epage%3D722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">O’Connor, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutoh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friend, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fornace, A. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, K. W.</span><span> </span><span class="NLM_article-title">Characterization of the p53 Tumor Suppressor Pathway in Cell Lines of the National Cancer Institute Anticancer Drug Screen and Correlations with the Growth-inhibitory Potency of 123 Anticancer Agents</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4285</span><span class="NLM_x">–</span> <span class="NLM_lpage">4300</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=4285-4300&author=P.+M.+O%E2%80%99Connorauthor=J.+Jackmanauthor=I.+Baeauthor=T.+G.+Myersauthor=S.+Fanauthor=M.+Mutohauthor=D.+A.+Scudieroauthor=A.+Monksauthor=E.+A.+Sausvilleauthor=J.+N.+Weinsteinauthor=S.+Friendauthor=A.+J.+Fornaceauthor=K.+W.+Kohn&title=Characterization+of+the+p53+Tumor+Suppressor+Pathway+in+Cell+Lines+of+the+National+Cancer+Institute+Anticancer+Drug+Screen+and+Correlations+with+the+Growth-inhibitory+Potency+of+123+Anticancer+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%2BM.%26aulast%3DJackman%26aufirst%3DJ.%26aulast%3DBae%26aufirst%3DI.%26aulast%3DMyers%26aufirst%3DT.%2BG.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DMutoh%26aufirst%3DM.%26aulast%3DScudiero%26aufirst%3DD.%2BA.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DWeinstein%26aufirst%3DJ.%2BN.%26aulast%3DFriend%26aufirst%3DS.%26aulast%3DFornace%26aufirst%3DA.%2BJ.%26aulast%3DKohn%26aufirst%3DK.%2BW.%26atitle%3DCharacterization%2520of%2520the%2520p53%2520Tumor%2520Suppressor%2520Pathway%2520in%2520Cell%2520Lines%2520of%2520the%2520National%2520Cancer%2520Institute%2520Anticancer%2520Drug%2520Screen%2520and%2520Correlations%2520with%2520the%2520Growth-inhibitory%2520Potency%2520of%2520123%2520Anticancer%2520Agents%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D4285%26epage%3D4300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Risinger, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooberry, S. L.</span><span> </span><span class="NLM_article-title">Microtubule Dynamics as a Target in Oncology</span> <span class="citation_source-journal">Cancer Treat. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1016%2Fj.ctrv.2008.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=19117686" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=255-261&author=A.+L.+Risingerauthor=F.+J.+Gilesauthor=S.+L.+Mooberry&title=Microtubule+Dynamics+as+a+Target+in+Oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2008.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2008.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DRisinger%26aufirst%3DA.%2BL.%26aulast%3DGiles%26aufirst%3DF.%2BJ.%26aulast%3DMooberry%26aufirst%3DS.%2BL.%26atitle%3DMicrotubule%2520Dynamics%2520as%2520a%2520Target%2520in%2520Oncology%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2008%26volume%3D35%26spage%3D255%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Hamel, E.</span><span> </span><span class="NLM_article-title">An Overview of Compounds That Interact With tubulin and their Effects on Microtubule Assembly</span>. In  <span class="citation_source-book">The Role of Microtubules in Cell Biology, Neurobiology and Oncology</span>; <span class="NLM_contrib-group">Fojo, T.</span>, Ed.; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1</span>− <span class="NLM_lpage">19</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1007%2F978-1-59745-336-3_1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=1-19&author=E.+Hamelauthor=T.+Fojo&title=The+Role+of+Microtubules+in+Cell+Biology%2C+Neurobiology+and+Oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2F978-1-59745-336-3_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-59745-336-3_1%26sid%3Dliteratum%253Aachs%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DAn%2520Overview%2520of%2520Compounds%2520That%2520Interact%2520With%2520tubulin%2520and%2520their%2520Effects%2520on%2520Microtubule%2520Assembly%26btitle%3DThe%2520Role%2520of%2520Microtubules%2520in%2520Cell%2520Biology%252C%2520Neurobiology%2520and%2520Oncology%26aulast%3DFojo%26aufirst%3DT.%26pub%3DHumana%2520Press%26date%3D2008%26spage%3D1%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ling, V.</span><span> </span><span class="NLM_article-title">Multidrug Resistance: Molecular Mechanisms and Clinical Relevance</span> <span class="citation_source-journal">Cancer Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">S3</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=S3-8&author=V.+Ling&title=Multidrug+Resistance%3A+Molecular+Mechanisms+and+Clinical+Relevance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DV.%26atitle%3DMultidrug%2520Resistance%253A%2520Molecular%2520Mechanisms%2520and%2520Clinical%2520Relevance%26jtitle%3DCancer%2520Chemother.%26date%3D1997%26volume%3D40%26spage%3DS3%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Leonard, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">The Role of ABC Transporters in Clinical Practice</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1634%2Ftheoncologist.8-5-411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=14530494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXoslyls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=411-424&author=G.+D.+Leonardauthor=T.+Fojoauthor=S.+E.+Bates&title=The+Role+of+ABC+Transporters+in+Clinical+Practice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The role of ABC transporters in clinical practice</span></div><div class="casAuthors">Leonard, Gregory D.; Fojo, Tito; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Oncologist</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">411-424</span>CODEN:
                <span class="NLM_cas:coden">OCOLF6</span>;
        ISSN:<span class="NLM_cas:issn">1083-7159</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">A review.  Drug resistance remains one of the primary causes of suboptimal outcomes in cancer therapy.  ATP-binding cassette (ABC) transporters are a family of transporter proteins that contribute to drug resistance via ATP-dependent drug efflux pumps.  P-glycoprotein (P-gp), encoded by the MDR1 gene, is an ABC transporter normally involved in the excretion of toxins from cells.  It also confers resistance to certain chemotherapeutic agents.  P-gp is overexpressed at baseline in chemotherapy-resistant tumors, such as colon and kidney cancers, and is upregulated after disease progression following chemotherapy in malignancies such as leukemia and breast cancer.  Other transporter proteins mediating drug resistance include those in the multidrug-resistance-assocd. protein (MRP) family, notably MRP1, and ABCG2.  These transporters are also involved in normal physiol. functions.  The expressions of MRP family members and ABCG2 were not well worked out in cancer.  Increased drug accumulation and drug resistance reversal with P-gp inhibitors were well documented in vitro, but only suggested in clin. trials.  Limitations in the design of early resistance reversal trials contributed to disappointing results.  Despite this, 3 randomized trials have shown statistically significant benefits with the use of a P-gp inhibitor in combination with chemotherapy.  Improved diagnostic techniques aimed at the selection of patients with tumors that express P-gp should result in more successful outcomes.  Further optimism is warranted with the advent of potent, nontoxic inhibitors and new treatment strategies, including the combination of new targeted therapies with therapies aimed at the prevention of drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr317MZ9jawCbVg90H21EOLACvtfcHk0ljOU_oX7VWMKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXoslyls74%253D&md5=b474f45fd5c45962acfff61840c04a6b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1634%2Ftheoncologist.8-5-411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Ftheoncologist.8-5-411%26sid%3Dliteratum%253Aachs%26aulast%3DLeonard%26aufirst%3DG.%2BD.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DThe%2520Role%2520of%2520ABC%2520Transporters%2520in%2520Clinical%2520Practice%26jtitle%3DOncologist%26date%3D2003%26volume%3D8%26spage%3D411%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Yeh, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, A.</span><span> </span><span class="NLM_article-title">Predicting Chemotherapy Response to Taxol-based Therapy in Advanced Non-Small-Cell Lung Cancer with P-glycoprotein Expression</span> <span class="citation_source-journal">Respiration</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2003&pages=32-35&author=J.+J.+Yehauthor=W.+H.+Hsuauthor=J.+J.+Wangauthor=S.+T.+Hoauthor=A.+Kao&title=Predicting+Chemotherapy+Response+to+Taxol-based+Therapy+in+Advanced+Non-Small-Cell+Lung+Cancer+with+P-glycoprotein+Expression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYeh%26aufirst%3DJ.%2BJ.%26aulast%3DHsu%26aufirst%3DW.%2BH.%26aulast%3DWang%26aufirst%3DJ.%2BJ.%26aulast%3DHo%26aufirst%3DS.%2BT.%26aulast%3DKao%26aufirst%3DA.%26atitle%3DPredicting%2520Chemotherapy%2520Response%2520to%2520Taxol-based%2520Therapy%2520in%2520Advanced%2520Non-Small-Cell%2520Lung%2520Cancer%2520with%2520P-glycoprotein%2520Expression%26jtitle%3DRespiration%26date%3D2003%26volume%3D70%26spage%3D32%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Chiou, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, A.</span><span> </span><span class="NLM_article-title">Comparing the Relationship of Taxol-based Chemotherpay Response with P-glycoprotein and Lung Resistance-related Protein Expression in Non-Small Cell Lung Cancer</span> <span class="citation_source-journal">Lung</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">181</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2003&pages=267-273&author=J.+F.+Chiouauthor=J.+A.+Liangauthor=W.+H.+Hsuauthor=J.+J.+Wangauthor=S.+T.+Hoauthor=A.+Kao&title=Comparing+the+Relationship+of+Taxol-based+Chemotherpay+Response+with+P-glycoprotein+and+Lung+Resistance-related+Protein+Expression+in+Non-Small+Cell+Lung+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiou%26aufirst%3DJ.%2BF.%26aulast%3DLiang%26aufirst%3DJ.%2BA.%26aulast%3DHsu%26aufirst%3DW.%2BH.%26aulast%3DWang%26aufirst%3DJ.%2BJ.%26aulast%3DHo%26aufirst%3DS.%2BT.%26aulast%3DKao%26aufirst%3DA.%26atitle%3DComparing%2520the%2520Relationship%2520of%2520Taxol-based%2520Chemotherpay%2520Response%2520with%2520P-glycoprotein%2520and%2520Lung%2520Resistance-related%2520Protein%2520Expression%2520in%2520Non-Small%2520Cell%2520Lung%2520Cancer%26jtitle%3DLung%26date%3D2003%26volume%3D181%26spage%3D267%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Nooter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westerman, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flens, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaman, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheper, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Wingerden, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oostrum, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boersma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonneveld, P.</span><span> </span><span class="NLM_article-title">Expression of the Multidrug Resistance-Associated Protein (MRP) Gene in Human Cancers</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1301</span><span class="NLM_x">–</span> <span class="NLM_lpage">1310</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=9815925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADyaK28XjvF2gsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=1301-1310&author=K.+Nooterauthor=A.+M.+Westermanauthor=M.+J.+Flensauthor=G.+J.+Zamanauthor=R.+J.+Scheperauthor=K.+E.+van+Wingerdenauthor=H.+Burgerauthor=R.+Oostrumauthor=T.+Boersmaauthor=P.+Sonneveld&title=Expression+of+the+Multidrug+Resistance-Associated+Protein+%28MRP%29+Gene+in+Human+Cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of the multidrug resistance-associated protein (MRP) gene in human cancers</span></div><div class="casAuthors">Nooter, Kees; Westerman, Anne Marie; Flens, Marcel J.; Zaman, Guido J. R.; Scheper, Rik J.; van Wingerden, Kyra E.; Burger, Herman; Oostrum, Robert; Boersma, Ton; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1301-10</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We detd. the expression of a newly recognized drug resistance gene, the multidrug resistance-assocd. protein (MRP) gene, in normal human tissues and in >370 human tumor biopsies using a quant. RNase protection assay and immunohistochem.  MRP mRNA appeared to be ubiquitously expressed at low levels in all normal tissues, including peripheral blood, the endocrine glands (adrenal and thyroid), striated muscle, the lymphoreticular system (spleen and tonsil), the digestive tract (salivary gland, esophagus, liver, gall bladder, pancreas, and colon), the respiratory tract (lung), and the urogenital tract (kidney, bladder, testis, and ovary).  The human cancers analyzed could be divided into three groups with regard to MRP expression.  Group 1 consists of tumors that often exhibit high to very high MRP mRNA levels (e.g., chronic lymphocytic leukemia).  Group 2 comprises the tumors that often exhibit low, but occasionally exhibit high MRP mRNA expression (e.g., esophagus squamous cell carcinoma, non-small cell lung cancer, and acute myelocytic leukemia).  Group 3 comprises the tumors with predominantly low levels of MRP mRNA, comparable to the levels found in normal tissues (e.g., other hematol. malignancies, soft tissue sarcomas, melanoma, and cancers of the prostate, breast, kidney, bladder, testis, ovary, and colon).  Using the MRP-specific mAbs MRPr1 and MRPm6, we confirmed the elevated MRP mRNA levels in tumor tissues by immunohistochem.  We conclude that hyperexpression of MRP is obsd. in several human cancers, and that addnl. studies are needed to assess the clin. relevance of MRP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovEhBg_07inLVg90H21EOLACvtfcHk0lhGyU_YEh0aJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvF2gsw%253D%253D&md5=21feaa6ab3a1effd2aecf165c2665969</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNooter%26aufirst%3DK.%26aulast%3DWesterman%26aufirst%3DA.%2BM.%26aulast%3DFlens%26aufirst%3DM.%2BJ.%26aulast%3DZaman%26aufirst%3DG.%2BJ.%26aulast%3DScheper%26aufirst%3DR.%2BJ.%26aulast%3Dvan%2BWingerden%26aufirst%3DK.%2BE.%26aulast%3DBurger%26aufirst%3DH.%26aulast%3DOostrum%26aufirst%3DR.%26aulast%3DBoersma%26aufirst%3DT.%26aulast%3DSonneveld%26aufirst%3DP.%26atitle%3DExpression%2520of%2520the%2520Multidrug%2520Resistance-Associated%2520Protein%2520%2528MRP%2529%2520Gene%2520in%2520Human%2520Cancers%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1995%26volume%3D1%26spage%3D1301%26epage%3D1310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menefee, M.</span><span> </span><span class="NLM_article-title">Mechanisms of Multidrug Resistance: The Potential Role of Microtubule-stabilizing Agents</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1093%2Fannonc%2Fmdm172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=17656560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A280%3ADC%252BD2sngs1SitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=3-8&author=T.+Fojoauthor=M.+Menefee&title=Mechanisms+of+Multidrug+Resistance%3A+The+Potential+Role+of+Microtubule-stabilizing+Agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents</span></div><div class="casAuthors">Fojo T; Menefee M</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology / ESMO</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18 Suppl 5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">v3-8</span>
        ISSN:<span class="NLM_cas:issn">0923-7534</span>.
    </div><div class="casAbstract">Antimitotic agents that target the dynamic equilibrium between the microtubule polymer and tubulin heterodimers are key components of chemotherapeutic regimens for various solid tumors.  These agents can be divided into two major classes based on their effect on microtubule polymerization and the mass of microtubule polymers: those that inhibit polymerization, such as the vinca alkaloids and those that stabilize microtubules, such as the taxanes and epothilones.  The taxanes paclitaxel (Taxol) and docetaxel (Taxotere) were the first antimicrotubule agents approved for use in solid tumors, but their usefulness is often limited by development of drug resistance.  The epothilones are distinguished from the taxanes structurally and functionally and have been shown in vitro and in preclinical models to have superior potency to the taxanes.  The epothilones are not susceptible to P-glycoprotein-mediated efflux and have shown activity against taxane-resistant tumors.  Other natural-product microtubule-stabilizing agents also have promising pharmacologic profiles.  This article discusses mechanisms of drug resistance and summarizes scientific and clinical data supporting the potential of novel microtubule-stabilizing agents for achieving broad antitumor efficacy without the emergence of drug resistance.  The ability to reduce the development of resistance with the epothilones and other microtubule-stabilizing agents may provide additional treatment options at the time of presentation and in the setting of taxane resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTF5uhi21MM5z0O18WR3iAofW6udTcc2eZz5UXWRAZDJrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sngs1SitA%253D%253D&md5=ddbd9ea289b1a1cb1f79d6be860f2bfa</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdm172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdm172%26sid%3Dliteratum%253Aachs%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DMenefee%26aufirst%3DM.%26atitle%3DMechanisms%2520of%2520Multidrug%2520Resistance%253A%2520The%2520Potential%2520Role%2520of%2520Microtubule-stabilizing%2520Agents%26jtitle%3DAnn.%2520Oncol.%26date%3D2007%26volume%3D18%26spage%3D3%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Rosell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scagliotti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danenberg, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, R. V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bepler, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novello, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooc, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Marinis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marangolo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozzelino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Costanzo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rinaldi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salonga, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, C.</span><span> </span><span class="NLM_article-title">Transcripts in Pretreatment Biopsies From A Three-Arm Randomized Trial In Metastatic Non-Small-Cell Lung Cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3548</span><span class="NLM_x">–</span> <span class="NLM_lpage">3553</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=3548-3553&author=R.+Rosellauthor=G.+Scagliottiauthor=K.+D.+Danenbergauthor=R.+V.+N.+Lordauthor=G.+Beplerauthor=S.+Novelloauthor=J.+Coocauthor=L.+Crinoauthor=J.+J.+Sanchezauthor=M.+Taronauthor=C.+Boniauthor=F.+De+Marinisauthor=M.+Tonatoauthor=M.+Marangoloauthor=F.+Gozzelinoauthor=F.+Di+Costanzoauthor=M.+Rinaldiauthor=D.+Salongaauthor=C.+Stephens&title=Transcripts+in+Pretreatment+Biopsies+From+A+Three-Arm+Randomized+Trial+In+Metastatic+Non-Small-Cell+Lung+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosell%26aufirst%3DR.%26aulast%3DScagliotti%26aufirst%3DG.%26aulast%3DDanenberg%26aufirst%3DK.%2BD.%26aulast%3DLord%26aufirst%3DR.%2BV.%2BN.%26aulast%3DBepler%26aufirst%3DG.%26aulast%3DNovello%26aufirst%3DS.%26aulast%3DCooc%26aufirst%3DJ.%26aulast%3DCrino%26aufirst%3DL.%26aulast%3DSanchez%26aufirst%3DJ.%2BJ.%26aulast%3DTaron%26aufirst%3DM.%26aulast%3DBoni%26aufirst%3DC.%26aulast%3DDe%2BMarinis%26aufirst%3DF.%26aulast%3DTonato%26aufirst%3DM.%26aulast%3DMarangolo%26aufirst%3DM.%26aulast%3DGozzelino%26aufirst%3DF.%26aulast%3DDi%2BCostanzo%26aufirst%3DF.%26aulast%3DRinaldi%26aufirst%3DM.%26aulast%3DSalonga%26aufirst%3DD.%26aulast%3DStephens%26aufirst%3DC.%26atitle%3DTranscripts%2520in%2520Pretreatment%2520Biopsies%2520From%2520A%2520Three-Arm%2520Randomized%2520Trial%2520In%2520Metastatic%2520Non-Small-Cell%2520Lung%2520Cancer%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D3548%26epage%3D3553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Dumontet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaac, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souquet, P.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bejui-Thivolet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacheco, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peloux, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frankfurter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luduena, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perol, M.</span><span> </span><span class="NLM_article-title">Expression of Class III Beta Tubulin In Non-Small Cell Lung Cancer Is Correlated With Resistance To Taxane Chemotherapy</span> <span class="citation_source-journal">Bull. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">E25</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2005&pages=E25-30&author=C.+Dumontetauthor=S.+Isaacauthor=P.-J.+Souquetauthor=F.+Bejui-Thivoletauthor=Y.+Pachecoauthor=N.+Pelouxauthor=A.+Frankfurterauthor=R.+Luduenaauthor=M.+Perol&title=Expression+of+Class+III+Beta+Tubulin+In+Non-Small+Cell+Lung+Cancer+Is+Correlated+With+Resistance+To+Taxane+Chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDumontet%26aufirst%3DC.%26aulast%3DIsaac%26aufirst%3DS.%26aulast%3DSouquet%26aufirst%3DP.-J.%26aulast%3DBejui-Thivolet%26aufirst%3DF.%26aulast%3DPacheco%26aufirst%3DY.%26aulast%3DPeloux%26aufirst%3DN.%26aulast%3DFrankfurter%26aufirst%3DA.%26aulast%3DLuduena%26aufirst%3DR.%26aulast%3DPerol%26aufirst%3DM.%26atitle%3DExpression%2520of%2520Class%2520III%2520Beta%2520Tubulin%2520In%2520Non-Small%2520Cell%2520Lung%2520Cancer%2520Is%2520Correlated%2520With%2520Resistance%2520To%2520Taxane%2520Chemotherapy%26jtitle%3DBull.%2520Cancer%26date%3D2005%26volume%3D92%26spage%3DE25%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Seve, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaac, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tredan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souquet, P.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacheco, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perol, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafanechere, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peiller, E.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumontet, C.</span><span> </span><span class="NLM_article-title">Expression of Class III β -Tubulin Is Predictive of Patient Outcome in Patients with Non-Small Cell Lung Cancer Receiving Vinorelbine-Based Chemotherapy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">5481</span><span class="NLM_x">–</span> <span class="NLM_lpage">5486</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1158%2F1078-0432.CCR-05-0285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=16061864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFSmtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=5481-5486&author=P.+Seveauthor=S.+Isaacauthor=O.+Tredanauthor=P.-J.+Souquetauthor=Y.+Pachecoauthor=M.+Perolauthor=L.+Lafanechereauthor=A.+Penetauthor=E.-L.+Peillerauthor=C.+Dumontet&title=Expression+of+Class+III+%CE%B2+-Tubulin+Is+Predictive+of+Patient+Outcome+in+Patients+with+Non-Small+Cell+Lung+Cancer+Receiving+Vinorelbine-Based+Chemotherapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of Class III β-Tubulin Is Predictive of Patient Outcome in Patients with Non-Small Cell Lung Cancer Receiving Vinorelbine-Based Chemotherapy</span></div><div class="casAuthors">Seve, Pascal; Isaac, Sylvie; Tredan, Olivier; Souquet, Pierre-Jean; Pacheco, Yves; Perol, Maurice; Lafanechere, Laurence; Penet, Aurelie; Peiller, Eva-Laure; Dumontet, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5481-5486</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: To det. the prevalence and the prognostic value of microtubule component expression in tumors of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).  Exptl. Design: Expression of microtubular components was immunohistochem. examd. in 93 tumor samples from untreated patients with stage III and IV NSCLC.  All patients received vinorelbine-based chemotherapy.  Response to chemotherapy, progression-free survival, and overall survival were correlated with the expression of microtubule proteins.  RESULTS: The response rate was 27.3% (21 partial responses among 77 valuable patients).  Although expression of microtubule components was not assocd. with the response rate, high class III {szligbeta}-tubulin expression was correlated with resistance to vinorelbine, defined as disease progression under treatment.  Patients whose tumors expressed high levels of class III β-tubulin isotype had shorter progression-free survival and overall survival (P = 0.002 and 0.001, resp.).  High Δ2 α-tubulin expression was assocd. with a shorter overall survival (P = 0.018).  Tubulin II levels were not found to be correlated with patient outcome.  A multivariate anal., taking into account sex, age, histol., stage, wt. loss, and class II β-tubulin, class III β-tubulin, and Δ2 α-tubulin levels, confirmed that class III {szligbeta}-tubulin expression was independently correlated with progression-free survival (P = 0.04) and overall survival (P = 0.012).  CONCLUSIONS: These findings suggest that a high level of expression of class III {szligbeta}-tubulin in tumor cells is assocd. with resistance to vinorelbine and a poor prognosis in patients with NSCLC receiving vinorelbine-based chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQLbZO_aEZCLVg90H21EOLACvtfcHk0lgpRt6svIy70w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFSmtbc%253D&md5=144a54ce9966814240d86f5b92dbc2e6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-0285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-0285%26sid%3Dliteratum%253Aachs%26aulast%3DSeve%26aufirst%3DP.%26aulast%3DIsaac%26aufirst%3DS.%26aulast%3DTredan%26aufirst%3DO.%26aulast%3DSouquet%26aufirst%3DP.-J.%26aulast%3DPacheco%26aufirst%3DY.%26aulast%3DPerol%26aufirst%3DM.%26aulast%3DLafanechere%26aufirst%3DL.%26aulast%3DPenet%26aufirst%3DA.%26aulast%3DPeiller%26aufirst%3DE.-L.%26aulast%3DDumontet%26aufirst%3DC.%26atitle%3DExpression%2520of%2520Class%2520III%2520%25CE%25B2%2520-Tubulin%2520Is%2520Predictive%2520of%2520Patient%2520Outcome%2520in%2520Patients%2520with%2520Non-Small%2520Cell%2520Lung%2520Cancer%2520Receiving%2520Vinorelbine-Based%2520Chemotherapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D5481%26epage%3D5486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Tommasi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacalamita, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedele, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiriatti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomssen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendzierski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latorre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorusso, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schittulli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zito, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavallaris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paradiso, A.</span><span> </span><span class="NLM_article-title">Cytoskeleton and Paclitaxel Sensitivity In Breast Cancer: The Role Of Beta-Tubulins</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">2078</span><span class="NLM_x">–</span> <span class="NLM_lpage">2085</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1002%2Fijc.22557" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=17285590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1Oitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2007&pages=2078-2085&author=S.+Tommasiauthor=A.+Mangiaauthor=R.+Lacalamitaauthor=A.+Bellizziauthor=V.+Fedeleauthor=A.+Chiriattiauthor=C.+Thomssenauthor=N.+Kendzierskiauthor=A.+Latorreauthor=V.+Lorussoauthor=F.+Schittulliauthor=F.+Zitoauthor=M.+Kavallarisauthor=A.+Paradiso&title=Cytoskeleton+and+Paclitaxel+Sensitivity+In+Breast+Cancer%3A+The+Role+Of+Beta-Tubulins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of β-tubulins</span></div><div class="casAuthors">Tommasi, Stefania; Mangia, Anita; Lacalamita, Rosanna; Bellizzi, Antonia; Fedele, Vita; Chiriatti, Annalisa; Thomssen, Christopher; Kendzierski, Nancy; Latorre, Agnese; Lorusso, Vito; Schittulli, Francesco; Zito, Francesco; Kavallaris, Maria; Paradiso, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2078-2085</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The antineoplastic effect of paclitaxel is mainly related to its ability to bind the β subunit of tubulin, thus preventing tubulin chain depolarization and inducing apoptosis.  The relevance of the Class 1 β-tubulin characteristics have also been confirmed in the clin. setting where mutations of paclitaxel-binding site of β-tubulin Class I have been related to paclitaxel resistance in non small cell lung and ovarian cancers.  In the present study, we verified the hypothesis of a relationship between mol. alterations of β-tubulin Class I and paclitaxel sensitivity in a panel of breast cell lines with different drug IC50.  The Class I β-tubulin gene cDNA has been sequenced detecting heterozygous missense mutations (exon 1 and 4) only in MCF-7 and SK-BR-3 lines.  Furthermore, the expression (at both mRNA and protein level) of the different isotypes have been analyzed demonstrating an assocn. between low cell sensitivity to paclitaxel and Class III β-tubulin expression increasing.  Antisense oligonucleotide (ODN) expts. confirmed that the inhibition of Class III β-tubulin could at least partially increase paclitaxel-chemosensitivity.  The hypothesis of a relationship between β-tubulin tumor expression and paclitaxel clin. response has been finally verified in a series of 92 advanced breast cancer patients treated with a first line paclitaxel-based chemotherapy.  Thirty-five percent (95% CI: 45-31) of patients with high Class III β-tubulin expression showed a disease progression vs. only 7% of patients with low expression (35% vs. 7%, p < 0.002).  Our study suggests that Class III β-tubulin tumor expression could be considered a predictive biomarker of paclitaxel-clin. resistance for breast cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBTFhVq0oPHrVg90H21EOLACvtfcHk0lgpRt6svIy70w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1Oitbo%253D&md5=efd1c3424ce6be7595069049392d016c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fijc.22557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.22557%26sid%3Dliteratum%253Aachs%26aulast%3DTommasi%26aufirst%3DS.%26aulast%3DMangia%26aufirst%3DA.%26aulast%3DLacalamita%26aufirst%3DR.%26aulast%3DBellizzi%26aufirst%3DA.%26aulast%3DFedele%26aufirst%3DV.%26aulast%3DChiriatti%26aufirst%3DA.%26aulast%3DThomssen%26aufirst%3DC.%26aulast%3DKendzierski%26aufirst%3DN.%26aulast%3DLatorre%26aufirst%3DA.%26aulast%3DLorusso%26aufirst%3DV.%26aulast%3DSchittulli%26aufirst%3DF.%26aulast%3DZito%26aufirst%3DF.%26aulast%3DKavallaris%26aufirst%3DM.%26aulast%3DParadiso%26aufirst%3DA.%26atitle%3DCytoskeleton%2520and%2520Paclitaxel%2520Sensitivity%2520In%2520Breast%2520Cancer%253A%2520The%2520Role%2520Of%2520Beta-Tubulins%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2007%26volume%3D120%26spage%3D2078%26epage%3D2085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Mozzetti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferlini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Concolino, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raspaglio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prislei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranelletti, F. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scambia, G.</span><span> </span><span class="NLM_article-title">Class III β-tubulin Overexpression Is A Prominent Mechanism Of Paclitaxel Resistance In Ovarian Cancer Patients</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">305</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=15671559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVegtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=298-305&author=S.+Mozzettiauthor=C.+Ferliniauthor=P.+Concolinoauthor=F.+Filippettiauthor=G.+Raspaglioauthor=S.+Prisleiauthor=D.+Galloauthor=E.+Martinelliauthor=F.+O.+Ranellettiauthor=G.+Ferrandinaauthor=G.+Scambia&title=Class+III+%CE%B2-tubulin+Overexpression+Is+A+Prominent+Mechanism+Of+Paclitaxel+Resistance+In+Ovarian+Cancer+Patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Class III β-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients</span></div><div class="casAuthors">Mozzetti, Simona; Ferlini, Cristiano; Concolino, Paola; Filippetti, Flavia; Raspaglio, Giuseppina; Prislei, Silvia; Gallo, Daniela; Martinelli, Enrica; Ranelletti, Franco Oreste; Ferrandina, Gabriella; Scambia, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">298-305</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The vast majority of women with advanced ovarian cancer will ultimately relapse and develop a drug-resistant disease with an overall 5-yr survival of <50%.  Unfortunately, the mechanisms of drug resistance actually operating in patients are still unknown.  To address this issue, in 41 patients affected by advanced ovarian cancer the three main mechanisms of paclitaxel resistance were investigated: overexpression of MDR-1 gene, point mutations at prominently expressed α-tubulin and β-tubulin genes and selective alterations in the expression of β-tubulin isotypes.  MDR-1 and the β-tubulin isotypes expression were evaluated by semiquant. and real-time PCR.  On the same specimens, quant. immunohistochem. was also done in the tumor area.  No statistically significant changes of MDR-1 expression were noticed between the sensitive and resistant patients either at the mRNA or protein level.  The tubulin mutations for the ubiquitous α-tubulin and β-tubulin genes were evaluated by automated DNA sequencing, and in all patients, no mutations were detected in both resistant and sensitive cases.  With regard to the expression of tubulin isoforms, a statistically significant up-regulation of class III β-tubulin was found in the resistant subset.  It is worth noting that this statistically significant increase of the expression of class III β-tubulin was detectable at the mRNA and protein level.  By a direct comparison of the three main known mechanisms of paclitaxel resistance, this study indicates that overexpression of class III β-tubulin is the most prominent mechanism of paclitaxel resistance in ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_j0ZXNlGPW7Vg90H21EOLACvtfcHk0lgpRt6svIy70w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVegtrg%253D&md5=861e1e01da277ff2f4d76b458ebe5e48</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMozzetti%26aufirst%3DS.%26aulast%3DFerlini%26aufirst%3DC.%26aulast%3DConcolino%26aufirst%3DP.%26aulast%3DFilippetti%26aufirst%3DF.%26aulast%3DRaspaglio%26aufirst%3DG.%26aulast%3DPrislei%26aufirst%3DS.%26aulast%3DGallo%26aufirst%3DD.%26aulast%3DMartinelli%26aufirst%3DE.%26aulast%3DRanelletti%26aufirst%3DF.%2BO.%26aulast%3DFerrandina%26aufirst%3DG.%26aulast%3DScambia%26aufirst%3DG.%26atitle%3DClass%2520III%2520%25CE%25B2-tubulin%2520Overexpression%2520Is%2520A%2520Prominent%2520Mechanism%2520Of%2520Paclitaxel%2520Resistance%2520In%2520Ovarian%2520Cancer%2520Patients%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D298%26epage%3D305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Ferrandina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zannoni, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paglia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallotta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mozzetti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scambia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferlini, C.</span><span> </span><span class="NLM_article-title">Class III β -Tubulin Overexpression Is A Marker Of Poor Clinical Outcome In Advanced Ovarian Cancer Patients</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2774</span><span class="NLM_x">–</span> <span class="NLM_lpage">2779</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1158%2F1078-0432.CCR-05-2715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=16675570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD28Xltlamsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=2774-2779&author=G.+Ferrandinaauthor=G.+F.+Zannoniauthor=E.+Martinelliauthor=A.+Pagliaauthor=V.+Gallottaauthor=S.+Mozzettiauthor=G.+Scambiaauthor=C.+Ferlini&title=Class+III+%CE%B2+-Tubulin+Overexpression+Is+A+Marker+Of+Poor+Clinical+Outcome+In+Advanced+Ovarian+Cancer+Patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Class III β-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients</span></div><div class="casAuthors">Ferrandina, Gabriella; Zannoni, Gian Franco; Martinelli, Enrica; Paglia, Amelia; Gallotta, Valerio; Mozzetti, Simona; Scambia, Giovanni; Ferlini, Cristiano</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2774-2779</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Overexpression of β III tubulin has been involved in paclitaxel resistance in several exptl. models.  We investigated the role of β III tubulin as predictor of clin. outcome in ovarian cancer patients given platinum/paclitaxel treatment.  We also investigated whether β III tubulin expression could be modified after the selective pressure represented by chemotherapy in vivo.  Exptl. Design: The study was designed to include a series of consecutive ovarian cancer patients with unresectable disease at time of first surgery, who underwent interval debulking surgery with pathol. assessment of response to treatment with platinum/paclitaxel chemotherapy.  Immunostaining was done on formalin-fixed, paraffin-embedded tissue sections from pretreatment and posttreatment tissue biopsies by using the polyclonal rabbit anti-class III β-tubulin antibody.  Results: β III Tubulin immunoreaction was obsd. in 51 of 62 (82.2%) cases.  β III Tubulin positivity was neither assocd. with clinicopathol. variables nor with pathol. response to chemotherapy.  Significantly lower percentages of β III tubulin positivity were obsd. in posttreatment (range, 5-80%; median, 20%) vs. pretreatment (range 10-100%; median, 40%) tissue biopsies (P = 0.0011).  Cases with high β III tubulin expression showed a worse overall survival with respect to cases with low β III tubulin expression (median overall survival, 25 vs. 46 mo; P = 0.002).  Multivariate anal. showed that high content of β III tubulin remains independently assocd. with a worse prognosis.  Conclusions: Assessment of β III tubulin could be useful to identify poor prognosis ovarian cancer patients candidates to more aggressive and/or targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkRULoF4-0uLVg90H21EOLACvtfcHk0lj8yxWRvpcu5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xltlamsb0%253D&md5=569d52a398426b7b06eddeb7b0e98751</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-2715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-2715%26sid%3Dliteratum%253Aachs%26aulast%3DFerrandina%26aufirst%3DG.%26aulast%3DZannoni%26aufirst%3DG.%2BF.%26aulast%3DMartinelli%26aufirst%3DE.%26aulast%3DPaglia%26aufirst%3DA.%26aulast%3DGallotta%26aufirst%3DV.%26aulast%3DMozzetti%26aufirst%3DS.%26aulast%3DScambia%26aufirst%3DG.%26aulast%3DFerlini%26aufirst%3DC.%26atitle%3DClass%2520III%2520%25CE%25B2%2520-Tubulin%2520Overexpression%2520Is%2520A%2520Marker%2520Of%2520Poor%2520Clinical%2520Outcome%2520In%2520Advanced%2520Ovarian%2520Cancer%2520Patients%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D2774%26epage%3D2779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Seve, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumontet, C.</span><span> </span><span class="NLM_article-title">Is Class III β-Tubulin a Predictive Factor in Patients Receiving Tubulin-binding Agents?</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1016%2FS1470-2045%2808%2970029-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=18237851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=168-175&author=P.+Seveauthor=C.+Dumontet&title=Is+Class+III+%CE%B2-Tubulin+a+Predictive+Factor+in+Patients+Receiving+Tubulin-binding+Agents%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Is class III β-tubulin a predictive factor in patients receiving tubulin-binding agents?</span></div><div class="casAuthors">Seve, Pascal; Dumontet, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">168-175</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: On the basis of preclin. studies that show overexpression of class III β-tubulin is assocd. with resistance to tubulin-binding agents, several investigators have addressed the relation between class III β-tubulin and outcome in patients treated with such agents.  High expression of class III β-tubulin has been found to be correlated either with low response rates in patients treated with regimens contg. taxanes or vinorelbine or with reduced survival in patients with non-small-cell lung cancer, in breast, ovarian, and gastric cancers, and in cancers of unknown primary site.  Two studies have shown patients with advanced non-small-cell lung cancer receiving paclitaxel whose tumors expressed high levels of class III β-tubulin had a lower response to paclitaxel and shorter survival, whereas this variable was not found to be predictive in patients receiving regimens without tubulin-binding agents.  Conversely, anal. of samples from patients in the JBR-10 trial, which compared adjuvant chemotherapy to no further therapy in operable non-small-cell lung cancer, showed that chemotherapy seemed to overcome the neg. prognostic effect of high levels of expression of class III β-tubulin and the greatest benefit from cisplatin/vinorelbine was seen in patients with high levels of expression of class III β-tubulin.  Further analyses in operable and advanced non-small-cell lung cancer showed a relation between high expression of class III β-tubulin and baseline factors such as age under 60 years, adenocarcinoma and large-cell carcinoma histologies, and advanced stage of disease.  These results suggest that class III β-tubulin could be both a prognostic and a predictive factor.  Large randomized studies are warranted to det. the prognostic or predictive value of class III β-tubulin in different settings and tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopsXLbaFHm3LVg90H21EOLACvtfcHk0lj8yxWRvpcu5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOmsr8%253D&md5=4d4adaf4db80a5eb71c771c9f09d74b4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2808%2970029-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252808%252970029-9%26sid%3Dliteratum%253Aachs%26aulast%3DSeve%26aufirst%3DP.%26aulast%3DDumontet%26aufirst%3DC.%26atitle%3DIs%2520Class%2520III%2520%25CE%25B2-Tubulin%2520a%2520Predictive%2520Factor%2520in%2520Patients%2520Receiving%2520Tubulin-binding%2520Agents%253F%26jtitle%3DLancet%2520Oncol.%26date%3D2008%26volume%3D9%26spage%3D168%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Strengel, C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesse, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">Class III Beta- Tubulin Expression and in vitro Resistance To Microtubule Targeting Agents</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1038%2Fsj.bjc.6605489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=20029418" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2010&pages=316-324&author=C+Strengelauthor=S.+P.+Newmanauthor=M.+P.+Lesseauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohit&title=Class+III+Beta-+Tubulin+Expression+and+in+vitro+Resistance+To+Microtubule+Targeting+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6605489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6605489%26sid%3Dliteratum%253Aachs%26aulast%3DStrengel%26aufirst%3DC%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DLesse%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3DClass%2520III%2520Beta-%2520Tubulin%2520Expression%2520and%2520in%2520vitro%2520Resistance%2520To%2520Microtubule%2520Targeting%2520Agents%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2010%26volume%3D102%26spage%3D316%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risinger, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooberry, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Biological Evaluations of 2,5-Diaryl-2,3-dihydro-1,3,4-oxadiazoline Analogs of Combretastatin-A4</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901268n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=325-334&author=L.+Leeauthor=L.+M.+Robbauthor=M.+Leeauthor=R.+Davisauthor=H.+Mackayauthor=S.+Chavdaauthor=E.+L.+O%E2%80%99Brienauthor=A.+L.+Risingerauthor=S.+L.+Mooberryauthor=M.+Lee&title=Design%2C+Synthesis+and+Biological+Evaluations+of+2%2C5-Diaryl-2%2C3-dihydro-1%2C3%2C4-oxadiazoline+Analogs+of+Combretastatin-A4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm901268n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901268n%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DL.%26aulast%3DRobb%26aufirst%3DL.%2BM.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DMackay%26aufirst%3DH.%26aulast%3DChavda%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DE.%2BL.%26aulast%3DRisinger%26aufirst%3DA.%2BL.%26aulast%3DMooberry%26aufirst%3DS.%2BL.%26aulast%3DLee%26aufirst%3DM.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biological%2520Evaluations%2520of%25202%252C5-Diaryl-2%252C3-dihydro-1%252C3%252C4-oxadiazoline%2520Analogs%2520of%2520Combretastatin-A4%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D325%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Dumontet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. F. Y.</span><span> </span><span class="NLM_article-title">Ixabepilone: Targeting βIII-Tubulin Expression in Taxane-resistant Malignancies</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1158%2F1535-7163.MCT-08-0986" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=19139109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFSmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=17-25&author=C.+Dumontetauthor=M.+A.+Jordanauthor=F.+F.+Y.+Lee&title=Ixabepilone%3A+Targeting+%CE%B2III-Tubulin+Expression+in+Taxane-resistant+Malignancies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Ixabepilone: targeting βIII-tubulin expression in taxane-resistant malignancies</span></div><div class="casAuthors">Dumontet, Charles; Jordan, Mary Ann; Lee, Francis F. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-25</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Microtubule-targeting agents, such as taxanes and epothilones, block mitosis and cell proliferation by targeting the dynamics of the cytoskeleton.  The taxanes are widely used for treatment of various malignancies, but primary and acquired resistance to chemotherapy remains a significant clin. concern.  Class I, II, III, IV, and V β-tubulin isotypes are expressed in human tumors.  Overexpression of the βIII-tubulin isotype is one mechanism that can render tumor cells resistant to taxanes.  The relative expression of βIII-tubulin correlates with clin. outcomes in several tumor types, including breast cancer, non-small cell lung cancer, and ovarian cancer.  A novel analog of epothilone B, ixabepilone, has recently been approved in combination with capecitabine for the treatment of patients with anthracycline- and taxane-resistant locally advanced or metastatic breast cancer and as monotherapy in patients whose tumors are resistant or refractory to an anthracycline, a taxane, and capecitabine.  The significant antitumor activity of ixabepilone in taxane-resistant tumors may be related to its preferential suppression of the dynamic instability of α/βIII-microtubules in cells expressing high levels of βIII-tubulin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDIBa1OKa6abVg90H21EOLACvtfcHk0ljovP6-Q6qY8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFSmtA%253D%253D&md5=0073f077c14f0cefbc034f6f5bafa0b5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0986%26sid%3Dliteratum%253Aachs%26aulast%3DDumontet%26aufirst%3DC.%26aulast%3DJordan%26aufirst%3DM.%2BA.%26aulast%3DLee%26aufirst%3DF.%2BF.%2BY.%26atitle%3DIxabepilone%253A%2520Targeting%2520%25CE%25B2III-Tubulin%2520Expression%2520in%2520Taxane-resistant%2520Malignancies%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D17%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Speicher, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barone, L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tew, K. D.</span><span> </span><span class="NLM_article-title">Combined Antimicrotubule Activity of Estramustine and Taxol in Human Prostate Carcinoam Cell lines</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4433</span><span class="NLM_x">–</span> <span class="NLM_lpage">4440</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1992&pages=4433-4440&author=L.+A.+Speicherauthor=L+Baroneauthor=K.+D.+Tew&title=Combined+Antimicrotubule+Activity+of+Estramustine+and+Taxol+in+Human+Prostate+Carcinoam+Cell+lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpeicher%26aufirst%3DL.%2BA.%26aulast%3DBarone%26aufirst%3DL%26aulast%3DTew%26aufirst%3DK.%2BD.%26atitle%3DCombined%2520Antimicrotubule%2520Activity%2520of%2520Estramustine%2520and%2520Taxol%2520in%2520Human%2520Prostate%2520Carcinoam%2520Cell%2520lines%26jtitle%3DCancer%2520Res.%26date%3D1992%26volume%3D52%26spage%3D4433%26epage%3D4440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Giannakakou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalba, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poruchynsky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span> </span><span class="NLM_article-title">Combinations of Paclitaxel and Vinblastine and Their Effects on Tubulin Polymerization and Cellular Cytotoxicity: Characterization of a Synergistic Schedule</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1002%2F%28SICI%291097-0215%2819980105%2975%3A1%3C57%3A%3AAID-IJC10%3E3.0.CO%3B2-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=9426691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADyaK1cXjsFKqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1998&pages=57-63&author=P.+Giannakakouauthor=L.+Villalbaauthor=H.+Liauthor=M.+Poruchynskyauthor=T.+Fojo&title=Combinations+of+Paclitaxel+and+Vinblastine+and+Their+Effects+on+Tubulin+Polymerization+and+Cellular+Cytotoxicity%3A+Characterization+of+a+Synergistic+Schedule"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Combinations of paclitaxel and vinblastine and their effects on tubulin polymerization and cellular cytotoxicity: characterization of a synergistic schedule</span></div><div class="casAuthors">Giannakakou, Paraskevi; Villalba, Lourdes; Li, Hang; Poruchynsky, Marianne; Fojo, Tito</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-63</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Paclitaxel (PTX) and vinblastine (VBL) represent 2 classes of drugs that target tubulin but have sep. binding properties and opposing mechanisms of action.  To evaluate the potential use of these agents together in a chemotherapeutic regimen, their effects on the dynamics of tubulin polymn. and cellular cytotoxicity, when administered singly or in combination, were investigated.  In human epidermoid carcinoma KB cells and MCF-7 breast carcinoma cells, there was a time- and concn.-dependent effect of both PTX and VBL on cytoskeletal dynamics.  Tubulin polymn. induced by PTX was stable for >24 h.  When PTX was followed by addn. of VBL, a time- and concn.-dependent reversal of tubulin polymn. was obsd.  In contrast, rapid tubulin polymn. occurred when VBL was followed by PTX.  When both agents were added simultaneously, a diminution of PTX-induced tubulin polymn. occurred with increasing concns. of VBL; a max. redn. was achieved when equal concns. were used.  Examn. of the tubulin pattern by immunofluorescence in MCF-7 breast cancer cells confirmed and extended these findings.  Bundle formation followed treatment with PTX.  Addn. of increasing concns. of VBL prevented bundling; however, the normal cytoskeletal architecture was not restored.  Cytotoxicity studies carried out by using median concn. effect principles and combination index anal. showed synergism when VBL and PTX were added sequentially, and antagonism for simultaneous addn.  The results demonstrate changes in tubulin dynamics following drug treatment and provide a rationale for combined PTX/VBL therapy after careful evaluation of the schedule of administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqROGtMFC6SabVg90H21EOLACvtfcHk0ljovP6-Q6qY8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjsFKqsA%253D%253D&md5=976a9cebba0e2d6899762f532c8df8bd</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2819980105%2975%3A1%3C57%3A%3AAID-IJC10%3E3.0.CO%3B2-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252819980105%252975%253A1%253C57%253A%253AAID-IJC10%253E3.0.CO%253B2-A%26sid%3Dliteratum%253Aachs%26aulast%3DGiannakakou%26aufirst%3DP.%26aulast%3DVillalba%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DPoruchynsky%26aufirst%3DM.%26aulast%3DFojo%26aufirst%3DT.%26atitle%3DCombinations%2520of%2520Paclitaxel%2520and%2520Vinblastine%2520and%2520Their%2520Effects%2520on%2520Tubulin%2520Polymerization%2520and%2520Cellular%2520Cytotoxicity%253A%2520Characterization%2520of%2520a%2520Synergistic%2520Schedule%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1998%26volume%3D75%26spage%3D57%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Shi, W.; Horsman, M. R.; Siemann, D. W.</span><span> </span><span class="NLM_article-title">Combined Modality Approaches Using Vasculature-disrupting Agents</span>. In  <span class="citation_source-book">Vascular-Targeted Therapies in Oncology</span>; <span class="NLM_contrib-group">Siemann, D. W.</span>, Ed.; <span class="NLM_publisher-name">J. Wiley & Sons, Ltd.</span>: <span class="NLM_publisher-loc">West Sussex, England</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">123</span>− <span class="NLM_lpage">136</span> and other chapters in the text.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1002%2F0470035439.ch7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=123-136&author=W.+Shi&author=M.+R.+Horsman&author=D.+W.+Siemannauthor=D.+W.+Siemann&title=Vascular-Targeted+Therapies+in+Oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2F0470035439.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0470035439.ch7%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DW.%26atitle%3DCombined%2520Modality%2520Approaches%2520Using%2520Vasculature-disrupting%2520Agents%26btitle%3DVascular-Targeted%2520Therapies%2520in%2520Oncology%26aulast%3DSiemann%26aufirst%3DD.%2BW.%26pub%3DJ.%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26date%3D2006%26spage%3D123%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Gangjee, A.; Zhao, Y.; Ihnat, M. A.; Green, D.; Miller, W. T.</span><span> </span><span class="NLM_article-title">Synthesis of 2-Amino-4-<i>m</i>-bromoanilino-6-arylmethyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidines as Tyrosine Kinase Inhibitors and Antiangiogenic Agents</span>. Presented at the 96th American Association for Cancer Research (AACR) Annual Meeting, Anaheim, CA, April 16−20,<span class="NLM_x"> </span><span class="NLM_year">2005</span>. Poster No. 3946.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=A.+Gangjee&author=Y.+Zhao&author=M.+A.+Ihnat&author=D.+Green&author=W.+T.+Miller&title=Synthesis+of+2-Amino-4-m-bromoanilino-6-arylmethyl-7H-pyrrolo%5B2%2C3-d%5Dpyrimidines+as+Tyrosine+Kinase+Inhibitors+and+Antiangiogenic+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGangjee%26aufirst%3DA.%26atitle%3DSynthesis%2520of%25202-Amino-4-m-bromoanilino-6-arylmethyl-7H-pyrrolo%255B2%252C3-d%255Dpyrimidines%2520as%2520Tyrosine%2520Kinase%2520Inhibitors%2520and%2520Antiangiogenic%2520Agents%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Gangjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raghavan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihnat, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Disch, B. C.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Evaluation of 2-Amino-4-<i>m</i>-bromoanilino-6-arylmethyl-<i>7H</i>-pyrrolo[2,3-<i>d</i>]pyrimidines as Tyrosine Kinase Inhibitors and Antiangiogenic Agents</span> <span class="citation_source-journal">Bioorg. Med . Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5261</span><span class="NLM_x">–</span> <span class="NLM_lpage">5273</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=5261-5273&author=A.+Gangjeeauthor=Y.+Zhaoauthor=S.+Raghavanauthor=M.+A.+Ihnatauthor=B.+C.+Disch&title=Design%2C+Synthesis+and+Evaluation+of+2-Amino-4-m-bromoanilino-6-arylmethyl-7H-pyrrolo%5B2%2C3-d%5Dpyrimidines+as+Tyrosine+Kinase+Inhibitors+and+Antiangiogenic+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGangjee%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DRaghavan%26aufirst%3DS.%26aulast%3DIhnat%26aufirst%3DM.%2BA.%26aulast%3DDisch%26aufirst%3DB.%2BC.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Evaluation%2520of%25202-Amino-4-m-bromoanilino-6-arylmethyl-7H-pyrrolo%255B2%252C3-d%255Dpyrimidines%2520as%2520Tyrosine%2520Kinase%2520Inhibitors%2520and%2520Antiangiogenic%2520Agents%26jtitle%3DBioorg.%2520Med%2520.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D5261%26epage%3D5273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Bai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paull, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herald, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettit, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span> </span><span class="NLM_article-title">Halichondrin B and Homohalichondrin B, Marine Natural Products Binding in the Vinca Domain of Tubulin. Discovery of Tubulin-based Mechanism of Action by Analysis of Differential Cytotoxicity Data</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">266</span><span class="NLM_x">, </span> <span class="NLM_fpage">15882</span><span class="NLM_x">–</span> <span class="NLM_lpage">15889</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=1874739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADyaK3MXmsVOls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1991&pages=15882-15889&author=R.+Baiauthor=K.+D.+Paullauthor=C.+L.+Heraldauthor=G.+R.+Pettitauthor=E.+Hamel&title=Halichondrin+B+and+Homohalichondrin+B%2C+Marine+Natural+Products+Binding+in+the+Vinca+Domain+of+Tubulin.+Discovery+of+Tubulin-based+Mechanism+of+Action+by+Analysis+of+Differential+Cytotoxicity+Data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin.  Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data</span></div><div class="casAuthors">Bai, Ruoli; Paull, Kenneth D.; Herald, Cherry L.; Malspeis, Louis; Pettit, George R.; Hamel, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">266</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">15882-9</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Data generated in the new National Cancer Institute drug evaluation program, which is based on inhibition of cell growth in 60 human tumor cell lines, were used to compare new compds. with agents of known mechanism of action in terms of their differential cytotoxicity.  Two marine natural products, halichondrin B (I) and homohalichondrin B (II), appeared repeatedly when the data base was probed with known antimitotic agents.  The authors confirmed that both compds. were highly cytotoxic (IC50 values for L1210 murine leukemia cells of 0.3 and 1 nM, resp.), with accumulation of cells arrested in mitosis at toxic concns., that both inhibited the polymn. of purified tubulin, and that both inhibited microtubule assembly dependent on microtubule-assocd. proteins.  Limited amts. of II, the less active agent, were available, so only I was studied in detail.  I did not interfere with colchicine binding to tubulin, but it was a noncompetitive inhibitor of the binding of vinblastine to tubulin (apparent Ki, 5.0 μM).  I was therefore compared with other agents which interfere with the binding of vinca alkaloids to tubulin (vinblastine, maytansine, dolastatin 10, phomopsin A, rhizoxin) in terms of its effects on tubulin polymn., inhibition of GTP hydrolysis, inhibition of nucleotide exchange, and stabilization of tubulin, as well as the quant. assessment of its effects on vinca alkaloid binding and inhibition of cell growth.  Since I was originally isolated from the same organism as the phosphatase inhibitor okadaic acid, and since it is about 50-fold more effective than okadaic acid as an inhibitor of L1210 cell growth, perturbations of cellular microtubules obsd. following treatment with okadaic acid should be interpreted cautiously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHQ_94iRSg7rVg90H21EOLACvtfcHk0lgiEE-WNCI9pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmsVOls74%253D&md5=292cdeb1c3c262dac15d6af5bf2f100c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DR.%26aulast%3DPaull%26aufirst%3DK.%2BD.%26aulast%3DHerald%26aufirst%3DC.%2BL.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DHalichondrin%2520B%2520and%2520Homohalichondrin%2520B%252C%2520Marine%2520Natural%2520Products%2520Binding%2520in%2520the%2520Vinca%2520Domain%2520of%2520Tubulin.%2520Discovery%2520of%2520Tubulin-based%2520Mechanism%2520of%2520Action%2520by%2520Analysis%2520of%2520Differential%2520Cytotoxicity%2520Data%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1991%26volume%3D266%26spage%3D15882%26epage%3D15889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Paull, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malspeis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span> </span><span class="NLM_article-title">Identification of Novel Antimitotic Agents Acting at the Tubulin Level by Computer-assisted Evaluation of Differential Cytotoxicity Data</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3892</span><span class="NLM_x">–</span> <span class="NLM_lpage">3900</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=1617665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADyaK38XmtVClt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1992&pages=3892-3900&author=K.+D.+Paullauthor=C.+M.+Linauthor=L.+Malspeisauthor=E.+Hamel&title=Identification+of+Novel+Antimitotic+Agents+Acting+at+the+Tubulin+Level+by+Computer-assisted+Evaluation+of+Differential+Cytotoxicity+Data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel antimitotic agents acting at the tubulin level by computer-assisted evaluation of differential cytotoxicity data</span></div><div class="casAuthors">Paull, Kenneth D.; Lin, Chii M.; Malspeis, Louis; Hamel, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3892-900</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Data generated in the new National Cancer Institute drug evaluation program, which are based on inhibition of cell growth in 60 human tumor cells lines, were probed with nine known antimitotic agents using the COMPARE algorithm.  Cytotoxicity data were available on approx. 7000 compds. at the time of anal., and, based on the criteria used, 82 compds. were selected as pos. by the computer search.  Nine were the probe compds. themselves, and 41 were analogs of known antimitotic agents.  Among the remaining 32 compds. there were 19 distinct chem. species.  Agents in ten of these groups (contg. 20 compds.) were effective inhibitors of in vitro tubulin polymn. and caused the mitotic arrest of cells grown in culture.  Two compds. were related natural products binding in the Vinca domain of tubulin, and the others were synthetic agents which interfered with colchicine binding.  The remaining 12 agents (one natural product, the remainder synthetic) fell into several groups: two compds. were weak inhibitors of tubulin polymn., inhibited colchicine binding, and caused mitotic arrest; one compd. weakly inhibited tubulin polymn. but did not cause an increase in the no. of cells arrested in mitosis; two compds. caused mitotic arrest at micromolar concns., but thus far no in vitro interaction with tubulin has been obsd.; the remainder neither inhibited tubulin polymn. nor caused a rise in the no. of cultured cells arrested in mitosis.  Tubulin-dependent GTP hydrolysis was stimulated or inhibited by all agents which inhibited tubulin polymn. with the exception of one compd.  The anal. of differential cytotoxicity data thus appears to have great promise for the identification of new antimitotic agents with antineoplastic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS4q-eezqocbVg90H21EOLACvtfcHk0lgiEE-WNCI9pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XmtVClt74%253D&md5=d53ce5e4e91048c340c10069ec71f2bb</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaull%26aufirst%3DK.%2BD.%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DMalspeis%26aufirst%3DL.%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DIdentification%2520of%2520Novel%2520Antimitotic%2520Agents%2520Acting%2520at%2520the%2520Tubulin%2520Level%2520by%2520Computer-assisted%2520Evaluation%2520of%2520Differential%2520Cytotoxicity%2520Data%26jtitle%3DCancer%2520Res.%26date%3D1992%26volume%3D52%26spage%3D3892%26epage%3D3900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Paull, K. D.; Hamel, E.; Malspeis, L.</span><span> </span><span class="NLM_article-title">The Prediction of Biochemical Mechanism of Action From the in vivo Antitumor Screen of the National Cancer Institute</span>. In  <span class="citation_source-book">Cancer Chemotherapeutic Agents</span>; <span class="NLM_contrib-group">Foye, W. O.</span>, Ed.; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">1995</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">9</span>− <span class="NLM_lpage">45</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=9-45&author=K.+D.+Paull&author=E.+Hamel&author=L.+Malspeisauthor=W.+O.+Foye&title=Cancer+Chemotherapeutic+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPaull%26aufirst%3DK.%2BD.%26atitle%3DThe%2520Prediction%2520of%2520Biochemical%2520Mechanism%2520of%2520Action%2520From%2520the%2520in%2520vivo%2520Antitumor%2520Screen%2520of%2520the%2520National%2520Cancer%2520Institute%26btitle%3DCancer%2520Chemotherapeutic%2520Agents%26aulast%3DFoye%26aufirst%3DW.%2BO.%26pub%3DAmerican%2520Chemical%2520Society%26date%3D1995%26spage%3D9%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">West, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauchamp, L.</span><span> </span><span class="NLM_article-title">2-Alkyl(aryl)- and 2,7-Dimethyl-4-substituted Aminopyrrolo [2,3-<i>d</i>] pyrimidines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">3809</span><span class="NLM_x">–</span> <span class="NLM_lpage">3812</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01068a044" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1961&pages=3809-3812&author=R.+A.+Westauthor=L.+Beauchamp&title=2-Alkyl%28aryl%29-+and+2%2C7-Dimethyl-4-substituted+Aminopyrrolo+%5B2%2C3-d%5D+pyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjo01068a044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01068a044%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DR.%2BA.%26aulast%3DBeauchamp%26aufirst%3DL.%26atitle%3D2-Alkyl%2528aryl%2529-%2520and%25202%252C7-Dimethyl-4-substituted%2520Aminopyrrolo%2520%255B2%252C3-d%255D%2520pyrimidines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1961%26volume%3D26%26spage%3D3809%26epage%3D3812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Ohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukoshi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagasaka, M.</span><span> </span><span class="NLM_article-title">Synthesis and Hypoglycemic Activity of 7,8-Dihydro-6H-thiopyrano[3,2-<i>d</i>]pyrimidine Derivatives and Related Compounds</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">4150</span><span class="NLM_x">–</span> <span class="NLM_lpage">4165</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1986&pages=4150-4165&author=S.+Ohnoauthor=K.+Mizukoshiauthor=O.+Komatsuauthor=Y.+Kunoauthor=Y.+Nakamuraauthor=E.+Katoauthor=M.+Nagasaka&title=Synthesis+and+Hypoglycemic+Activity+of+7%2C8-Dihydro-6H-thiopyrano%5B3%2C2-d%5Dpyrimidine+Derivatives+and+Related+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhno%26aufirst%3DS.%26aulast%3DMizukoshi%26aufirst%3DK.%26aulast%3DKomatsu%26aufirst%3DO.%26aulast%3DKuno%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DKato%26aufirst%3DE.%26aulast%3DNagasaka%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Hypoglycemic%2520Activity%2520of%25207%252C8-Dihydro-6H-thiopyrano%255B3%252C2-d%255Dpyrimidine%2520Derivatives%2520and%2520Related%2520Compounds%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1986%26volume%3D34%26spage%3D4150%26epage%3D4165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Skehan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storeng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vistica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bokesch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span> </span><span class="NLM_article-title">New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1093%2Fjnci%2F82.13.1107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=2359136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADyaK3cXltVylsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1990&pages=1107-1112&author=P.+Skehanauthor=R.+Storengauthor=D.+Scudieroauthor=A.+Monksauthor=J.+McMahonauthor=D.+Visticaauthor=J.+T.+Warrenauthor=H.+Bokeschauthor=S.+Kenneyauthor=M.+R.+Boyd&title=New+Colorimetric+Cytotoxicity+Assay+for+Anticancer-Drug+Screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">New colorimetric cytotoxicity assay for anticancer-drug screening</span></div><div class="casAuthors">Skehan, Philip; Storeng, Ritsa; Scudiero, Dominic; Monks, Anne; McMahon, James; Vistica, David; Warren, Jonathan T.; Bokesch, Heidi; Kenney, Susan; Boyd, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1107-12</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">A rapid, sensitive, and inexpensive method was developed for measuring the cellular protein content of adherent and suspension cultures in 96-well microtiter plates.  The method is suitable for ordinary lab. purposes and for very large-scale applications, such as the National Cancer Institute's disease-oriented in vitro anticancer-drug discovery screen, which requires the use of several million culture wells per yr.  Cultures fixed with trichloroacetic acid were stained for 30 min with 0.4% (wt/vol) sulforhodamine B (SRB) dissolved in 1% acetic acid.  Unbound dye was removed by four washes with 1% acetic acid, and protein-bound dye was extd. with 10 mM unbuffered Tris base [tris(hydroxymethyl)aminomethane] for detn. of optical d. in a computer-interfaced, 96-well microtiter plate reader.  The SRB assay results were linear with the no. of cells and with values for cellular protein measured by both the Lowry and Bradford assays at densities ranging from sparse subconfluence to multilayered supraconfluence.  The signal-to-noise ratio at 564 nm was approx. 1.5 with 1,000 cells per well.  The sensitivity of the SRB assay compared favorably with sensitivities of several fluorescence assays and was superior to those of both the Lowry and Bradford assays and to those of 20 other visible dyes.  The SRB assay provides a colorimetric end point that is nondestructive, indefinitely stable, and visible to the naked eye.  It provides a sensitive measure of drug-induced cytotoxicity, is useful in quantitating clonogenicity, and is well suited to high-vol., automated drug screening.  SRB fluoresces strongly with laser excitation at 488 nm and can be measured quant. at the single-cell level by static fluorescence cytometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA1MIZ3rkcqLVg90H21EOLACvtfcHk0lhEWBar75T0dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXltVylsL8%253D&md5=d7bc1784a1f181842d2999efa7fa870c</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F82.13.1107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F82.13.1107%26sid%3Dliteratum%253Aachs%26aulast%3DSkehan%26aufirst%3DP.%26aulast%3DStoreng%26aufirst%3DR.%26aulast%3DScudiero%26aufirst%3DD.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DMcMahon%26aufirst%3DJ.%26aulast%3DVistica%26aufirst%3DD.%26aulast%3DWarren%26aufirst%3DJ.%2BT.%26aulast%3DBokesch%26aufirst%3DH.%26aulast%3DKenney%26aufirst%3DS.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DNew%2520Colorimetric%2520Cytotoxicity%2520Assay%2520for%2520Anticancer-Drug%2520Screening%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1990%26volume%3D82%26spage%3D1107%26epage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Boyd, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paull, K. D.</span><span> </span><span class="NLM_article-title">Some Practical Considerations and Applications of the National Cancer Institute <i>in vitro</i> Anticancer Discovery Screen</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=91-109&author=M.+R.+Boydauthor=K.+D.+Paull&title=Some+Practical+Considerations+and+Applications+of+the+National+Cancer+Institute+in+vitro+Anticancer+Discovery+Screen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26aulast%3DPaull%26aufirst%3DK.%2BD.%26atitle%3DSome%2520Practical%2520Considerations%2520and%2520Applications%2520of%2520the%2520National%2520Cancer%2520Institute%2520in%2520vitro%2520Anticancer%2520Discovery%2520Screen%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1995%26volume%3D34%26spage%3D91%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Risinger, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polin, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helms, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeBoeuf, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joe, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopper-Borge, E</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludueña, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruh, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooberry, S. L.</span><span> </span><span class="NLM_article-title">The Taccalonolides: Microtubule Stabilizers that Circumvent Clinically Relevant Taxane Resistance Mechanisms</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">8881</span><span class="NLM_x">–</span> <span class="NLM_lpage">8888</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=8881-8888&author=A.+L.+Risingerauthor=E.+M.+Jacksonauthor=L.+A.+Polinauthor=G.+L.+Helmsauthor=D.+A.+LeBoeufauthor=P.+A.+Joeauthor=E+Hopper-Borgeauthor=R.+F.+Ludue%C3%B1aauthor=G.+D.+Kruhauthor=S.+L.+Mooberry&title=The+Taccalonolides%3A+Microtubule+Stabilizers+that+Circumvent+Clinically+Relevant+Taxane+Resistance+Mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRisinger%26aufirst%3DA.%2BL.%26aulast%3DJackson%26aufirst%3DE.%2BM.%26aulast%3DPolin%26aufirst%3DL.%2BA.%26aulast%3DHelms%26aufirst%3DG.%2BL.%26aulast%3DLeBoeuf%26aufirst%3DD.%2BA.%26aulast%3DJoe%26aufirst%3DP.%2BA.%26aulast%3DHopper-Borge%26aufirst%3DE%26aulast%3DLudue%25C3%25B1a%26aufirst%3DR.%2BF.%26aulast%3DKruh%26aufirst%3DG.%2BD.%26aulast%3DMooberry%26aufirst%3DS.%2BL.%26atitle%3DThe%2520Taccalonolides%253A%2520Microtubule%2520Stabilizers%2520that%2520Circumvent%2520Clinically%2520Relevant%2520Taxane%2520Resistance%2520Mechanisms%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D8881%26epage%3D8888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Ravelli, R. B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigant, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curmi, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knossow, M.</span><span> </span><span class="NLM_article-title">Insight into Tubulin Regulation from a Complex with Colchicine and a Stathmin-like Domain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">428</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1038%2Fnature02393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=15014504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFCls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=428&publication_year=2004&pages=198-202&author=R.+B.+G.+Ravelliauthor=B.+Gigantauthor=P.+A.+Curmiauthor=I.+Jourdainauthor=S.+Lachkarauthor=A.+Sobelauthor=M.+Knossow&title=Insight+into+Tubulin+Regulation+from+a+Complex+with+Colchicine+and+a+Stathmin-like+Domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain</span></div><div class="casAuthors">Ravelli, Raimond B. G.; Gigant, Benoit; Curmi, Patrick A.; Jourdain, Isabelle; Lachkar, Sylvie; Sobel, Andre; Knossow, Marcel</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">428</span>
        (<span class="NLM_cas:issue">6979</span>),
    <span class="NLM_cas:pages">198-202</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Microtubules are cytoskeletal polymers of tubulin involved in many cellular functions.  Their dynamic instability is controlled by numerous compds. and proteins, including colchicine and stathmin family proteins.  The way in which microtubule instability is regulated at the mol. level has remained elusive, mainly because of the lack of appropriate structural data.  Here, the authors present the structure, at 3.5 Å resoln., of tubulin in complex with colchicine (I) and with the stathmin-like domain (SLD) of RB3.  It showed the interaction of RB3-SLD with 2 tubulin heterodimers in a curved complex capped by the SLD N-terminal domain, which prevented the incorporation of the complexed tubulin into microtubules.  A comparison with the structure of tubulin in protofilaments showed changes in the subunits of tubulin as it switched from its straight conformation to a curved one.  These changes correlated with the loss of lateral contacts and provided a rationale for the rapid microtubule depolymn. characteristic of dynamic instability.  Moreover, the tubulin-I complex shed light on the mechanism of I activity; it was shown that I binds at a location where it prevents curved tubulin from adopting a straight structure, which inhibits assembly.  Thus, the results establish a relation between the onset and speed of microtubule disassembly and the changes in tubulin subunits when tubulin switches from its straight to its curved conformation.  The results further provide a mol. description of the interaction of RB3-SLD and I with tubulin, and may be useful for the development of novel therapeutic I analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx2vePjtf347Vg90H21EOLACvtfcHk0lhkIl8euzhs6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFCls7g%253D&md5=9fbb1edfc64239638a3c2eac879bffe9</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnature02393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02393%26sid%3Dliteratum%253Aachs%26aulast%3DRavelli%26aufirst%3DR.%2BB.%2BG.%26aulast%3DGigant%26aufirst%3DB.%26aulast%3DCurmi%26aufirst%3DP.%2BA.%26aulast%3DJourdain%26aufirst%3DI.%26aulast%3DLachkar%26aufirst%3DS.%26aulast%3DSobel%26aufirst%3DA.%26aulast%3DKnossow%26aufirst%3DM.%26atitle%3DInsight%2520into%2520Tubulin%2520Regulation%2520from%2520a%2520Complex%2520with%2520Colchicine%2520and%2520a%2520Stathmin-like%2520Domain%26jtitle%3DNature%26date%3D2004%26volume%3D428%26spage%3D198%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Nguyen, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermone, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaharevitz, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wipf, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gussio, R.</span><span> </span><span class="NLM_article-title">A Common Pharmacophore for a Diverse Set of Colchicine Site Inhibitors Using a Structure-based Approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6107</span><span class="NLM_x">–</span> <span class="NLM_lpage">6116</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050502t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpt1WitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6107-6116&author=T.+L.+Nguyenauthor=C.+McGrathauthor=A.+R.+Hermoneauthor=J.+C.+Burnettauthor=D.+W.+Zaharevitzauthor=B.+W.+Dayauthor=P.+Wipfauthor=E.+Hamelauthor=R.+Gussio&title=A+Common+Pharmacophore+for+a+Diverse+Set+of+Colchicine+Site+Inhibitors+Using+a+Structure-based+Approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach</span></div><div class="casAuthors">Nguyen, Tam Luong; McGrath, Connor; Hermone, Ann R.; Burnett, James C.; Zaharevitz, Daniel W.; Day, Billy W.; Wipf, Peter; Hamel, Ernest; Gussio, Rick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6107-6116</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Modulating the structure and function of tubulin and microtubules is an important route to anticancer therapeutics, and therefore, small mols. that bind to tubulin and cause mitotic arrest are of immense interest.  A large no. of synthetic and natural compds. with diverse structures have been shown to bind at the colchicine site, one of the major binding sites on tubulin, and inhibit tubulin assembly.  Using the recently detd. x-ray structure of the tubulin:colchicinoid complex as the template, we employed docking studies to det. the binding modes of a set of structurally diverse colchicine site inhibitors.  These binding models were subsequently used to construct a comprehensive, structure-based pharmacophore that in combination with mol. dynamics simulations confirms and extends our understanding of binding interactions at the colchicine site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp40uoXQZMHULVg90H21EOLACvtfcHk0lhkIl8euzhs6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpt1WitL8%253D&md5=443f25ca9212b379813d91ccdf820c5a</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm050502t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050502t%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DT.%2BL.%26aulast%3DMcGrath%26aufirst%3DC.%26aulast%3DHermone%26aufirst%3DA.%2BR.%26aulast%3DBurnett%26aufirst%3DJ.%2BC.%26aulast%3DZaharevitz%26aufirst%3DD.%2BW.%26aulast%3DDay%26aufirst%3DB.%2BW.%26aulast%3DWipf%26aufirst%3DP.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DGussio%26aufirst%3DR.%26atitle%3DA%2520Common%2520Pharmacophore%2520for%2520a%2520Diverse%2520Set%2520of%2520Colchicine%2520Site%2520Inhibitors%2520Using%2520a%2520Structure-based%2520Approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6107%26epage%3D6116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Bhattacharyya, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, M.</span><span> </span><span class="NLM_article-title">Anti-Mitotic Activity of Colchicine and the Structural Basis for its Interaction with Tubulin</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1002%2Fmed.20097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=17464966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVSjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=155-183&author=B.+Bhattacharyyaauthor=D.+Pandaauthor=S.+Guptaauthor=M.+Banerjee&title=Anti-Mitotic+Activity+of+Colchicine+and+the+Structural+Basis+for+its+Interaction+with+Tubulin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin</span></div><div class="casAuthors">Bhattacharyya, Bhabatarak; Panda, Dulal; Gupta, Suvroma; Banerjee, Mithu</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">155-183</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">In this review, an attempt has been made to throw light on the mechanism of action of colchicine and its different analogs as anti-cancer agents.  Colchicine interacts with tubulin and perturbs the assembly dynamics of microtubules.  Though its use has been limited because of its toxicity, colchicine can still be used as a lead compd. for the generation of potent anti-cancer drugs.  Colchicine binds to tubulin in a poorly reversible manner with high activation energy.  The binding interaction is favored entropically.  In contrast, binding of its simple analogs AC or DAAC is enthalpically favored and commences with comparatively low activation energy.  Colchicine-tubulin interaction, which is normally pH dependent, has been found to be independent of pH in the presence of microtubule-assocd. proteins, salts or upon cleavage of carboxy termini of tubulin.  Biphasic kinetics of colchicines-tubulin interaction has been explained in light of the variation in the residues around the drug-binding site on β-tubulin.  Using the crystal structure of the tubulin-DAMAcolchicine complex, a detailed discussion on the pharmacophore concept that explains the variation of affinity for different colchicine site inhibitors (CSI) has been discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9F4KA4GVMr7Vg90H21EOLACvtfcHk0lhkIl8euzhs6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVSjsA%253D%253D&md5=720f26c98a40dd91634dbe558d982e98</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fmed.20097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20097%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharyya%26aufirst%3DB.%26aulast%3DPanda%26aufirst%3DD.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DBanerjee%26aufirst%3DM.%26atitle%3DAnti-Mitotic%2520Activity%2520of%2520Colchicine%2520and%2520the%2520Structural%2520Basis%2520for%2520its%2520Interaction%2520with%2520Tubulin%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2008%26volume%3D28%26spage%3D155%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span>Molecular Operating Environment (MOE 2008.10); <span class="NLM_publisher-name">Chemical Computing Group, Inc.</span>: <span class="NLM_publisher-loc">Montreal, Quebec, Canada</span>, 2008; <a href="http://www.chemcomp.com" class="extLink">www.chemcomp.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Molecular+Operating+Environment+%28MOE+2008.10%29%3B+Chemical+Computing+Group%2C+Inc.%3A+Montreal%2C+Quebec%2C+Canada%2C+2008%3B+www.chemcomp.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Operating%2520Environment%2520%2528MOE%25202008.10%2529%26pub%3DChemical%2520Computing%2520Group%252C%2520Inc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">De Martino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Regina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coluccia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edler, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbera, M. C.</span><span> </span><span class="NLM_article-title">Arylthioindoles, Potent Inhibitors of Tubulin Polymerization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6120</span><span class="NLM_x">–</span> <span class="NLM_lpage">6123</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049360d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6120-6123&author=G.+De+Martinoauthor=G.+La+Reginaauthor=A.+Colucciaauthor=M.+C.+Edlerauthor=M.+C.+Barbera&title=Arylthioindoles%2C+Potent+Inhibitors+of+Tubulin+Polymerization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm049360d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049360d%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BMartino%26aufirst%3DG.%26aulast%3DLa%2BRegina%26aufirst%3DG.%26aulast%3DColuccia%26aufirst%3DA.%26aulast%3DEdler%26aufirst%3DM.%2BC.%26aulast%3DBarbera%26aufirst%3DM.%2BC.%26atitle%3DArylthioindoles%252C%2520Potent%2520Inhibitors%2520of%2520Tubulin%2520Polymerization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6120%26epage%3D6123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Gangjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisliuk, R. L.</span><span> </span><span class="NLM_article-title">5-Arylthio Substituted 2-Amino-4-oxo-6-methylpyrrolo[2,3-<i>d</i>]pyrimidine Antifolates as Thymidylate Synthase Inhibitors and Antitumor Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">4495</span><span class="NLM_x">–</span> <span class="NLM_lpage">4502</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00022a015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=4495-4502&author=A.+Gangjeeauthor=R.+Devrajauthor=J.+J.+McGuireauthor=R.+L.+Kisliuk&title=5-Arylthio+Substituted+2-Amino-4-oxo-6-methylpyrrolo%5B2%2C3-d%5Dpyrimidine+Antifolates+as+Thymidylate+Synthase+Inhibitors+and+Antitumor+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm00022a015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00022a015%26sid%3Dliteratum%253Aachs%26aulast%3DGangjee%26aufirst%3DA.%26aulast%3DDevraj%26aufirst%3DR.%26aulast%3DMcGuire%26aufirst%3DJ.%2BJ.%26aulast%3DKisliuk%26aufirst%3DR.%2BL.%26atitle%3D5-Arylthio%2520Substituted%25202-Amino-4-oxo-6-methylpyrrolo%255B2%252C3-d%255Dpyrimidine%2520Antifolates%2520as%2520Thymidylate%2520Synthase%2520Inhibitors%2520and%2520Antitumor%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D4495%26epage%3D4502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Gangjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasudevan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisliuk, R. L.</span><span> </span><span class="NLM_article-title">Nonclassical 5-Substituted Tetrahydroquinazolines as Potential Inhibitors of Thymidylate Synthase</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1669</span><span class="NLM_x">–</span> <span class="NLM_lpage">1676</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1997&pages=1669-1676&author=A.+Gangjeeauthor=A.+Vasudevanauthor=R.+L.+Kisliuk&title=Nonclassical+5-Substituted+Tetrahydroquinazolines+as+Potential+Inhibitors+of+Thymidylate+Synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGangjee%26aufirst%3DA.%26aulast%3DVasudevan%26aufirst%3DA.%26aulast%3DKisliuk%26aufirst%3DR.%2BL.%26atitle%3DNonclassical%25205-Substituted%2520Tetrahydroquinazolines%2520as%2520Potential%2520Inhibitors%2520of%2520Thymidylate%2520Synthase%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1997%26volume%3D34%26spage%3D1669%26epage%3D1676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Gangjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mavandadi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisliuk, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Queener, S. F.</span><span> </span><span class="NLM_article-title">Synthesis of Classical and a Nonclassical 2-Amino-4-oxo-6-methyl-5-substituted Pyrrolo[2,3-<i>d</i>]pyrimidine Antifolate Inhibitors of Thymidylate Synthase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2272</span><span class="NLM_x">–</span> <span class="NLM_lpage">2279</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980586o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=2272-2279&author=A.+Gangjeeauthor=F.+Mavandadiauthor=R.+L.+Kisliukauthor=S.+F.+Queener&title=Synthesis+of+Classical+and+a+Nonclassical+2-Amino-4-oxo-6-methyl-5-substituted+Pyrrolo%5B2%2C3-d%5Dpyrimidine+Antifolate+Inhibitors+of+Thymidylate+Synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm980586o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980586o%26sid%3Dliteratum%253Aachs%26aulast%3DGangjee%26aufirst%3DA.%26aulast%3DMavandadi%26aufirst%3DF.%26aulast%3DKisliuk%26aufirst%3DR.%2BL.%26aulast%3DQueener%26aufirst%3DS.%2BF.%26atitle%3DSynthesis%2520of%2520Classical%2520and%2520a%2520Nonclassical%25202-Amino-4-oxo-6-methyl-5-substituted%2520Pyrrolo%255B2%252C3-d%255Dpyrimidine%2520Antifolate%2520Inhibitors%2520of%2520Thymidylate%2520Synthase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D2272%26epage%3D2279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Gangjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisliuk, R. L.</span><span> </span><span class="NLM_article-title">Benzoyl Ring Halogenated Classical 2-Amino-6-methyl-3,4-dihydro-4-oxo-5-substituted Thiobenzoyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine Antifolates as Inhibitors of Thymidylate Synthase and as Antitumor Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6730</span><span class="NLM_x">–</span> <span class="NLM_lpage">6739</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040144e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6730-6739&author=A.+Gangjeeauthor=H.+D.+Jainauthor=J.+J.+McGuireauthor=R.+L.+Kisliuk&title=Benzoyl+Ring+Halogenated+Classical+2-Amino-6-methyl-3%2C4-dihydro-4-oxo-5-substituted+Thiobenzoyl-7H-pyrrolo%5B2%2C3-d%5Dpyrimidine+Antifolates+as+Inhibitors+of+Thymidylate+Synthase+and+as+Antitumor+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm040144e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040144e%26sid%3Dliteratum%253Aachs%26aulast%3DGangjee%26aufirst%3DA.%26aulast%3DJain%26aufirst%3DH.%2BD.%26aulast%3DMcGuire%26aufirst%3DJ.%2BJ.%26aulast%3DKisliuk%26aufirst%3DR.%2BL.%26atitle%3DBenzoyl%2520Ring%2520Halogenated%2520Classical%25202-Amino-6-methyl-3%252C4-dihydro-4-oxo-5-substituted%2520Thiobenzoyl-7H-pyrrolo%255B2%252C3-d%255Dpyrimidine%2520Antifolates%2520as%2520Inhibitors%2520of%2520Thymidylate%2520Synthase%2520and%2520as%2520Antitumor%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6730%26epage%3D6739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Gangjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisliuk, R. L.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of Classical and Nonclassical 2-Amino-4-oxo-5-substituted-6-methylpyrrolo[3,2-<i>d</i>]pyrimidines as Dual Thymidylate Synthase and Dihydrofolate Reductase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701052u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=68-76&author=A.+Gangjeeauthor=W.+Liauthor=J.+Yangauthor=R.+L.+Kisliuk&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Classical+and+Nonclassical+2-Amino-4-oxo-5-substituted-6-methylpyrrolo%5B3%2C2-d%5Dpyrimidines+as+Dual+Thymidylate+Synthase+and+Dihydrofolate+Reductase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm701052u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701052u%26sid%3Dliteratum%253Aachs%26aulast%3DGangjee%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DKisliuk%26aufirst%3DR.%2BL.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Classical%2520and%2520Nonclassical%25202-Amino-4-oxo-5-substituted-6-methylpyrrolo%255B3%252C2-d%255Dpyrimidines%2520as%2520Dual%2520Thymidylate%2520Synthase%2520and%2520Dihydrofolate%2520Reductase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D68%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Webber, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleckman, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deal, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kathardekar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsh, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, D. A.</span><span> </span><span class="NLM_article-title">Design of Thymidylate Synthase Inhibitors Using Protein Crystal Structures: The Synthesis and Biological Evaluation of a Novel Class of 5-Substituted Quinazolinones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00058a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=733-746&author=S.+J.+Webberauthor=T.+M.+Bleckmanauthor=J.+Attardauthor=J.+G.+Dealauthor=V.+Kathardekarauthor=K.+M.+Welshauthor=S.+Webberauthor=C.+A.+Jansonauthor=D.+A.+Matthews&title=Design+of+Thymidylate+Synthase+Inhibitors+Using+Protein+Crystal+Structures%3A+The+Synthesis+and+Biological+Evaluation+of+a+Novel+Class+of+5-Substituted+Quinazolinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm00058a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00058a010%26sid%3Dliteratum%253Aachs%26aulast%3DWebber%26aufirst%3DS.%2BJ.%26aulast%3DBleckman%26aufirst%3DT.%2BM.%26aulast%3DAttard%26aufirst%3DJ.%26aulast%3DDeal%26aufirst%3DJ.%2BG.%26aulast%3DKathardekar%26aufirst%3DV.%26aulast%3DWelsh%26aufirst%3DK.%2BM.%26aulast%3DWebber%26aufirst%3DS.%26aulast%3DJanson%26aufirst%3DC.%2BA.%26aulast%3DMatthews%26aufirst%3DD.%2BA.%26atitle%3DDesign%2520of%2520Thymidylate%2520Synthase%2520Inhibitors%2520Using%2520Protein%2520Crystal%2520Structures%253A%2520The%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520a%2520Novel%2520Class%2520of%25205-Substituted%2520Quinazolinones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D733%26epage%3D746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span>Sybyl X 1.1; <span class="NLM_publisher-name">Tripos, Inc.</span>: <span class="NLM_publisher-loc">St. Louis, MO</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sybyl+X+1.1%3B+Tripos%2C+Inc.%3A+St.+Louis%2C+MO%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSybyl%2520X%25201.1%26pub%3DTripos%252C%2520Inc%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baichwal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skvortsova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skvortsov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">English, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirisoma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pervin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiman, C. M.</span><span> </span><span class="NLM_article-title">MPC-6827: A Small Molecule Inhibitor of Microtubule Formation that is not a Substrate for Multidrug Resistance Pumps</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">5865</span><span class="NLM_x">–</span> <span class="NLM_lpage">5871</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=5865-5871&author=S.+Kasibhatlaauthor=V.+Baichwalauthor=S.+X.+Caiauthor=B.+Rothauthor=I.+Skvortsovaauthor=S.+Skvortsovauthor=P.+Lukasauthor=N.+M.+Englishauthor=N.+Sirisomaauthor=J.+Dreweauthor=A.+Pervinauthor=B.+Tsengauthor=R.+O.+Carlsonauthor=C.+M.+Pleiman&title=MPC-6827%3A+A+Small+Molecule+Inhibitor+of+Microtubule+Formation+that+is+not+a+Substrate+for+Multidrug+Resistance+Pumps"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DBaichwal%26aufirst%3DV.%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DRoth%26aufirst%3DB.%26aulast%3DSkvortsova%26aufirst%3DI.%26aulast%3DSkvortsov%26aufirst%3DS.%26aulast%3DLukas%26aufirst%3DP.%26aulast%3DEnglish%26aufirst%3DN.%2BM.%26aulast%3DSirisoma%26aufirst%3DN.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DPervin%26aufirst%3DA.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DCarlson%26aufirst%3DR.%2BO.%26aulast%3DPleiman%26aufirst%3DC.%2BM.%26atitle%3DMPC-6827%253A%2520A%2520Small%2520Molecule%2520Inhibitor%2520of%2520Microtubule%2520Formation%2520that%2520is%2520not%2520a%2520Substrate%2520for%2520Multidrug%2520Resistance%2520Pumps%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D5865%26epage%3D5871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Sirisoma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pervin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willardsen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baichwal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessing, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiman, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery of 2-Chloro-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (EP128265, MPI-0441138) as a Potent Inducer of Apoptosis with High In Vivo Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4771</span><span class="NLM_x">–</span> <span class="NLM_lpage">4779</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8003653" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4771-4779&author=N.+Sirisomaauthor=S.+Kasibhatlaauthor=A.+Pervinauthor=H.+Zhangauthor=S.+Jiangauthor=J.+A.+Willardsenauthor=M.+Andersonauthor=V.+Baichwalauthor=G.+G.+Matherauthor=K.+Jessingauthor=R.+Hussainauthor=K.+Hoangauthor=C.+M.+Pleimanauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery+of+2-Chloro-N-%284-methoxyphenyl%29-N-methylquinazolin-4-amine+%28EP128265%2C+MPI-0441138%29+as+a+Potent+Inducer+of+Apoptosis+with+High+In+Vivo+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm8003653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8003653%26sid%3Dliteratum%253Aachs%26aulast%3DSirisoma%26aufirst%3DN.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DPervin%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26aulast%3DAnderson%26aufirst%3DM.%26aulast%3DBaichwal%26aufirst%3DV.%26aulast%3DMather%26aufirst%3DG.%2BG.%26aulast%3DJessing%26aufirst%3DK.%26aulast%3DHussain%26aufirst%3DR.%26aulast%3DHoang%26aufirst%3DK.%26aulast%3DPleiman%26aufirst%3DC.%2BM.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%25202-Chloro-N-%25284-methoxyphenyl%2529-N-methylquinazolin-4-amine%2520%2528EP128265%252C%2520MPI-0441138%2529%2520as%2520a%2520Potent%2520Inducer%2520of%2520Apoptosis%2520with%2520High%2520In%2520Vivo%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4771%26epage%3D4779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Sirisoma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pervin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willardsen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiman, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-(4-Methoxyphenyl)-<i>N</i>,2-dimethylquinazolin-4-amine, a Potent Apoptosis Inducer and Efficacious Anticancer Agent with High Blood Brain Barrier Penetration</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2341</span><span class="NLM_x">–</span> <span class="NLM_lpage">2351</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801315b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2341-2351&author=N.+Sirisomaauthor=A.+Pervinauthor=H.+Zhangauthor=S.+Jiangauthor=J.+A.+Willardsenauthor=M.+Andersonauthor=G.+G.+Matherauthor=C.+M.+Pleimanauthor=S.+Kasibhatlaauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery+of+N-%284-Methoxyphenyl%29-N%2C2-dimethylquinazolin-4-amine%2C+a+Potent+Apoptosis+Inducer+and+Efficacious+Anticancer+Agent+with+High+Blood+Brain+Barrier+Penetration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm801315b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801315b%26sid%3Dliteratum%253Aachs%26aulast%3DSirisoma%26aufirst%3DN.%26aulast%3DPervin%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26aulast%3DAnderson%26aufirst%3DM.%26aulast%3DMather%26aufirst%3DG.%2BG.%26aulast%3DPleiman%26aufirst%3DC.%2BM.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%2520N-%25284-Methoxyphenyl%2529-N%252C2-dimethylquinazolin-4-amine%252C%2520a%2520Potent%2520Apoptosis%2520Inducer%2520and%2520Efficacious%2520Anticancer%2520Agent%2520with%2520High%2520Blood%2520Brain%2520Barrier%2520Penetration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2341%26epage%3D2351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Sirisoma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pervin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willardsen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiman, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-methyl-4-(4-methoxyanilino) quinazolines as Potent Apoptosis Inducers. Structure−Activity Relationship of the Quinazoline Ring</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2030</span><span class="NLM_x">–</span> <span class="NLM_lpage">2334</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2030-2334&author=N.+Sirisomaauthor=A.+Pervinauthor=H.+Zhangauthor=S.+Jiangauthor=J.+A.+Willardsenauthor=M.+Andersonauthor=G.+G.+Matherauthor=C.+M.+Pleimanauthor=S.+Kasibhatlaauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery+of+N-methyl-4-%284-methoxyanilino%29+quinazolines+as+Potent+Apoptosis+Inducers.+Structure%E2%88%92Activity+Relationship+of+the+Quinazoline+Ring"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSirisoma%26aufirst%3DN.%26aulast%3DPervin%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26aulast%3DAnderson%26aufirst%3DM.%26aulast%3DMather%26aufirst%3DG.%2BG.%26aulast%3DPleiman%26aufirst%3DC.%2BM.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%2520N-methyl-4-%25284-methoxyanilino%2529%2520quinazolines%2520as%2520Potent%2520Apoptosis%2520Inducers.%2520Structure%25E2%2588%2592Activity%2520Relationship%2520of%2520the%2520Quinazoline%2520Ring%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2030%26epage%3D2334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Kemnitzer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirisoma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery of 4-Anilino-N-methylthieno[3,2-<i>d</i>]pyrimidines and 4-Anilino-N-methylthieno[2,3-d]pyrimidines as Potent Apoptosis Inducers</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3536</span><span class="NLM_x">–</span> <span class="NLM_lpage">3540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3536-3540&author=W.+Kemnitzerauthor=N.+Sirisomaauthor=C.+Mayauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery+of+4-Anilino-N-methylthieno%5B3%2C2-d%5Dpyrimidines+and+4-Anilino-N-methylthieno%5B2%2C3-d%5Dpyrimidines+as+Potent+Apoptosis+Inducers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKemnitzer%26aufirst%3DW.%26aulast%3DSirisoma%26aufirst%3DN.%26aulast%3DMay%26aufirst%3DC.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%25204-Anilino-N-methylthieno%255B3%252C2-d%255Dpyrimidines%2520and%25204-Anilino-N-methylthieno%255B2%252C3-d%255Dpyrimidines%2520as%2520Potent%2520Apoptosis%2520Inducers%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3536%26epage%3D3540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span> </span><span class="NLM_article-title">Separation of Active Tubulin and Microtubule-associated Proteins by Ultracentrifugation and Isolation of a Component Causing the Formation of Microtubule bundles</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4173</span><span class="NLM_x">–</span> <span class="NLM_lpage">4184</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00313a026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1984&pages=4173-4184&author=E.+Hamelauthor=C.+M.+Lin&title=Separation+of+Active+Tubulin+and+Microtubule-associated+Proteins+by+Ultracentrifugation+and+Isolation+of+a+Component+Causing+the+Formation+of+Microtubule+bundles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fbi00313a026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00313a026%26sid%3Dliteratum%253Aachs%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DC.%2BM.%26atitle%3DSeparation%2520of%2520Active%2520Tubulin%2520and%2520Microtubule-associated%2520Proteins%2520by%2520Ultracentrifugation%2520and%2520Isolation%2520of%2520a%2520Component%2520Causing%2520the%2520Formation%2520of%2520Microtubule%2520bundles%26jtitle%3DBiochemistry%26date%3D1984%26volume%3D23%26spage%3D4173%26epage%3D4184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Hamel, E.</span><span> </span><span class="NLM_article-title">Evaluation of Antimitotic Agents by Quantitative Comparisons of Their Effects on the Polymerization of Purified Tubulin</span> <span class="citation_source-journal">Cell Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1385%2FCBB%3A38%3A1%3A1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=12663938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtVaisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=1-22&author=E.+Hamel&title=Evaluation+of+Antimitotic+Agents+by+Quantitative+Comparisons+of+Their+Effects+on+the+Polymerization+of+Purified+Tubulin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin</span></div><div class="casAuthors">Hamel, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-21</span>CODEN:
                <span class="NLM_cas:coden">CBBIFV</span>;
        ISSN:<span class="NLM_cas:issn">1085-9195</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Most antimitotic compds. have highly specific interactions with tubulin, the major protein component of microtubules.  It is, therefore, often desirable to characterize interactions of these agents with tubulin.  In particular, quant. comparisons between new and old ("std.") agents, between different classes of agent, and between structural analogs (e.g., for a structure-activity relationship study) are important.  Because antimitotic drugs have a variety of effects on tubulin and bind at multiple distinct sites on the protein, the tubulin assembly reaction is probably the only universally applicable reaction that can be analyzed.  In my lab., we use the assembly of purified tubulin induced by higher concns. of monosodium glutamate as our basic assay system.  This report presents a detailed description of our current routine assay, including the effects of a variety of reaction components on the reaction.  In addn., the variety of effects that reaction components can have on the quant. results obtained with drugs, using the colchicine site drug combretastatin A-4 as a model compd., is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLvDICXLUiYbVg90H21EOLACvtfcHk0ljsYFIcGFnWxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtVaisLY%253D&md5=c37c365cc707e237f43feffca64d706b</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1385%2FCBB%3A38%3A1%3A1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FCBB%253A38%253A1%253A1%26sid%3Dliteratum%253Aachs%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DEvaluation%2520of%2520Antimitotic%2520Agents%2520by%2520Quantitative%2520Comparisons%2520of%2520Their%2520Effects%2520on%2520the%2520Polymerization%2520of%2520Purified%2520Tubulin%26jtitle%3DCell%2520Biochem.%2520Biophys.%26date%3D2003%26volume%3D38%26spage%3D1%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Verdier-Pinard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, H.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Márquez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagle, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falck, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerwick, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span> </span><span class="NLM_article-title">Structure-Activity Analysis of the Interaction of Curacin a, the Potent Colchicine Site Antimitotic Agent, with Tubulin and Effects of Analogs on the Growth of MCF-7 Breast Cancer Cells</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1998&pages=62-76&author=P.+Verdier-Pinardauthor=J.-Y.+Laiauthor=H.-D.+Yooauthor=J.+Yuauthor=B.+M%C3%A1rquezauthor=D.+G.+Nagleauthor=M.+Nambuauthor=J.+D.+Whiteauthor=J.+R.+Falckauthor=W.+H.+Gerwickauthor=B.+W.+Dayauthor=E.+Hamel&title=Structure-Activity+Analysis+of+the+Interaction+of+Curacin+a%2C+the+Potent+Colchicine+Site+Antimitotic+Agent%2C+with+Tubulin+and+Effects+of+Analogs+on+the+Growth+of+MCF-7+Breast+Cancer+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerdier-Pinard%26aufirst%3DP.%26aulast%3DLai%26aufirst%3DJ.-Y.%26aulast%3DYoo%26aufirst%3DH.-D.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DM%25C3%25A1rquez%26aufirst%3DB.%26aulast%3DNagle%26aufirst%3DD.%2BG.%26aulast%3DNambu%26aufirst%3DM.%26aulast%3DWhite%26aufirst%3DJ.%2BD.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DGerwick%26aufirst%3DW.%2BH.%26aulast%3DDay%26aufirst%3DB.%2BW.%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DStructure-Activity%2520Analysis%2520of%2520the%2520Interaction%2520of%2520Curacin%2520a%252C%2520the%2520Potent%2520Colchicine%2520Site%2520Antimitotic%2520Agent%252C%2520with%2520Tubulin%2520and%2520Effects%2520of%2520Analogs%2520on%2520the%2520Growth%2520of%2520MCF-7%2520Breast%2520Cancer%2520Cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D1998%26volume%3D53%26spage%3D62%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 50 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Junting Zhou, Xueyang Jiang, Siyu He, Hongli Jiang, Feng Feng, Wenyuan Liu, Wei Qu, <span class="NLM_string-name hlFld-ContribAuthor">Haopeng Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (20)
                                     , 8881-8914. <a href="https://doi.org/10.1021/acs.jmedchem.9b00017" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00017%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252BDesign%252Bof%252BMultitarget-Directed%252BLigands%25253A%252BStrategies%252Band%252BEmerging%252BParadigms%26aulast%3DZhou%26aufirst%3DJunting%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D04012019%26date%3D28052019%26date%3D13052019%26volume%3D62%26issue%3D20%26spage%3D8881%26epage%3D8914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Haichan Niu, Tracy E. Strecker, Jeni L. Gerberich, James W. Campbell, III, Debabrata Saha, Deboprosad Mondal, Ernest Hamel, David J. Chaplin, Ralph P. Mason, Mary Lynn Trawick, <span class="NLM_string-name hlFld-ContribAuthor">Kevin G. Pinney</span>. </span><span class="cited-content_cbyCitation_article-title">Structure Guided Design, Synthesis, and Biological Evaluation of Novel Benzosuberene Analogues as Inhibitors of Tubulin Polymerization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (11)
                                     , 5594-5615. <a href="https://doi.org/10.1021/acs.jmedchem.9b00551" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00551</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00551%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%252BGuided%252BDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BBenzosuberene%252BAnalogues%252Bas%252BInhibitors%252Bof%252BTubulin%252BPolymerization%26aulast%3DNiu%26aufirst%3DHaichan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D30032019%26date%3D24052019%26date%3D06052019%26volume%3D62%26issue%3D11%26spage%3D5594%26epage%3D5615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Souvik  Banerjee</span>, <span class="hlFld-ContribAuthor ">Kinsie E.  Arnst</span>, <span class="hlFld-ContribAuthor ">Yuxi  Wang</span>, <span class="hlFld-ContribAuthor ">Gyanendra  Kumar</span>, <span class="hlFld-ContribAuthor ">Shanshan  Deng</span>, <span class="hlFld-ContribAuthor ">Lei  Yang</span>, <span class="hlFld-ContribAuthor ">Guo-bo  Li</span>, <span class="hlFld-ContribAuthor ">Jinliang  Yang</span>, <span class="hlFld-ContribAuthor ">Stephen W.  White</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, and <span class="hlFld-ContribAuthor ">Duane D.  Miller</span>  . </span><span class="cited-content_cbyCitation_article-title">Heterocyclic-Fused Pyrimidines as Novel Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site: Structural Basis and Antitumor Efficacy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (4)
                                     , 1704-1718. <a href="https://doi.org/10.1021/acs.jmedchem.7b01858" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01858</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01858%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHeterocyclic-Fused%252BPyrimidines%252Bas%252BNovel%252BTubulin%252BPolymerization%252BInhibitors%252BTargeting%252Bthe%252BColchicine%252BBinding%252BSite%25253A%252BStructural%252BBasis%252Band%252BAntitumor%252BEfficacy%26aulast%3DBanerjee%26aufirst%3DSouvik%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D21122017%26date%3D12022018%26date%3D22022018%26date%3D06022018%26volume%3D61%26issue%3D4%26spage%3D1704%26epage%3D1718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María-Jesús  Pérez-Pérez</span>, <span class="hlFld-ContribAuthor ">Eva-María  Priego</span>, <span class="hlFld-ContribAuthor ">Oskía  Bueno</span>, <span class="hlFld-ContribAuthor ">Maria Solange  Martins</span>, <span class="hlFld-ContribAuthor ">María-Dolores  Canela</span>, and <span class="hlFld-ContribAuthor ">Sandra  Liekens</span>  . </span><span class="cited-content_cbyCitation_article-title">Blocking Blood Flow to Solid Tumors by Destabilizing Tubulin: An Approach to Targeting Tumor Growth. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (19)
                                     , 8685-8711. <a href="https://doi.org/10.1021/acs.jmedchem.6b00463" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00463%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBlocking%252BBlood%252BFlow%252Bto%252BSolid%252BTumors%252Bby%252BDestabilizing%252BTubulin%25253A%252BAn%252BApproach%252Bto%252BTargeting%252BTumor%252BGrowth%26aulast%3DP%25C3%25A9rez-P%25C3%25A9rez%26aufirst%3DMar%25C3%25ADa-Jes%25C3%25BAs%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D29032016%26date%3D27062016%26date%3D13102016%26volume%3D59%26issue%3D19%26spage%3D8685%26epage%3D8711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laurens M.  De Coen</span>, <span class="hlFld-ContribAuthor ">Thomas S. A.  Heugebaert</span>, <span class="hlFld-ContribAuthor ">Daniel  García</span>, and <span class="hlFld-ContribAuthor ">Christian V.  Stevens</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthetic Entries to and Biological Activity of Pyrrolopyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (1)
                                     , 80-139. <a href="https://doi.org/10.1021/acs.chemrev.5b00483" title="DOI URL">https://doi.org/10.1021/acs.chemrev.5b00483</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.5b00483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.5b00483%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DSynthetic%252BEntries%252Bto%252Band%252BBiological%252BActivity%252Bof%252BPyrrolopyrimidines%26aulast%3DDe%2BCoen%26aufirst%3DLaurens%2BM.%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D14082015%26date%3D23122015%26date%3D13012016%26volume%3D116%26issue%3D1%26spage%3D80%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tingting  Gao</span> and <span class="hlFld-ContribAuthor ">Peipei  Sun</span>  . </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed N-Nitroso-Directed C–H Alkoxylation of Arenes and Subsequent Formation of 2-Alkoxy-N-alkylarylamines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>79 </em>
                                    (20)
                                     , 9888-9893. <a href="https://doi.org/10.1021/jo501902d" title="DOI URL">https://doi.org/10.1021/jo501902d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo501902d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo501902d%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPalladium-Catalyzed%252BN-Nitroso-Directed%252BC%2525E2%252580%252593H%252BAlkoxylation%252Bof%252BArenes%252Band%252BSubsequent%252BFormation%252Bof%252B2-Alkoxy-N-alkylarylamines%26aulast%3DGao%26aufirst%3DTingting%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D17082014%26date%3D02102014%26date%3D17102014%26date%3D24092014%26volume%3D79%26issue%3D20%26spage%3D9888%26epage%3D9893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Petr  Nauš</span>, <span class="hlFld-ContribAuthor ">Olga  Caletková</span>, <span class="hlFld-ContribAuthor ">Petr  Konečný</span>, <span class="hlFld-ContribAuthor ">Petr  Džubák</span>, <span class="hlFld-ContribAuthor ">Kateřina  Bogdanová</span>, <span class="hlFld-ContribAuthor ">Milan  Kolář</span>, <span class="hlFld-ContribAuthor ">Jana  Vrbková</span>, <span class="hlFld-ContribAuthor ">Lenka  Slavětínská</span>, <span class="hlFld-ContribAuthor ">Eva  Tloušt’ová</span>, <span class="hlFld-ContribAuthor ">Pavla  Perlíková</span>, <span class="hlFld-ContribAuthor ">Marián  Hajdúch</span>, and <span class="hlFld-ContribAuthor ">Michal  Hocek</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis, Cytostatic, Antimicrobial, and Anti-HCV Activity of 6-Substituted 7-(Het)aryl-7-deazapurine Ribonucleosides. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (3)
                                     , 1097-1110. <a href="https://doi.org/10.1021/jm4018948" title="DOI URL">https://doi.org/10.1021/jm4018948</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4018948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4018948%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252BCytostatic%25252C%252BAntimicrobial%25252C%252Band%252BAnti-HCV%252BActivity%252Bof%252B6-Substituted%252B7-%252528Het%252529aryl-7-deazapurine%252BRibonucleosides%26aulast%3DNau%25C5%25A1%26aufirst%3DPetr%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D10122013%26date%3D16012014%26date%3D13022014%26date%3D07012014%26volume%3D57%26issue%3D3%26spage%3D1097%26epage%3D1110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hsueh-Yun  Lee</span>, <span class="hlFld-ContribAuthor ">Shiow-Lin  Pan</span>, <span class="hlFld-ContribAuthor ">Min-Chieh  Su</span>, <span class="hlFld-ContribAuthor ">Yi-Min  Liu</span>, <span class="hlFld-ContribAuthor ">Ching-Chuan  Kuo</span>, <span class="hlFld-ContribAuthor ">Yi-Ting  Chang</span>, <span class="hlFld-ContribAuthor ">Jian-Sung  Wu</span>, <span class="hlFld-ContribAuthor ">Chih-Ying  Nien</span>, <span class="hlFld-ContribAuthor ">Samir  Mehndiratta</span>, <span class="hlFld-ContribAuthor ">Chi-Yen  Chang</span>, <span class="hlFld-ContribAuthor ">Su-Ying  Wu</span>, <span class="hlFld-ContribAuthor ">Mei-Jung  Lai</span>, <span class="hlFld-ContribAuthor ">Jang-Yang  Chang</span>, and <span class="hlFld-ContribAuthor ">Jing-Ping  Liou</span>  . </span><span class="cited-content_cbyCitation_article-title">Furanylazaindoles: Potent Anticancer Agents in Vitro and in Vivo. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (20)
                                     , 8008-8018. <a href="https://doi.org/10.1021/jm4011115" title="DOI URL">https://doi.org/10.1021/jm4011115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4011115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4011115%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFuranylazaindoles%25253A%252BPotent%252BAnticancer%252BAgents%252Bin%252BVitro%252Band%252Bin%252BVivo%26aulast%3DLee%26aufirst%3DHsueh-Yun%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D16072013%26date%3D09102013%26date%3D24102013%26date%3D24092013%26volume%3D56%26issue%3D20%26spage%3D8008%26epage%3D8018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chenxiao  Da</span>, <span class="hlFld-ContribAuthor ">Susan L.  Mooberry</span>, <span class="hlFld-ContribAuthor ">John T.  Gupton</span>, and <span class="hlFld-ContribAuthor ">Glen E.  Kellogg</span>  . </span><span class="cited-content_cbyCitation_article-title">How to Deal with Low-Resolution Target Structures: Using SAR, Ensemble Docking, Hydropathic Analysis, and 3D-QSAR to Definitively Map the αβ-Tubulin Colchicine Site. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (18)
                                     , 7382-7395. <a href="https://doi.org/10.1021/jm400954h" title="DOI URL">https://doi.org/10.1021/jm400954h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400954h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400954h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHow%252Bto%252BDeal%252Bwith%252BLow-Resolution%252BTarget%252BStructures%25253A%252BUsing%252BSAR%25252C%252BEnsemble%252BDocking%25252C%252BHydropathic%252BAnalysis%25252C%252Band%252B3D-QSAR%252Bto%252BDefinitively%252BMap%252Bthe%252B%2525CE%2525B1%2525CE%2525B2-Tubulin%252BColchicine%252BSite%26aulast%3DDa%26aufirst%3DChenxiao%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D25062013%26date%3D09092013%26date%3D26092013%26date%3D20082013%26volume%3D56%26issue%3D18%26spage%3D7382%26epage%3D7395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>, <span class="hlFld-ContribAuthor ">Ying  Zhao</span>, <span class="hlFld-ContribAuthor ">Sudhir  Raghavan</span>, <span class="hlFld-ContribAuthor ">Cristina C.  Rohena</span>, <span class="hlFld-ContribAuthor ">Susan L.  Mooberry</span>, and <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationship and in Vitro and in Vivo Evaluation of the Potent Cytotoxic Anti-microtubule Agent N-(4-Methoxyphenyl)-N,2,6-trimethyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-aminium Chloride and Its Analogues As Antitumor Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (17)
                                     , 6829-6844. <a href="https://doi.org/10.1021/jm400639z" title="DOI URL">https://doi.org/10.1021/jm400639z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400639z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400639z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationship%252Band%252Bin%252BVitro%252Band%252Bin%252BVivo%252BEvaluation%252Bof%252Bthe%252BPotent%252BCytotoxic%252BAnti-microtubule%252BAgent%252BN-%2525284-Methoxyphenyl%252529-N%25252C2%25252C6-trimethyl-6%25252C7-dihydro-5H-cyclopenta%25255Bd%25255Dpyrimidin-4-aminium%252BChloride%252Band%252BIts%252BAnalogues%252BAs%252BAntitumor%252BAgents%26aulast%3DGangjee%26aufirst%3DAleem%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D30042013%26date%3D29082013%26date%3D12092013%26date%3D29072013%26volume%3D56%26issue%3D17%26spage%3D6829%26epage%3D6844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liliya V.  Frolova</span>, <span class="hlFld-ContribAuthor ">Igor V.  Magedov</span>, <span class="hlFld-ContribAuthor ">Anntherese E.  Romero</span>, <span class="hlFld-ContribAuthor ">Menuka  Karki</span>, <span class="hlFld-ContribAuthor ">Isaiah  Otero</span>, <span class="hlFld-ContribAuthor ">Kathryn  Hayden</span>, <span class="hlFld-ContribAuthor ">Nikolai M.  Evdokimov</span>, <span class="hlFld-ContribAuthor ">Laetitia Moreno Y.  Banuls</span>, <span class="hlFld-ContribAuthor ">Shiva K.  Rastogi</span>, <span class="hlFld-ContribAuthor ">W. Ross  Smith</span>, <span class="hlFld-ContribAuthor ">Shi-Long  Lu</span>, <span class="hlFld-ContribAuthor ">Robert  Kiss</span>, <span class="hlFld-ContribAuthor ">Charles B.  Shuster</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Tania  Betancourt</span>, <span class="hlFld-ContribAuthor ">Snezna  Rogelj</span>, and <span class="hlFld-ContribAuthor ">Alexander  Kornienko</span>  . </span><span class="cited-content_cbyCitation_article-title">Exploring Natural Product Chemistry and Biology with Multicomponent Reactions. 5. Discovery of a Novel Tubulin-Targeting Scaffold Derived from the Rigidin Family of Marine Alkaloids. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (17)
                                     , 6886-6900. <a href="https://doi.org/10.1021/jm400711t" title="DOI URL">https://doi.org/10.1021/jm400711t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400711t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400711t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploring%252BNatural%252BProduct%252BChemistry%252Band%252BBiology%252Bwith%252BMulticomponent%252BReactions.%252B5.%252BDiscovery%252Bof%252Ba%252BNovel%252BTubulin-Targeting%252BScaffold%252BDerived%252Bfrom%252Bthe%252BRigidin%252BFamily%252Bof%252BMarine%252BAlkaloids%26aulast%3DFrolova%26aufirst%3DLiliya%2BV.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D13052013%26date%3D23082013%26date%3D12092013%26date%3D08082013%26volume%3D56%26issue%3D17%26spage%3D6886%26epage%3D6900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hsueh-Yun  Lee</span>, <span class="hlFld-ContribAuthor ">Jang-Yang  Chang</span>, <span class="hlFld-ContribAuthor ">Chih-Ying  Nien</span>, <span class="hlFld-ContribAuthor ">Ching-Chuan  Kuo</span>, <span class="hlFld-ContribAuthor ">Kuang-Hsing  Shih</span>, <span class="hlFld-ContribAuthor ">Chun-Hsein  Wu</span>, <span class="hlFld-ContribAuthor ">Chi-Yen  Chang</span>, <span class="hlFld-ContribAuthor ">Wen-Yang  Lai</span>, and <span class="hlFld-ContribAuthor ">Jing-Ping  Liou</span>  . </span><span class="cited-content_cbyCitation_article-title">5-Amino-2-aroylquinolines as Highly Potent Tubulin Polymerization Inhibitors. Part 2. The Impact of Bridging Groups at Position C-2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (24)
                                     , 8517-8525. <a href="https://doi.org/10.1021/jm201031f" title="DOI URL">https://doi.org/10.1021/jm201031f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201031f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201031f%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D5-Amino-2-aroylquinolines%252Bas%252BHighly%252BPotent%252BTubulin%252BPolymerization%252BInhibitors.%252BPart%252B2.%252BThe%252BImpact%252Bof%252BBridging%252BGroups%252Bat%252BPosition%252BC-2%26aulast%3DLee%26aufirst%3DHsueh-Yun%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D02082011%26date%3D23112011%26date%3D22122011%26date%3D07112011%26volume%3D54%26issue%3D24%26spage%3D8517%26epage%3D8525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bernard L.  Flynn</span>, <span class="hlFld-ContribAuthor ">Gurmit S.  Gill</span>, <span class="hlFld-ContribAuthor ">Damian W.  Grobelny</span>, <span class="hlFld-ContribAuthor ">Jason H.  Chaplin</span>, <span class="hlFld-ContribAuthor ">Dharam  Paul</span>, <span class="hlFld-ContribAuthor ">Annabell F.  Leske</span>, <span class="hlFld-ContribAuthor ">Tina C.  Lavranos</span>, <span class="hlFld-ContribAuthor ">David K.  Chalmers</span>, <span class="hlFld-ContribAuthor ">Susan A.  Charman</span>, <span class="hlFld-ContribAuthor ">Edmund  Kostewicz</span>, <span class="hlFld-ContribAuthor ">David M.  Shackleford</span>, <span class="hlFld-ContribAuthor ">Julia  Morizzi</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">M. Katherine  Jung</span>, and <span class="hlFld-ContribAuthor ">Gabriel  Kremmidiotis</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 7-Hydroxy-6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzo[b]furan (BNC105), a Tubulin Polymerization Inhibitor with Potent Antiproliferative and Tumor Vascular Disrupting Properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (17)
                                     , 6014-6027. <a href="https://doi.org/10.1021/jm200454y" title="DOI URL">https://doi.org/10.1021/jm200454y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200454y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200454y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B7-Hydroxy-6-methoxy-2-methyl-3-%2525283%25252C4%25252C5-trimethoxybenzoyl%252529benzo%25255Bb%25255Dfuran%252B%252528BNC105%252529%25252C%252Ba%252BTubulin%252BPolymerization%252BInhibitor%252Bwith%252BPotent%252BAntiproliferative%252Band%252BTumor%252BVascular%252BDisrupting%252BProperties%26aulast%3DFlynn%26aufirst%3DBernard%2BL.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D14042011%26date%3D05082011%26date%3D08092011%26date%3D20072011%26volume%3D54%26issue%3D17%26spage%3D6014%26epage%3D6027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>, <span class="hlFld-ContribAuthor ">Ying  Zhao</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Cara  Westbrook</span>, and <span class="hlFld-ContribAuthor ">Susan L.  Mooberry</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Activities of (R)- and (S)-N-(4-Methoxyphenyl)-N,2,6-trimethyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-aminium Chloride as Potent Cytotoxic Antitubulin Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (17)
                                     , 6151-6155. <a href="https://doi.org/10.1021/jm2007722" title="DOI URL">https://doi.org/10.1021/jm2007722</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm2007722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm2007722%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BActivities%252Bof%252B%252528R%252529-%252Band%252B%252528S%252529-N-%2525284-Methoxyphenyl%252529-N%25252C2%25252C6-trimethyl-6%25252C7-dihydro-5H-cyclopenta%25255Bd%25255Dpyrimidin-4-aminium%252BChloride%252Bas%252BPotent%252BCytotoxic%252BAntitubulin%252BAgents%26aulast%3DGangjee%26aufirst%3DAleem%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D14062011%26date%3D05082011%26date%3D08092011%26date%3D25072011%26volume%3D54%26issue%3D17%26spage%3D6151%26epage%3D6155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Szumilak</span>, <span class="hlFld-ContribAuthor ">Anna  Wiktorowska-Owczarek</span>, <span class="hlFld-ContribAuthor ">Andrzej  Stanczak</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrid Drugs—A Strategy for Overcoming Anticancer Drug Resistance?. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (9)
                                     , 2601. <a href="https://doi.org/10.3390/molecules26092601" title="DOI URL">https://doi.org/10.3390/molecules26092601</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26092601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26092601%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DHybrid%252BDrugs%2525E2%252580%252594A%252BStrategy%252Bfor%252BOvercoming%252BAnticancer%252BDrug%252BResistance%25253F%26aulast%3DSzumilak%26aufirst%3DMarta%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D9%26spage%3D2601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Wang</span>, <span class="hlFld-ContribAuthor ">Li-Ren  Wang</span>, <span class="hlFld-ContribAuthor ">Lu-Lu  Liu</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Ruo-Jun  Man</span>, <span class="hlFld-ContribAuthor ">Da-Jun  Zheng</span>, <span class="hlFld-ContribAuthor ">Yu-Shan  Deng</span>, <span class="hlFld-ContribAuthor ">Yu-Shun  Yang</span>, <span class="hlFld-ContribAuthor ">Chen  Xu</span>, <span class="hlFld-ContribAuthor ">Hai-Liang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">A novel series of benzothiazepine derivatives as tubulin polymerization inhibitors with anti-tumor potency. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>108 </em>, 104585. <a href="https://doi.org/10.1016/j.bioorg.2020.104585" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104585</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104585%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DA%252Bnovel%252Bseries%252Bof%252Bbenzothiazepine%252Bderivatives%252Bas%252Btubulin%252Bpolymerization%252Binhibitors%252Bwith%252Banti-tumor%252Bpotency%26aulast%3DWang%26aufirst%3DBin%26date%3D2021%26volume%3D108%26spage%3D104585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiguo  Xiang</span>, <span class="hlFld-ContribAuthor ">Tasdique M.  Quadery</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Lerin R.  Luckett-Chastain</span>, <span class="hlFld-ContribAuthor ">Michael A.  Ihnat</span>, <span class="hlFld-ContribAuthor ">Susan L.  Mooberry</span>, <span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>. </span><span class="cited-content_cbyCitation_article-title">The 3-D conformational shape of N-naphthyl-cyclopenta[d]pyrimidines affects their potency as microtubule targeting agents and their antitumor activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>29 </em>, 115887. <a href="https://doi.org/10.1016/j.bmc.2020.115887" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115887</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115887%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DThe%252B3-D%252Bconformational%252Bshape%252Bof%252BN-naphthyl-cyclopenta%25255Bd%25255Dpyrimidines%252Baffects%252Btheir%252Bpotency%252Bas%252Bmicrotubule%252Btargeting%252Bagents%252Band%252Btheir%252Bantitumor%252Bactivity%26aulast%3DXiang%26aufirst%3DWeiguo%26date%3D2021%26volume%3D29%26spage%3D115887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kinsie E.  Arnst</span>, <span class="hlFld-ContribAuthor ">Yuxi  Wang</span>, <span class="hlFld-ContribAuthor ">Zi-Ning  Lei</span>, <span class="hlFld-ContribAuthor ">Dong-Jin  Hwang</span>, <span class="hlFld-ContribAuthor ">Gyanendra  Kumar</span>, <span class="hlFld-ContribAuthor ">Dejian  Ma</span>, <span class="hlFld-ContribAuthor ">Deanna N.  Parke</span>, <span class="hlFld-ContribAuthor ">Qiang  Chen</span>, <span class="hlFld-ContribAuthor ">Jinliang  Yang</span>, <span class="hlFld-ContribAuthor ">Stephen W.  White</span>, <span class="hlFld-ContribAuthor ">Tiffany N.  Seagroves</span>, <span class="hlFld-ContribAuthor ">Zhe-Sheng  Chen</span>, <span class="hlFld-ContribAuthor ">Duane D.  Miller</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Colchicine Binding Site Agent DJ95 Overcomes Drug Resistance and Exhibits Antitumor Efficacy. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2019,</strong> <em>96 </em>
                                    (1)
                                     , 73-89. <a href="https://doi.org/10.1124/mol.118.114801" title="DOI URL">https://doi.org/10.1124/mol.118.114801</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.118.114801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.118.114801%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DColchicine%252BBinding%252BSite%252BAgent%252BDJ95%252BOvercomes%252BDrug%252BResistance%252Band%252BExhibits%252BAntitumor%252BEfficacy%26aulast%3DArnst%26aufirst%3DKinsie%2BE.%26date%3D2019%26date%3D2019%26volume%3D96%26issue%3D1%26spage%3D73%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianguo  Qi</span>, <span class="hlFld-ContribAuthor ">Jing  Huang</span>, <span class="hlFld-ContribAuthor ">Xiaomin  Zhou</span>, <span class="hlFld-ContribAuthor ">Wen  Luo</span>, <span class="hlFld-ContribAuthor ">Jiaxin  Xie</span>, <span class="hlFld-ContribAuthor ">Linqiang  Niu</span>, <span class="hlFld-ContribAuthor ">Zhijie  Yan</span>, <span class="hlFld-ContribAuthor ">Yang  Luo</span>, <span class="hlFld-ContribAuthor ">Yuhui  Men</span>, <span class="hlFld-ContribAuthor ">Yanan  Chen</span>, <span class="hlFld-ContribAuthor ">Yahong  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianhong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of quinoxaline derivatives as tubulin polymerization inhibitors that elevate intracellular
              ROS
              and triggers apoptosis via mitochondrial pathway. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2019,</strong> <em>93 </em>
                                    (4)
                                     , 617-627. <a href="https://doi.org/10.1111/cbdd.13459" title="DOI URL">https://doi.org/10.1111/cbdd.13459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13459%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bquinoxaline%252Bderivatives%252Bas%252Btubulin%252Bpolymerization%252Binhibitors%252Bthat%252Belevate%252Bintracellular%252BROS%252Band%252Btriggers%252Bapoptosis%252Bvia%252Bmitochondrial%252Bpathway%26aulast%3DQi%26aufirst%3DJianguo%26date%3D2019%26date%3D2019%26volume%3D93%26issue%3D4%26spage%3D617%26epage%3D627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roheeth Kumar  Pavana</span>, <span class="hlFld-ContribAuthor ">Khushbu  Shah</span>, <span class="hlFld-ContribAuthor ">Taylor  Gentile</span>, <span class="hlFld-ContribAuthor ">Nicholas F.  Dybdal-Hargreaves</span>, <span class="hlFld-ContribAuthor ">April L.  Risinger</span>, <span class="hlFld-ContribAuthor ">Susan L.  Mooberry</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>. </span><span class="cited-content_cbyCitation_article-title">Sterically induced conformational restriction: Discovery and preclinical evaluation of novel pyrrolo[3,2-d]pyrimidines as microtubule targeting agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (20)
                                     , 5470-5478. <a href="https://doi.org/10.1016/j.bmc.2018.09.025" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.09.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.09.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.09.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSterically%252Binduced%252Bconformational%252Brestriction%25253A%252BDiscovery%252Band%252Bpreclinical%252Bevaluation%252Bof%252Bnovel%252Bpyrrolo%25255B3%25252C2-d%25255Dpyrimidines%252Bas%252Bmicrotubule%252Btargeting%252Bagents%26aulast%3DPavana%26aufirst%3DRoheeth%2BKumar%26date%3D2018%26volume%3D26%26issue%3D20%26spage%3D5470%26epage%3D5478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kathryn A.  Mills</span>, <span class="hlFld-ContribAuthor ">S. Tanner  Roach</span>, <span class="hlFld-ContribAuthor ">Jeanne M.  Quinn</span>, <span class="hlFld-ContribAuthor ">Lei  Guo</span>, <span class="hlFld-ContribAuthor ">Hollie M.  Beck</span>, <span class="hlFld-ContribAuthor ">Elena  Lomonosova</span>, <span class="hlFld-ContribAuthor ">Anna R.  Ilivicky</span>, <span class="hlFld-ContribAuthor ">Courtney M.  Starks</span>, <span class="hlFld-ContribAuthor ">Julie A.  Lawrence</span>, <span class="hlFld-ContribAuthor ">Andrea R.  Hagemann</span>, <span class="hlFld-ContribAuthor ">Carolyn  McCourt</span>, <span class="hlFld-ContribAuthor ">Premal H.  Thaker</span>, <span class="hlFld-ContribAuthor ">Matthew A.  Powell</span>, <span class="hlFld-ContribAuthor ">David G.  Mutch</span>, <span class="hlFld-ContribAuthor ">Katherine C.  Fuh</span>. </span><span class="cited-content_cbyCitation_article-title">SQ1274, a novel microtubule inhibitor, inhibits ovarian and uterine cancer cell growth. </span><span class="cited-content_cbyCitation_journal-name">Gynecologic Oncology</span><span> <strong>2018,</strong> <em>151 </em>
                                    (2)
                                     , 337-344. <a href="https://doi.org/10.1016/j.ygyno.2018.08.008" title="DOI URL">https://doi.org/10.1016/j.ygyno.2018.08.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ygyno.2018.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ygyno.2018.08.008%26sid%3Dliteratum%253Aachs%26jtitle%3DGynecologic%2520Oncology%26atitle%3DSQ1274%25252C%252Ba%252Bnovel%252Bmicrotubule%252Binhibitor%25252C%252Binhibits%252Bovarian%252Band%252Buterine%252Bcancer%252Bcell%252Bgrowth%26aulast%3DMills%26aufirst%3DKathryn%2BA.%26date%3D2018%26volume%3D151%26issue%3D2%26spage%3D337%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhupinder  Kumar</span>, <span class="hlFld-ContribAuthor ">Praveen  Sharma</span>, <span class="hlFld-ContribAuthor ">Vivek Prakash  Gupta</span>, <span class="hlFld-ContribAuthor ">Madhu  Khullar</span>, <span class="hlFld-ContribAuthor ">Sandeep  Singh</span>, <span class="hlFld-ContribAuthor ">Nilambra  Dogra</span>, <span class="hlFld-ContribAuthor ">Vinod  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of pyrimidine bridged combretastatin derivatives as potential anticancer agents and mechanistic studies. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>78 </em>, 130-140. <a href="https://doi.org/10.1016/j.bioorg.2018.02.027" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.02.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.02.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.02.027%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bpyrimidine%252Bbridged%252Bcombretastatin%252Bderivatives%252Bas%252Bpotential%252Banticancer%252Bagents%252Band%252Bmechanistic%252Bstudies%26aulast%3DKumar%26aufirst%3DBhupinder%26date%3D2018%26volume%3D78%26spage%3D130%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaoyu  Xu</span>, <span class="hlFld-ContribAuthor ">Baijiao  An</span>, <span class="hlFld-ContribAuthor ">Yuxin  Li</span>, <span class="hlFld-ContribAuthor ">Xunbang  Luo</span>, <span class="hlFld-ContribAuthor ">Xingshu  Li</span>, <span class="hlFld-ContribAuthor ">Xian  Jia</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of new 2-chloro-4-aminopyrimidine and 2,6-dimethyl-4-aminopyrimidine derivatives as tubulin polymerization inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (10)
                                     , 1769-1775. <a href="https://doi.org/10.1016/j.bmcl.2018.04.026" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.04.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.04.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.04.026%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bnew%252B2-chloro-4-aminopyrimidine%252Band%252B2%25252C6-dimethyl-4-aminopyrimidine%252Bderivatives%252Bas%252Btubulin%252Bpolymerization%252Binhibitors%26aulast%3DXu%26aufirst%3DShaoyu%26date%3D2018%26volume%3D28%26issue%3D10%26spage%3D1769%26epage%3D1775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiguo  Xiang</span>, <span class="hlFld-ContribAuthor ">Shruti  Choudhary</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Susan L.  Mooberry</span>, <span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>. </span><span class="cited-content_cbyCitation_article-title">Structure based drug design and in vitro metabolism study: Discovery of N-(4-methylthiophenyl)-N,2-dimethyl-cyclopenta[d]pyrimidine as a potent microtubule targeting agent. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (9)
                                     , 2437-2451. <a href="https://doi.org/10.1016/j.bmc.2018.04.010" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.04.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.04.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DStructure%252Bbased%252Bdrug%252Bdesign%252Band%252Bin%252Bvitro%252Bmetabolism%252Bstudy%25253A%252BDiscovery%252Bof%252BN-%2525284-methylthiophenyl%252529-N%25252C2-dimethyl-cyclopenta%25255Bd%25255Dpyrimidine%252Bas%252Ba%252Bpotent%252Bmicrotubule%252Btargeting%252Bagent%26aulast%3DXiang%26aufirst%3DWeiguo%26date%3D2018%26volume%3D26%26issue%3D9%26spage%3D2437%26epage%3D2451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenlong  Li</span>, <span class="hlFld-ContribAuthor ">Honghao  Sun</span>, <span class="hlFld-ContribAuthor ">Shengtao  Xu</span>, <span class="hlFld-ContribAuthor ">Zheying  Zhu</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (15)
                                     , 1765-1794. <a href="https://doi.org/10.4155/fmc-2017-0100" title="DOI URL">https://doi.org/10.4155/fmc-2017-0100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0100%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DTubulin%252Binhibitors%252Btargeting%252Bthe%252Bcolchicine%252Bbinding%252Bsite%25253A%252Ba%252Bperspective%252Bof%252Bprivileged%252Bstructures%26aulast%3DLi%26aufirst%3DWenlong%26date%3D2017%26volume%3D9%26issue%3D15%26spage%3D1765%26epage%3D1794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhong-Zhen  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiu-Dong  Shi</span>, <span class="hlFld-ContribAuthor ">Hong-Fang  Feng</span>, <span class="hlFld-ContribAuthor ">Yu-Fang  Cheng</span>, <span class="hlFld-ContribAuthor ">Hai-Tao  Wang</span>, <span class="hlFld-ContribAuthor ">Jiang-Ping  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 9 H -purins as potential tubulin polymerization inhibitors: Synthesis, biological evaluation and structure−activity relationships. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>138 </em>, 1126-1134. <a href="https://doi.org/10.1016/j.ejmech.2017.07.054" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.07.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.07.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.07.054%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B9%252BH%252B-purins%252Bas%252Bpotential%252Btubulin%252Bpolymerization%252Binhibitors%25253A%252BSynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bstructure%2525E2%252588%252592activity%252Brelationships%26aulast%3DZhou%26aufirst%3DZhong-Zhen%26date%3D2017%26volume%3D138%26spage%3D1126%26epage%3D1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana  Marzo-Mas</span>, <span class="hlFld-ContribAuthor ">Pascale  Barbier</span>, <span class="hlFld-ContribAuthor ">Gilles  Breuzard</span>, <span class="hlFld-ContribAuthor ">Diane  Allegro</span>, <span class="hlFld-ContribAuthor ">Eva  Falomir</span>, <span class="hlFld-ContribAuthor ">Juan  Murga</span>, <span class="hlFld-ContribAuthor ">Miguel  Carda</span>, <span class="hlFld-ContribAuthor ">Vincent  Peyrot</span>, <span class="hlFld-ContribAuthor ">J. Alberto  Marco</span>. </span><span class="cited-content_cbyCitation_article-title">Interactions of long-chain homologues of colchicine with tubulin. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>126 </em>, 526-535. <a href="https://doi.org/10.1016/j.ejmech.2016.11.049" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.11.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.11.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.11.049%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInteractions%252Bof%252Blong-chain%252Bhomologues%252Bof%252Bcolchicine%252Bwith%252Btubulin%26aulast%3DMarzo-Mas%26aufirst%3DAna%26date%3D2017%26volume%3D126%26spage%3D526%26epage%3D535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roheeth Kumar  Pavana</span>, <span class="hlFld-ContribAuthor ">Shruti  Choudhary</span>, <span class="hlFld-ContribAuthor ">Anja  Bastian</span>, <span class="hlFld-ContribAuthor ">Michael A.  Ihnat</span>, <span class="hlFld-ContribAuthor ">Ruoli  Bai</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and preclinical evaluation of 7-benzyl-N-(substituted)-pyrrolo[3,2-d]pyrimidin-4-amines as single agents with microtubule targeting effects along with triple-acting angiokinase inhibition as antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (2)
                                     , 545-556. <a href="https://doi.org/10.1016/j.bmc.2016.11.026" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.11.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.11.026%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Bpreclinical%252Bevaluation%252Bof%252B7-benzyl-N-%252528substituted%252529-pyrrolo%25255B3%25252C2-d%25255Dpyrimidin-4-amines%252Bas%252Bsingle%252Bagents%252Bwith%252Bmicrotubule%252Btargeting%252Beffects%252Balong%252Bwith%252Btriple-acting%252Bangiokinase%252Binhibition%252Bas%252Bantitumor%252Bagents%26aulast%3DPavana%26aufirst%3DRoheeth%2BKumar%26date%3D2017%26volume%3D25%26issue%3D2%26spage%3D545%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina  Rohena</span>, <span class="hlFld-ContribAuthor ">April  Risinger</span>, <span class="hlFld-ContribAuthor ">Ravi  Devambatla</span>, <span class="hlFld-ContribAuthor ">Nicholas  Dybdal-Hargreaves</span>, <span class="hlFld-ContribAuthor ">Roma  Kaul</span>, <span class="hlFld-ContribAuthor ">Shruti  Choudhary</span>, <span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>, <span class="hlFld-ContribAuthor ">Susan  Mooberry</span>. </span><span class="cited-content_cbyCitation_article-title">Janus Compounds, 5-Chloro-N4-methyl-N4-aryl-9H-pyrimido[4,5-b]indole-2,4-diamines, Cause Both Microtubule Depolymerizing and Stabilizing Effects. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (12)
                                     , 1661. <a href="https://doi.org/10.3390/molecules21121661" title="DOI URL">https://doi.org/10.3390/molecules21121661</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21121661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21121661%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DJanus%252BCompounds%25252C%252B5-Chloro-N4-methyl-N4-aryl-9H-pyrimido%25255B4%25252C5-b%25255Dindole-2%25252C4-diamines%25252C%252BCause%252BBoth%252BMicrotubule%252BDepolymerizing%252Band%252BStabilizing%252BEffects%26aulast%3DRohena%26aufirst%3DCristina%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D12%26spage%3D1661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina C.  Rohena</span>, <span class="hlFld-ContribAuthor ">Nakul S.  Telang</span>, <span class="hlFld-ContribAuthor ">Chenxiao  Da</span>, <span class="hlFld-ContribAuthor ">April L.  Risinger</span>, <span class="hlFld-ContribAuthor ">James A.  Sikorski</span>, <span class="hlFld-ContribAuthor ">Glen E.  Kellogg</span>, <span class="hlFld-ContribAuthor ">John T.  Gupton</span>, <span class="hlFld-ContribAuthor ">Susan L.  Mooberry</span>. </span><span class="cited-content_cbyCitation_article-title">Biological Characterization of an Improved Pyrrole-Based Colchicine Site Agent Identified through Structure-Based Design. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2016,</strong> <em>89 </em>
                                    (2)
                                     , 287-296. <a href="https://doi.org/10.1124/mol.115.101592" title="DOI URL">https://doi.org/10.1124/mol.115.101592</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.115.101592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.115.101592%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DBiological%252BCharacterization%252Bof%252Ban%252BImproved%252BPyrrole-Based%252BColchicine%252BSite%252BAgent%252BIdentified%252Bthrough%252BStructure-Based%252BDesign%26aulast%3DRohena%26aufirst%3DCristina%2BC.%26date%3D2016%26date%3D2015%26volume%3D89%26issue%3D2%26spage%3D287%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manas M.  Sarmah</span>, <span class="hlFld-ContribAuthor ">Debajyoti  Bhuyan</span>, <span class="hlFld-ContribAuthor ">Dipak  Prajapati</span>. </span><span class="cited-content_cbyCitation_article-title">Indium-catalyzed microwave-accelerated pot economic C–C bond formation process towards the ‘dry-media’ synthesis of pyrimidine derivatives. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (17)
                                     , 12506-12510. <a href="https://doi.org/10.1039/C4RA14434A" title="DOI URL">https://doi.org/10.1039/C4RA14434A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4RA14434A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4RA14434A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DIndium-catalyzed%252Bmicrowave-accelerated%252Bpot%252Beconomic%252BC%2525E2%252580%252593C%252Bbond%252Bformation%252Bprocess%252Btowards%252Bthe%252B%2525E2%252580%252598dry-media%2525E2%252580%252599%252Bsynthesis%252Bof%252Bpyrimidine%252Bderivatives%26aulast%3DSarmah%26aufirst%3DManas%2BM.%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D17%26spage%3D12506%26epage%3D12510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Batakrishna  Jana</span>, <span class="hlFld-ContribAuthor ">Jayita  Sarkar</span>, <span class="hlFld-ContribAuthor ">Prasenjit  Mondal</span>, <span class="hlFld-ContribAuthor ">Surajit  Barman</span>, <span class="hlFld-ContribAuthor ">Saswat  Mohapatra</span>, <span class="hlFld-ContribAuthor ">Debmalya  Bhunia</span>, <span class="hlFld-ContribAuthor ">Krishnangsu  Pradhan</span>, <span class="hlFld-ContribAuthor ">Abhijit  Saha</span>, <span class="hlFld-ContribAuthor ">Anindyasundar  Adak</span>, <span class="hlFld-ContribAuthor ">Subhajit  Ghosh</span>, <span class="hlFld-ContribAuthor ">Surajit  Ghosh</span>. </span><span class="cited-content_cbyCitation_article-title">A short GC rich DNA derived from microbial origin targets tubulin/microtubules and induces apoptotic death of cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2015,</strong> <em>51 </em>
                                    (60)
                                     , 12024-12027. <a href="https://doi.org/10.1039/C5CC03432A" title="DOI URL">https://doi.org/10.1039/C5CC03432A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5CC03432A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5CC03432A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DA%252Bshort%252BGC%252Brich%252BDNA%252Bderived%252Bfrom%252Bmicrobial%252Borigin%252Btargets%252Btubulin%25252Fmicrotubules%252Band%252Binduces%252Bapoptotic%252Bdeath%252Bof%252Bcancer%252Bcells%26aulast%3DJana%26aufirst%3DBatakrishna%26date%3D2015%26date%3D2015%26volume%3D51%26issue%3D60%26spage%3D12024%26epage%3D12027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María-Dolores  Canela</span>, <span class="hlFld-ContribAuthor ">Sandra  Liekens</span>, <span class="hlFld-ContribAuthor ">María-José  Camarasa</span>, <span class="hlFld-ContribAuthor ">Eva María  Priego</span>, <span class="hlFld-ContribAuthor ">María-Jesús  Pérez-Pérez</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antiproliferative activity of 6-phenylaminopurines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>87 </em>, 421-428. <a href="https://doi.org/10.1016/j.ejmech.2014.09.093" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.09.093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.09.093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.09.093%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bantiproliferative%252Bactivity%252Bof%252B6-phenylaminopurines%26aulast%3DCanela%26aufirst%3DMar%25C3%25ADa-Dolores%26date%3D2014%26volume%3D87%26spage%3D421%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Sudhir  Raghavan</span>, <span class="hlFld-ContribAuthor ">Michael  Ihnat</span>, <span class="hlFld-ContribAuthor ">Jessica E.  Thorpe</span>, <span class="hlFld-ContribAuthor ">Bryan C.  Disch</span>, <span class="hlFld-ContribAuthor ">Anja  Bastian</span>, <span class="hlFld-ContribAuthor ">Lora C.  Bailey-Downs</span>, <span class="hlFld-ContribAuthor ">Nicholas F.  Dybdal-Hargreaves</span>, <span class="hlFld-ContribAuthor ">Cristina C.  Rohena</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Susan L.  Mooberry</span>, <span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>. </span><span class="cited-content_cbyCitation_article-title">The design and discovery of water soluble 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multitargeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (14)
                                     , 3753-3772. <a href="https://doi.org/10.1016/j.bmc.2014.04.049" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.04.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.04.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.04.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bdesign%252Band%252Bdiscovery%252Bof%252Bwater%252Bsoluble%252B4-substituted-2%25252C6-dimethylfuro%25255B2%25252C3-d%25255Dpyrimidines%252Bas%252Bmultitargeted%252Breceptor%252Btyrosine%252Bkinase%252Binhibitors%252Band%252Bmicrotubule%252Btargeting%252Bantitumor%252Bagents%26aulast%3DZhang%26aufirst%3DXin%26date%3D2014%26volume%3D22%26issue%3D14%26spage%3D3753%26epage%3D3772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R.  Dasari</span>, <span class="hlFld-ContribAuthor ">A.  Kornienko</span>. </span><span class="cited-content_cbyCitation_article-title">Multicomponent Synthesis of the Medicinally Important Pyrrolo[2,3-d]Pyrimidine Scaffold (Minireview). </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2014,</strong> <em>50 </em>
                                    (2)
                                     , 139-144. <a href="https://doi.org/10.1007/s10593-014-1456-9" title="DOI URL">https://doi.org/10.1007/s10593-014-1456-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-014-1456-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-014-1456-9%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DMulticomponent%252BSynthesis%252Bof%252Bthe%252BMedicinally%252BImportant%252BPyrrolo%25255B2%25252C3-d%25255DPyrimidine%252BScaffold%252B%252528Minireview%252529%26aulast%3DDasari%26aufirst%3DR.%26date%3D2014%26date%3D2014%26volume%3D50%26issue%3D2%26spage%3D139%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nitesh  Sanghai</span>, <span class="hlFld-ContribAuthor ">Vaibhav  Jain</span>, <span class="hlFld-ContribAuthor ">Ranjan  Preet</span>, <span class="hlFld-ContribAuthor ">Somnath  Kandekar</span>, <span class="hlFld-ContribAuthor ">Sarita  Das</span>, <span class="hlFld-ContribAuthor ">Neha  Trivedi</span>, <span class="hlFld-ContribAuthor ">Purusottam  Mohapatra</span>, <span class="hlFld-ContribAuthor ">Garima  Priyadarshani</span>, <span class="hlFld-ContribAuthor ">Maneesh  Kashyap</span>, <span class="hlFld-ContribAuthor ">Dipon  Das</span>, <span class="hlFld-ContribAuthor ">Shakti Ranjan  Satapathy</span>, <span class="hlFld-ContribAuthor ">Sumit  Siddharth</span>, <span class="hlFld-ContribAuthor ">Sankar K.  Guchhait</span>, <span class="hlFld-ContribAuthor ">Chanakya N.  Kundu</span>, <span class="hlFld-ContribAuthor ">Prasad V.  Bharatam</span>. </span><span class="cited-content_cbyCitation_article-title">Combretastatin A-4 inspired novel 2-aryl-3-arylamino-imidazo-pyridines/pyrazines as tubulin polymerization inhibitors, antimitotic and anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Med. Chem. Commun.</span><span> <strong>2014,</strong> <em>5 </em>
                                    (6)
                                     , 766-782. <a href="https://doi.org/10.1039/C3MD00357D" title="DOI URL">https://doi.org/10.1039/C3MD00357D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C3MD00357D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC3MD00357D%26sid%3Dliteratum%253Aachs%26jtitle%3DMed.%2520Chem.%2520Commun.%26atitle%3DCombretastatin%252BA-4%252Binspired%252Bnovel%252B2-aryl-3-arylamino-imidazo-pyridines%25252Fpyrazines%252Bas%252Btubulin%252Bpolymerization%252Binhibitors%25252C%252Bantimitotic%252Band%252Banticancer%252Bagents%26aulast%3DSanghai%26aufirst%3DNitesh%26date%3D2014%26date%3D2014%26volume%3D5%26issue%3D6%26spage%3D766%26epage%3D782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meenakshi  Sharma</span>, <span class="hlFld-ContribAuthor ">Pulak J.  Bhuyan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of symmetrical and unsymmetrical bis(pyrrolo[2,3-d]pyrimidinyl)methanes. </span><span class="cited-content_cbyCitation_journal-name">RSC Adv.</span><span> <strong>2014,</strong> <em>4 </em>
                                    (105)
                                     , 60640-60647. <a href="https://doi.org/10.1039/C4RA09729G" title="DOI URL">https://doi.org/10.1039/C4RA09729G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4RA09729G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4RA09729G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Adv.%26atitle%3DSynthesis%252Bof%252Bsymmetrical%252Band%252Bunsymmetrical%252Bbis%252528pyrrolo%25255B2%25252C3-d%25255Dpyrimidinyl%252529methanes%26aulast%3DSharma%26aufirst%3DMeenakshi%26date%3D2014%26date%3D2014%26volume%3D4%26issue%3D105%26spage%3D60640%26epage%3D60647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P. Seetham  Naidu</span>, <span class="hlFld-ContribAuthor ">Pulak J.  Bhuyan</span>. </span><span class="cited-content_cbyCitation_article-title">A novel one-pot three-component reaction for the synthesis of 5-arylamino-pyrrolo[2,3-d]pyrimidines under microwave irradiation. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2014,</strong> <em>4 </em>
                                    (20)
                                     , 9942. <a href="https://doi.org/10.1039/c3ra47143h" title="DOI URL">https://doi.org/10.1039/c3ra47143h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ra47143h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ra47143h%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DA%252Bnovel%252Bone-pot%252Bthree-component%252Breaction%252Bfor%252Bthe%252Bsynthesis%252Bof%252B5-arylamino-pyrrolo%25255B2%25252C3-d%25255Dpyrimidines%252Bunder%252Bmicrowave%252Birradiation%26aulast%3DNaidu%26aufirst%3DP.%2BSeetham%26date%3D2014%26volume%3D4%26issue%3D20%26spage%3D9942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meenakshi  Sharma</span>, <span class="hlFld-ContribAuthor ">Pulak J.  Bhuyan</span>. </span><span class="cited-content_cbyCitation_article-title">A mild process of carbon–carbon bond formation in aqueous medium: synthesis of bis(pyrrolo[2,3-d]pyrimidinyl)methanes, a novel class of compounds. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2014,</strong> <em>4 </em>
                                    (30)
                                     , 15709. <a href="https://doi.org/10.1039/c4ra00897a" title="DOI URL">https://doi.org/10.1039/c4ra00897a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c4ra00897a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc4ra00897a%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DA%252Bmild%252Bprocess%252Bof%252Bcarbon%2525E2%252580%252593carbon%252Bbond%252Bformation%252Bin%252Baqueous%252Bmedium%25253A%252Bsynthesis%252Bof%252Bbis%252528pyrrolo%25255B2%25252C3-d%25255Dpyrimidinyl%252529methanes%25252C%252Ba%252Bnovel%252Bclass%252Bof%252Bcompounds%26aulast%3DSharma%26aufirst%3DMeenakshi%26date%3D2014%26volume%3D4%26issue%3D30%26spage%3D15709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Feng  Wang</span>, <span class="hlFld-ContribAuthor ">Sheng-Biao  Wang</span>, <span class="hlFld-ContribAuthor ">Emika  Ohkoshi</span>, <span class="hlFld-ContribAuthor ">Li-Ting  Wang</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Keduo  Qian</span>, <span class="hlFld-ContribAuthor ">Susan L.  Morris-Natschke</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>, <span class="hlFld-ContribAuthor ">Lan  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">N-Aryl-6-methoxy-1,2,3,4-tetrahydroquinolines: A novel class of antitumor agents targeting the colchicine site on tubulin. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>67 </em>, 196-207. <a href="https://doi.org/10.1016/j.ejmech.2013.06.041" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.06.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.06.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.06.041%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DN-Aryl-6-methoxy-1%25252C2%25252C3%25252C4-tetrahydroquinolines%25253A%252BA%252Bnovel%252Bclass%252Bof%252Bantitumor%252Bagents%252Btargeting%252Bthe%252Bcolchicine%252Bsite%252Bon%252Btubulin%26aulast%3DWang%26aufirst%3DXiao-Feng%26date%3D2013%26volume%3D67%26spage%3D196%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amir  Assadieskandar</span>, <span class="hlFld-ContribAuthor ">Mohsen  Amini</span>, <span class="hlFld-ContribAuthor ">Seyed Nasser  Ostad</span>, <span class="hlFld-ContribAuthor ">Gholam Hossein  Riazi</span>, <span class="hlFld-ContribAuthor ">Tayebe  Cheraghi-Shavi</span>, <span class="hlFld-ContribAuthor ">Bentolhoda  Shafiei</span>, <span class="hlFld-ContribAuthor ">Abbas  Shafiee</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, cytotoxic evaluation and tubulin inhibitory activity of 4-aryl-5-(3,4,5-trimethoxyphenyl)-2-alkylthio-1H-imidazole derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (10)
                                     , 2703-2709. <a href="https://doi.org/10.1016/j.bmc.2013.03.011" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.03.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.03.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bcytotoxic%252Bevaluation%252Band%252Btubulin%252Binhibitory%252Bactivity%252Bof%252B4-aryl-5-%2525283%25252C4%25252C5-trimethoxyphenyl%252529-2-alkylthio-1H-imidazole%252Bderivatives%26aulast%3DAssadieskandar%26aufirst%3DAmir%26date%3D2013%26volume%3D21%26issue%3D10%26spage%3D2703%26epage%3D2709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E. V.  Verves</span>, <span class="hlFld-ContribAuthor ">A. V.  Kucher</span>, <span class="hlFld-ContribAuthor ">L. V.  Muzychka</span>, <span class="hlFld-ContribAuthor ">O. B.  Smolii</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 7-alkyl-4-amino-7H-pyrrolo-[2,3-d]pyrimidine-6-carboxylic acids. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2013,</strong> <em>48 </em>
                                    (12)
                                     , 1844-1852. <a href="https://doi.org/10.1007/s10593-013-1218-0" title="DOI URL">https://doi.org/10.1007/s10593-013-1218-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-013-1218-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-013-1218-0%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DSynthesis%252Bof%252B7-alkyl-4-amino-7H-pyrrolo-%25255B2%25252C3-d%25255Dpyrimidine-6-carboxylic%252Bacids%26aulast%3DVerves%26aufirst%3DE.%2BV.%26date%3D2013%26date%3D2013%26volume%3D48%26issue%3D12%26spage%3D1844%26epage%3D1852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>, <span class="hlFld-ContribAuthor ">Sonali  Kurup</span>, <span class="hlFld-ContribAuthor ">Charles D.  Smith</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 5,7-disubstituted-4-methyl-7H-pyrrolo[2,3-d]pyrimidin-2-amines as microtubule inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (5)
                                     , 1180-1189. <a href="https://doi.org/10.1016/j.bmc.2012.12.029" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.12.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.12.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.12.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252B5%25252C7-disubstituted-4-methyl-7H-pyrrolo%25255B2%25252C3-d%25255Dpyrimidin-2-amines%252Bas%252Bmicrotubule%252Binhibitors%26aulast%3DGangjee%26aufirst%3DAleem%26date%3D2013%26volume%3D21%26issue%3D5%26spage%3D1180%26epage%3D1189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>, <span class="hlFld-ContribAuthor ">Nilesh  Zaware</span>, <span class="hlFld-ContribAuthor ">Ravi Kumar Vyas  Devambatla</span>, <span class="hlFld-ContribAuthor ">Sudhir  Raghavan</span>, <span class="hlFld-ContribAuthor ">Cara D.  Westbrook</span>, <span class="hlFld-ContribAuthor ">Nicholas F.  Dybdal-Hargreaves</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Susan L.  Mooberry</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of N4-(substituted phenyl)-N4-alkyl/desalkyl-9H-pyrimido[4,5-b]indole-2,4-diamines and identification of new microtubule disrupting compounds that are effective against multidrug resistant cells. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (4)
                                     , 891-902. <a href="https://doi.org/10.1016/j.bmc.2012.12.010" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.12.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.12.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252BN4-%252528substituted%252Bphenyl%252529-N4-alkyl%25252Fdesalkyl-9H-pyrimido%25255B4%25252C5-b%25255Dindole-2%25252C4-diamines%252Band%252Bidentification%252Bof%252Bnew%252Bmicrotubule%252Bdisrupting%252Bcompounds%252Bthat%252Bare%252Beffective%252Bagainst%252Bmultidrug%252Bresistant%252Bcells%26aulast%3DGangjee%26aufirst%3DAleem%26date%3D2013%26volume%3D21%26issue%3D4%26spage%3D891%26epage%3D902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>, <span class="hlFld-ContribAuthor ">Roheeth K.  Pavana</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Cara  Westbrook</span>, <span class="hlFld-ContribAuthor ">Susan L.  Mooberry</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Water-Soluble Substituted Pyrrolo[3,2-d]pyrimidines: Design, Synthesis, and Biological Evaluation as Antitubulin Antitumor Agents. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Research</span><span> <strong>2012,</strong> <em>29 </em>
                                    (11)
                                     , 3033-3039. <a href="https://doi.org/10.1007/s11095-012-0816-3" title="DOI URL">https://doi.org/10.1007/s11095-012-0816-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11095-012-0816-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11095-012-0816-3%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Research%26atitle%3DNovel%252BWater-Soluble%252BSubstituted%252BPyrrolo%25255B3%25252C2-d%25255Dpyrimidines%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bas%252BAntitubulin%252BAntitumor%252BAgents%26aulast%3DGangjee%26aufirst%3DAleem%26date%3D2012%26date%3D2012%26volume%3D29%26issue%3D11%26spage%3D3033%26epage%3D3039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lian Ying  Lu</span>, <span class="hlFld-ContribAuthor ">Zhong Shan  Yu</span>, <span class="hlFld-ContribAuthor ">Zheng Dong  Fang</span>, <span class="hlFld-ContribAuthor ">Yong Zhou  Chen</span>, <span class="hlFld-ContribAuthor ">Wen  Zhou</span>, <span class="hlFld-ContribAuthor ">Xian Hong  Wei</span>, <span class="hlFld-ContribAuthor ">Qing  Tao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Characterization of New 2-Methoxy-Thieno[2,3-d]pyrimidin-4(3H)-One. </span><span class="cited-content_cbyCitation_journal-name">Advanced Materials Research</span><span> <strong>2012,</strong> <em>550-553 </em>, 89-92. <a href="https://doi.org/10.4028/www.scientific.net/AMR.550-553.89" title="DOI URL">https://doi.org/10.4028/www.scientific.net/AMR.550-553.89</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4028/www.scientific.net/AMR.550-553.89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4028%2Fwww.scientific.net%2FAMR.550-553.89%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Materials%2520Research%26atitle%3DSynthesis%252Band%252BCharacterization%252Bof%252BNew%252B2-Methoxy-Thieno%25255B2%25252C3-d%25255Dpyrimidin-4%2525283H%252529-One%26aulast%3DLu%26aufirst%3DLian%2BYing%26date%3D2012%26date%3D2012%26volume%3D550-553%26spage%3D89%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ji Hoon  Lee</span>, <span class="hlFld-ContribAuthor ">Hyun-Suk  Lim</span>. </span><span class="cited-content_cbyCitation_article-title">Solid-phase synthesis of tetrasubstituted pyrrolo[2,3-d]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2012,</strong> <em>10 </em>
                                    (21)
                                     , 4229. <a href="https://doi.org/10.1039/c2ob06899k" title="DOI URL">https://doi.org/10.1039/c2ob06899k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2ob06899k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2ob06899k%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSolid-phase%252Bsynthesis%252Bof%252Btetrasubstituted%252Bpyrrolo%25255B2%25252C3-d%25255Dpyrimidines%26aulast%3DLee%26aufirst%3DJi%2BHoon%26date%3D2012%26volume%3D10%26issue%3D21%26spage%3D4229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hsueh-Yun  Lee</span>, <span class="hlFld-ContribAuthor ">Lin-Wen  Lee</span>, <span class="hlFld-ContribAuthor ">Chih-Ying  Nien</span>, <span class="hlFld-ContribAuthor ">Ching-Chuan  Kuo</span>, <span class="hlFld-ContribAuthor ">Pen-Yuan  Lin</span>, <span class="hlFld-ContribAuthor ">Chi-Yen  Chang</span>, <span class="hlFld-ContribAuthor ">Jang-Yang  Chang</span>, <span class="hlFld-ContribAuthor ">Jing-Ping  Liou</span>. </span><span class="cited-content_cbyCitation_article-title">Application of Suzuki arylation, Sonogashira ethynylation and Rosenmund–von Braun cyanation in the exploration of substitution effects on the anticancer activity of 2-aroylquinolines. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2012,</strong> <em>10 </em>
                                    (48)
                                     , 9593. <a href="https://doi.org/10.1039/c2ob26614h" title="DOI URL">https://doi.org/10.1039/c2ob26614h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2ob26614h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2ob26614h%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DApplication%252Bof%252BSuzuki%252Barylation%25252C%252BSonogashira%252Bethynylation%252Band%252BRosenmund%2525E2%252580%252593von%252BBraun%252Bcyanation%252Bin%252Bthe%252Bexploration%252Bof%252Bsubstitution%252Beffects%252Bon%252Bthe%252Banticancer%252Bactivity%252Bof%252B2-aroylquinolines%26aulast%3DLee%26aufirst%3DHsueh-Yun%26date%3D2012%26volume%3D10%26issue%3D48%26spage%3D9593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Sun</span>, <span class="hlFld-ContribAuthor ">Jie  Wu</span>, <span class="hlFld-ContribAuthor ">Lingzi  Zhang</span>, <span class="hlFld-ContribAuthor ">Min  Luo</span>, <span class="hlFld-ContribAuthor ">Dequn  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Antifungal Activities of Some Novel Pyrimidine Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2011,</strong> <em>16 </em>
                                    (7)
                                     , 5618-5628. <a href="https://doi.org/10.3390/molecules16075618" title="DOI URL">https://doi.org/10.3390/molecules16075618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules16075618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules16075618%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BAntifungal%252BActivities%252Bof%252BSome%252BNovel%252BPyrimidine%252BDerivatives%26aulast%3DSun%26aufirst%3DLi%26date%3D2011%26date%3D2011%26volume%3D16%26issue%3D7%26spage%3D5618%26epage%3D5628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael M.  Miller</span>, <span class="hlFld-ContribAuthor ">Albert J.  DelMonte</span>. </span><span class="cited-content_cbyCitation_article-title">Six-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 371-402. <a href="https://doi.org/10.1016/B978-0-08-096805-6.00013-9" title="DOI URL">https://doi.org/10.1016/B978-0-08-096805-6.00013-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-096805-6.00013-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-096805-6.00013-9%26sid%3Dliteratum%253Aachs%26atitle%3DSix-Membered%252BRing%252BSystems%26aulast%3DMiller%26aufirst%3DMichael%2BM.%26date%3D2011%26spage%3D371%26epage%3D402%26pub%3DElsevier%26date%3D2011%26volume%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/medium/jm-2010-01010n_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101010n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/medium/jm-2010-01010n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of microtubule targeting agents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101010n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/medium/jm-2010-01010n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Lead compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101010n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/medium/jm-2010-01010n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0003.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Pyrrolo[2,3-<i>d</i>]pyrimidines <b>1</b> and <b>2</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101010n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) 2-bromo-1,1-diethoxyethane, NaOMe, anhyd. DMF, 90 °C, 4 h; (ii) acetamidine·HCl, NaOEt, EtOH, reflux, 3 h; (iii) conc. H<sub>2</sub>SO<sub>4</sub>, EtOH, reflux, 2 h. (b) POCl<sub>3</sub>, reflux, 3 h. (c) <i>i</i>-PrOH, HCl (1 drop), reflux, 4 h. (d) Anhyd. HCl gas, anhyd. ether.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/medium/jm-2010-01010n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0004.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Cyclopenta[<i>d</i>]pyrimidines (±)-3 − (±)-7 and Their HCl Salts<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101010n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) conc. H<sub>2</sub>SO<sub>4</sub>, EtOH, reflux, 8 h; (ii) Na, toluene, reflux, 3 h; (iii) acetamidine·HCl <b>9</b>, <i>t-</i>BuOK, <i>t</i>-BuOH. (b) POCl<sub>3</sub>, reflux, 3 h. (c) <i>i</i>-PrOH, HCl (2−3 drops), reflux, 3−6 h. (d) Anhyd. HCl gas, anhyd. ether.</p></p></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/medium/jm-2010-01010n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0005.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of CA4P, <b>1</b>, and (±)-<b>3</b>·HCl on interphase microtubules. A-10 cells were treated with vehicle or compounds as indicated for 18 h, and then the cells were fixed and microtubules visualized by indirect immunofluorescence techniques.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101010n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/medium/jm-2010-01010n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0006.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cell cycle distribution. MBA-MB-435 cells were treated with vehicle (A), 12.5 nM paclitaxel (B), 45 nM (±)-<b>3</b>·HCl (C), or 850 nM <b>1</b> (D) for 24 h. The cells were then harvested, stained with propidium iodide, and evaluated by flow cytometry.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101010n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/medium/jm-2010-01010n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0007.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of microtubule disrupting agents on tubulin polymerization. Paclitaxel represents a positive control for a microtubule stabilizer and colchicine the control for a microtubule depolymerizer. The assays were conducted using purified bovine brain tubulin from Cytoskeleton Inc. in the presence of 10% glycerol, 3 mg/mL purified tubulin, and 10 mM GTP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101010n&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/medium/jm-2010-01010n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0008.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Stereo view. Docked pose of (<i>R</i>)-<b>3</b> (white) overlaid with DAMA colchicine (red) in the colchicine site of tubulin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101010n&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/medium/jm-2010-01010n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0009.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Stereo view. Superimposition of the docked poses of (<i>R</i>)-<b>3</b> (white) and (<i>R</i>)-<b>4</b> (magenta) in the colchicine site of tubulin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101010n&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/medium/jm-2010-01010n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0010.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Stereo view. Superimposition of the docked poses of (<i>R</i>)-<b>3</b> (white), (<i>S</i>)-<b>3</b> (cyan), and DAMA colchicine (red) in the colchicine site of tubulin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101010n&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/medium/jm-2010-01010n_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0011.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Stereo view. Docking mode of (<i>R</i>)-<b>3</b> (white) overlaid with docked poses of 15 ligands<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (blue) in the colchicine site of tubulin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-22/jm101010n/production/images/large/jm-2010-01010n_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101010n&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i40">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56138" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56138" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 59 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Jordan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L.</span><span> </span><span class="NLM_article-title">Microtubules as a Target for Anticancer Drugs</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1038%2Fnrc1317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=15057285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1Gmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=253-265&author=M.+A.+Jordanauthor=L.+Wilson&title=Microtubules+as+a+Target+for+Anticancer+Drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubules as a target for anticancer drugs</span></div><div class="casAuthors">Jordan, Mary Ann; Wilson, Leslie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">253-265</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Highly dynamic mitotic-spindle microtubules are among the most successful targets for anticancer therapy.  Microtubule-targeted drugs, including paclitaxel and Vinca alkaloids, were previously considered to work primarily by increasing or decreasing the cellular microtubule mass.  Although these effects might have a role in their chemotherapeutic actions, we now know that at lower concns., microtubule-targeted drugs can suppress microtubule dynamics without changing microtubule mass; this action leads to mitotic block and apoptosis.  In addn. to the expanding array of chem. diverse antimitotic agents, some microtubule-targeted drugs can act as vascular-targeting agents, rapidly depolymg. microtubules of newly formed vasculature to shut down the blood supply to tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRJbrFnzwqjbVg90H21EOLACvtfcHk0lhpheNWJ8DYjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1Gmt74%253D&md5=bbbf212e03ffe6763098fc41f21a8158</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc1317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1317%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DM.%2BA.%26aulast%3DWilson%26aufirst%3DL.%26atitle%3DMicrotubules%2520as%2520a%2520Target%2520for%2520Anticancer%2520Drugs%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D253%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Jordan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, K.</span><span> </span><span class="NLM_article-title">How do Microtubule-Targeted Drugs Work? An Overview</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">730</span><span class="NLM_x">–</span> <span class="NLM_lpage">742</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.2174%2F156800907783220417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=18220533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFOnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=730-742&author=M.+A.+Jordanauthor=K.+Kamath&title=How+do+Microtubule-Targeted+Drugs+Work%3F+An+Overview"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">How do microtubule-targeted drugs work? An overview</span></div><div class="casAuthors">Jordan, Mary Ann; Kamath, Kathy</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">730-742</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The importance of microtubules in mitosis makes them a superb target for a group of highly successful, chem. diverse anticancer drugs.  Knowledge of the mechanistic differences among the many drugs of this class is vital to understanding their tissue and cell specificity, the development of resistance, the design of novel improved drugs, optimal scheduling of treatment, and potential synergistic combinations.  This overview covers microtubule assembly dynamics, the exquisite regulation of microtubule dynamics in cells by endogenous regulators, the important role of microtubule dynamics in mitosis, the diversity and no. of microtubule-targeted drugs undergoing clin. development, the antimitotic mechanisms of microtubule-targeted drugs with emphasis on suppression of microtubule dynamics by vinblastine and taxol, the role of drug uptake and retention in the efficacy of microtubule-targeted drugs, and the anti-angiogenic and vascular-disrupting mechanisms of microtubule targeted drugs.  In view of the success of this class of drugs, it has been argued that microtubules represent the single best cancer target identified to date, and it seems likely that drugs in this class will continue to remain an important chemotherapeutic class of drugs even as more selective chemotherapeutic approaches are developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrblMjKhFIo0rVg90H21EOLACvtfcHk0lhpheNWJ8DYjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFOnsbg%253D&md5=58b841471750af2499f766da0ea5e0d6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F156800907783220417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800907783220417%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DM.%2BA.%26aulast%3DKamath%26aufirst%3DK.%26atitle%3DHow%2520do%2520Microtubule-Targeted%2520Drugs%2520Work%253F%2520An%2520Overview%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2007%26volume%3D7%26spage%3D730%26epage%3D742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Lee, J. F.; Harris, L. N.</span><span> </span><span class="NLM_article-title">Antimicrotubule Agents</span>. In  <span class="citation_source-book">Cancer: Principles & Practice of Oncology</span>, <span class="NLM_edition">8</span>th ed.; <span class="NLM_contrib-group">DeVita, V. T.,  Jr.; Lawrence, T. S.,; Rosenberg, S. A.</span>, Eds.; <span class="NLM_publisher-name">Lippincott Williams & Wilkins</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">447</span>− <span class="NLM_lpage">456</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=447-456&author=J.+F.+Lee&author=L.+N.+Harrisauthor=V.+T.+DeVita&author=T.+S.+Lawrence&author=S.+A.+Rosenberg&title=Cancer%3A+Principles+%26+Practice+of+Oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BF.%26atitle%3DAntimicrotubule%2520Agents%26btitle%3DCancer%253A%2520Principles%2520%2526%2520Practice%2520of%2520Oncology%26aulast%3DDeVita%26aufirst%3DV.%2BT.%26pub%3DLippincott%2520Williams%2520%2526%2520Wilkins%26date%3D2008%26spage%3D447%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Löwe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downing, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nogales, E.</span><span> </span><span class="NLM_article-title">Refined Structure of αβ-Tubulin at 3.5Å Resolution</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">1045</span><span class="NLM_x">–</span> <span class="NLM_lpage">1057</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2001&pages=1045-1057&author=J.+L%C3%B6weauthor=H.+Liauthor=K.+H.+Downingauthor=E.+Nogales&title=Refined+Structure+of+%CE%B1%CE%B2-Tubulin+at+3.5%C3%85+Resolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6we%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DDowning%26aufirst%3DK.%2BH.%26aulast%3DNogales%26aufirst%3DE.%26atitle%3DRefined%2520Structure%2520of%2520%25CE%25B1%25CE%25B2-Tubulin%2520at%25203.5%25C3%2585%2520Resolution%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2001%26volume%3D313%26spage%3D1045%26epage%3D1057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Huey, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barasoain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pineda, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edler, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerezo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderwal, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorensen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreu, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J. F.</span><span> </span><span class="NLM_article-title">Cyclostreptin Binds Covalently to Microtubule Pores and Lumenal Taxoid Binding Sites</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1038%2Fnchembio853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=17206139" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=117-125&author=R.+M.+Hueyauthor=E.+Calvoauthor=I.+Barasoainauthor=O.+Pinedaauthor=M.+C.+Edlerauthor=R.+Matesanzauthor=G.+Cerezoauthor=C.+D.+Vanderwalauthor=B.+W.+Dayauthor=E.+J.+Sorensenauthor=J.+A.+Lopezauthor=J.+M.+Andreuauthor=E.+Hamelauthor=J.+F.+Diaz&title=Cyclostreptin+Binds+Covalently+to+Microtubule+Pores+and+Lumenal+Taxoid+Binding+Sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnchembio853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio853%26sid%3Dliteratum%253Aachs%26aulast%3DHuey%26aufirst%3DR.%2BM.%26aulast%3DCalvo%26aufirst%3DE.%26aulast%3DBarasoain%26aufirst%3DI.%26aulast%3DPineda%26aufirst%3DO.%26aulast%3DEdler%26aufirst%3DM.%2BC.%26aulast%3DMatesanz%26aufirst%3DR.%26aulast%3DCerezo%26aufirst%3DG.%26aulast%3DVanderwal%26aufirst%3DC.%2BD.%26aulast%3DDay%26aufirst%3DB.%2BW.%26aulast%3DSorensen%26aufirst%3DE.%2BJ.%26aulast%3DLopez%26aufirst%3DJ.%2BA.%26aulast%3DAndreu%26aufirst%3DJ.%2BM.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DDiaz%26aufirst%3DJ.%2BF.%26atitle%3DCyclostreptin%2520Binds%2520Covalently%2520to%2520Microtubule%2520Pores%2520and%2520Lumenal%2520Taxoid%2520Binding%2520Sites%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2007%26volume%3D3%26spage%3D117%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Kanthou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozer, M. T.</span><span> </span><span class="NLM_article-title">Microtubule Depolymerizing Vascular Disrupting Agents: Novel Therapeutic Agents for Oncology and Other Pathologies</span> <span class="citation_source-journal">Int. J. Exp. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1111%2Fj.1365-2613.2009.00651.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=19563611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotV2isr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2009&pages=284-294&author=C.+Kanthouauthor=M.+T.+Tozer&title=Microtubule+Depolymerizing+Vascular+Disrupting+Agents%3A+Novel+Therapeutic+Agents+for+Oncology+and+Other+Pathologies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies</span></div><div class="casAuthors">Kanthou, Chryso; Tozer, Gillian M.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Experimental Pathology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">284-294</span>CODEN:
                <span class="NLM_cas:coden">IJEPEI</span>;
        ISSN:<span class="NLM_cas:issn">0959-9673</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Vascular disrupting agents (VDAs) are a relatively new group of "vascular targeting" agents that exhibit selective activity against established tumor vascular networks, causing severe interruption of tumor blood flow and necrosis to the tumor mass.  Microtubule depolymg. agents form by far the largest group of small mol. wt. VDAs many of which, including lead compd. disodium combretastatin A-4 3-O-phosphate (CA-4-P), are under clin. development for cancer.  Although distinct from the angiogenesis inhibitors, VDAs can also interfere with angiogenesis and therefore constitute a potential group of novel drugs for the treatment of pathol. conditions characterized by excessive angiogenesis, in addn. to cancer.  The endothelial cytoskeleton is the primary cellular target of this family of drugs, and some progress in understanding the mol. and signalling mechanisms assocd. with their endothelial disrupting activity has been made in the last few years.  Susceptibility of tumor vessels to VDA damage is ascribed to their immature pericyte-defective nature, although the exact mol. mechanisms involved have not been clearly defined.  Despite causing profound damage to tumors, VDAs fail to halt tumor growth unless used together with conventional treatments.  This failure is attributed to resistance mechanisms, primarily assocd. with cells that remain viable within the tumor rim, and enhanced angiogenesis.  The focus is now to understand mechanisms of susceptibility and resistance to identify novel mol. targets and develop strategies that are more effective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmpN7il32X0rVg90H21EOLACvtfcHk0lg8KxOxCpsJaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotV2isr4%253D&md5=42b728813bf9c53bbc6d32d262639d15</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2613.2009.00651.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2613.2009.00651.x%26sid%3Dliteratum%253Aachs%26aulast%3DKanthou%26aufirst%3DC.%26aulast%3DTozer%26aufirst%3DM.%2BT.%26atitle%3DMicrotubule%2520Depolymerizing%2520Vascular%2520Disrupting%2520Agents%253A%2520Novel%2520Therapeutic%2520Agents%2520for%2520Oncology%2520and%2520Other%2520Pathologies%26jtitle%3DInt.%2520J.%2520Exp.%2520Pathol.%26date%3D2009%26volume%3D90%26spage%3D284%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Carlson, R. O.</span><span> </span><span class="NLM_article-title">New Tubulin Targeting Agents Currently in Clinical Development</span> <span class="citation_source-journal">Expert Opin. Investig. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">707</span><span class="NLM_x">–</span> <span class="NLM_lpage">722</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=707-722&author=R.+O.+Carlson&title=New+Tubulin+Targeting+Agents+Currently+in+Clinical+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarlson%26aufirst%3DR.%2BO.%26atitle%3DNew%2520Tubulin%2520Targeting%2520Agents%2520Currently%2520in%2520Clinical%2520Development%26jtitle%3DExpert%2520Opin.%2520Investig.%2520Drugs%26date%3D2008%26volume%3D17%26spage%3D707%26epage%3D722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">O’Connor, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutoh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friend, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fornace, A. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, K. W.</span><span> </span><span class="NLM_article-title">Characterization of the p53 Tumor Suppressor Pathway in Cell Lines of the National Cancer Institute Anticancer Drug Screen and Correlations with the Growth-inhibitory Potency of 123 Anticancer Agents</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4285</span><span class="NLM_x">–</span> <span class="NLM_lpage">4300</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=4285-4300&author=P.+M.+O%E2%80%99Connorauthor=J.+Jackmanauthor=I.+Baeauthor=T.+G.+Myersauthor=S.+Fanauthor=M.+Mutohauthor=D.+A.+Scudieroauthor=A.+Monksauthor=E.+A.+Sausvilleauthor=J.+N.+Weinsteinauthor=S.+Friendauthor=A.+J.+Fornaceauthor=K.+W.+Kohn&title=Characterization+of+the+p53+Tumor+Suppressor+Pathway+in+Cell+Lines+of+the+National+Cancer+Institute+Anticancer+Drug+Screen+and+Correlations+with+the+Growth-inhibitory+Potency+of+123+Anticancer+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%2BM.%26aulast%3DJackman%26aufirst%3DJ.%26aulast%3DBae%26aufirst%3DI.%26aulast%3DMyers%26aufirst%3DT.%2BG.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DMutoh%26aufirst%3DM.%26aulast%3DScudiero%26aufirst%3DD.%2BA.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DWeinstein%26aufirst%3DJ.%2BN.%26aulast%3DFriend%26aufirst%3DS.%26aulast%3DFornace%26aufirst%3DA.%2BJ.%26aulast%3DKohn%26aufirst%3DK.%2BW.%26atitle%3DCharacterization%2520of%2520the%2520p53%2520Tumor%2520Suppressor%2520Pathway%2520in%2520Cell%2520Lines%2520of%2520the%2520National%2520Cancer%2520Institute%2520Anticancer%2520Drug%2520Screen%2520and%2520Correlations%2520with%2520the%2520Growth-inhibitory%2520Potency%2520of%2520123%2520Anticancer%2520Agents%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D4285%26epage%3D4300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Risinger, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooberry, S. L.</span><span> </span><span class="NLM_article-title">Microtubule Dynamics as a Target in Oncology</span> <span class="citation_source-journal">Cancer Treat. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1016%2Fj.ctrv.2008.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=19117686" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=255-261&author=A.+L.+Risingerauthor=F.+J.+Gilesauthor=S.+L.+Mooberry&title=Microtubule+Dynamics+as+a+Target+in+Oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2008.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2008.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DRisinger%26aufirst%3DA.%2BL.%26aulast%3DGiles%26aufirst%3DF.%2BJ.%26aulast%3DMooberry%26aufirst%3DS.%2BL.%26atitle%3DMicrotubule%2520Dynamics%2520as%2520a%2520Target%2520in%2520Oncology%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2008%26volume%3D35%26spage%3D255%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Hamel, E.</span><span> </span><span class="NLM_article-title">An Overview of Compounds That Interact With tubulin and their Effects on Microtubule Assembly</span>. In  <span class="citation_source-book">The Role of Microtubules in Cell Biology, Neurobiology and Oncology</span>; <span class="NLM_contrib-group">Fojo, T.</span>, Ed.; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1</span>− <span class="NLM_lpage">19</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1007%2F978-1-59745-336-3_1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=1-19&author=E.+Hamelauthor=T.+Fojo&title=The+Role+of+Microtubules+in+Cell+Biology%2C+Neurobiology+and+Oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2F978-1-59745-336-3_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-59745-336-3_1%26sid%3Dliteratum%253Aachs%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DAn%2520Overview%2520of%2520Compounds%2520That%2520Interact%2520With%2520tubulin%2520and%2520their%2520Effects%2520on%2520Microtubule%2520Assembly%26btitle%3DThe%2520Role%2520of%2520Microtubules%2520in%2520Cell%2520Biology%252C%2520Neurobiology%2520and%2520Oncology%26aulast%3DFojo%26aufirst%3DT.%26pub%3DHumana%2520Press%26date%3D2008%26spage%3D1%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ling, V.</span><span> </span><span class="NLM_article-title">Multidrug Resistance: Molecular Mechanisms and Clinical Relevance</span> <span class="citation_source-journal">Cancer Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">S3</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=S3-8&author=V.+Ling&title=Multidrug+Resistance%3A+Molecular+Mechanisms+and+Clinical+Relevance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DV.%26atitle%3DMultidrug%2520Resistance%253A%2520Molecular%2520Mechanisms%2520and%2520Clinical%2520Relevance%26jtitle%3DCancer%2520Chemother.%26date%3D1997%26volume%3D40%26spage%3DS3%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Leonard, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">The Role of ABC Transporters in Clinical Practice</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1634%2Ftheoncologist.8-5-411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=14530494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXoslyls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=411-424&author=G.+D.+Leonardauthor=T.+Fojoauthor=S.+E.+Bates&title=The+Role+of+ABC+Transporters+in+Clinical+Practice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The role of ABC transporters in clinical practice</span></div><div class="casAuthors">Leonard, Gregory D.; Fojo, Tito; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Oncologist</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">411-424</span>CODEN:
                <span class="NLM_cas:coden">OCOLF6</span>;
        ISSN:<span class="NLM_cas:issn">1083-7159</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">A review.  Drug resistance remains one of the primary causes of suboptimal outcomes in cancer therapy.  ATP-binding cassette (ABC) transporters are a family of transporter proteins that contribute to drug resistance via ATP-dependent drug efflux pumps.  P-glycoprotein (P-gp), encoded by the MDR1 gene, is an ABC transporter normally involved in the excretion of toxins from cells.  It also confers resistance to certain chemotherapeutic agents.  P-gp is overexpressed at baseline in chemotherapy-resistant tumors, such as colon and kidney cancers, and is upregulated after disease progression following chemotherapy in malignancies such as leukemia and breast cancer.  Other transporter proteins mediating drug resistance include those in the multidrug-resistance-assocd. protein (MRP) family, notably MRP1, and ABCG2.  These transporters are also involved in normal physiol. functions.  The expressions of MRP family members and ABCG2 were not well worked out in cancer.  Increased drug accumulation and drug resistance reversal with P-gp inhibitors were well documented in vitro, but only suggested in clin. trials.  Limitations in the design of early resistance reversal trials contributed to disappointing results.  Despite this, 3 randomized trials have shown statistically significant benefits with the use of a P-gp inhibitor in combination with chemotherapy.  Improved diagnostic techniques aimed at the selection of patients with tumors that express P-gp should result in more successful outcomes.  Further optimism is warranted with the advent of potent, nontoxic inhibitors and new treatment strategies, including the combination of new targeted therapies with therapies aimed at the prevention of drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr317MZ9jawCbVg90H21EOLACvtfcHk0ljEIyBy928ziA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXoslyls74%253D&md5=b474f45fd5c45962acfff61840c04a6b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1634%2Ftheoncologist.8-5-411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Ftheoncologist.8-5-411%26sid%3Dliteratum%253Aachs%26aulast%3DLeonard%26aufirst%3DG.%2BD.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DThe%2520Role%2520of%2520ABC%2520Transporters%2520in%2520Clinical%2520Practice%26jtitle%3DOncologist%26date%3D2003%26volume%3D8%26spage%3D411%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Yeh, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, A.</span><span> </span><span class="NLM_article-title">Predicting Chemotherapy Response to Taxol-based Therapy in Advanced Non-Small-Cell Lung Cancer with P-glycoprotein Expression</span> <span class="citation_source-journal">Respiration</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2003&pages=32-35&author=J.+J.+Yehauthor=W.+H.+Hsuauthor=J.+J.+Wangauthor=S.+T.+Hoauthor=A.+Kao&title=Predicting+Chemotherapy+Response+to+Taxol-based+Therapy+in+Advanced+Non-Small-Cell+Lung+Cancer+with+P-glycoprotein+Expression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYeh%26aufirst%3DJ.%2BJ.%26aulast%3DHsu%26aufirst%3DW.%2BH.%26aulast%3DWang%26aufirst%3DJ.%2BJ.%26aulast%3DHo%26aufirst%3DS.%2BT.%26aulast%3DKao%26aufirst%3DA.%26atitle%3DPredicting%2520Chemotherapy%2520Response%2520to%2520Taxol-based%2520Therapy%2520in%2520Advanced%2520Non-Small-Cell%2520Lung%2520Cancer%2520with%2520P-glycoprotein%2520Expression%26jtitle%3DRespiration%26date%3D2003%26volume%3D70%26spage%3D32%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Chiou, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, A.</span><span> </span><span class="NLM_article-title">Comparing the Relationship of Taxol-based Chemotherpay Response with P-glycoprotein and Lung Resistance-related Protein Expression in Non-Small Cell Lung Cancer</span> <span class="citation_source-journal">Lung</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">181</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2003&pages=267-273&author=J.+F.+Chiouauthor=J.+A.+Liangauthor=W.+H.+Hsuauthor=J.+J.+Wangauthor=S.+T.+Hoauthor=A.+Kao&title=Comparing+the+Relationship+of+Taxol-based+Chemotherpay+Response+with+P-glycoprotein+and+Lung+Resistance-related+Protein+Expression+in+Non-Small+Cell+Lung+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiou%26aufirst%3DJ.%2BF.%26aulast%3DLiang%26aufirst%3DJ.%2BA.%26aulast%3DHsu%26aufirst%3DW.%2BH.%26aulast%3DWang%26aufirst%3DJ.%2BJ.%26aulast%3DHo%26aufirst%3DS.%2BT.%26aulast%3DKao%26aufirst%3DA.%26atitle%3DComparing%2520the%2520Relationship%2520of%2520Taxol-based%2520Chemotherpay%2520Response%2520with%2520P-glycoprotein%2520and%2520Lung%2520Resistance-related%2520Protein%2520Expression%2520in%2520Non-Small%2520Cell%2520Lung%2520Cancer%26jtitle%3DLung%26date%3D2003%26volume%3D181%26spage%3D267%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Nooter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westerman, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flens, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaman, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheper, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Wingerden, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oostrum, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boersma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonneveld, P.</span><span> </span><span class="NLM_article-title">Expression of the Multidrug Resistance-Associated Protein (MRP) Gene in Human Cancers</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1301</span><span class="NLM_x">–</span> <span class="NLM_lpage">1310</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=9815925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADyaK28XjvF2gsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=1301-1310&author=K.+Nooterauthor=A.+M.+Westermanauthor=M.+J.+Flensauthor=G.+J.+Zamanauthor=R.+J.+Scheperauthor=K.+E.+van+Wingerdenauthor=H.+Burgerauthor=R.+Oostrumauthor=T.+Boersmaauthor=P.+Sonneveld&title=Expression+of+the+Multidrug+Resistance-Associated+Protein+%28MRP%29+Gene+in+Human+Cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of the multidrug resistance-associated protein (MRP) gene in human cancers</span></div><div class="casAuthors">Nooter, Kees; Westerman, Anne Marie; Flens, Marcel J.; Zaman, Guido J. R.; Scheper, Rik J.; van Wingerden, Kyra E.; Burger, Herman; Oostrum, Robert; Boersma, Ton; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1301-10</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We detd. the expression of a newly recognized drug resistance gene, the multidrug resistance-assocd. protein (MRP) gene, in normal human tissues and in >370 human tumor biopsies using a quant. RNase protection assay and immunohistochem.  MRP mRNA appeared to be ubiquitously expressed at low levels in all normal tissues, including peripheral blood, the endocrine glands (adrenal and thyroid), striated muscle, the lymphoreticular system (spleen and tonsil), the digestive tract (salivary gland, esophagus, liver, gall bladder, pancreas, and colon), the respiratory tract (lung), and the urogenital tract (kidney, bladder, testis, and ovary).  The human cancers analyzed could be divided into three groups with regard to MRP expression.  Group 1 consists of tumors that often exhibit high to very high MRP mRNA levels (e.g., chronic lymphocytic leukemia).  Group 2 comprises the tumors that often exhibit low, but occasionally exhibit high MRP mRNA expression (e.g., esophagus squamous cell carcinoma, non-small cell lung cancer, and acute myelocytic leukemia).  Group 3 comprises the tumors with predominantly low levels of MRP mRNA, comparable to the levels found in normal tissues (e.g., other hematol. malignancies, soft tissue sarcomas, melanoma, and cancers of the prostate, breast, kidney, bladder, testis, ovary, and colon).  Using the MRP-specific mAbs MRPr1 and MRPm6, we confirmed the elevated MRP mRNA levels in tumor tissues by immunohistochem.  We conclude that hyperexpression of MRP is obsd. in several human cancers, and that addnl. studies are needed to assess the clin. relevance of MRP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovEhBg_07inLVg90H21EOLACvtfcHk0lgw3n-0-NyxDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvF2gsw%253D%253D&md5=21feaa6ab3a1effd2aecf165c2665969</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNooter%26aufirst%3DK.%26aulast%3DWesterman%26aufirst%3DA.%2BM.%26aulast%3DFlens%26aufirst%3DM.%2BJ.%26aulast%3DZaman%26aufirst%3DG.%2BJ.%26aulast%3DScheper%26aufirst%3DR.%2BJ.%26aulast%3Dvan%2BWingerden%26aufirst%3DK.%2BE.%26aulast%3DBurger%26aufirst%3DH.%26aulast%3DOostrum%26aufirst%3DR.%26aulast%3DBoersma%26aufirst%3DT.%26aulast%3DSonneveld%26aufirst%3DP.%26atitle%3DExpression%2520of%2520the%2520Multidrug%2520Resistance-Associated%2520Protein%2520%2528MRP%2529%2520Gene%2520in%2520Human%2520Cancers%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1995%26volume%3D1%26spage%3D1301%26epage%3D1310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menefee, M.</span><span> </span><span class="NLM_article-title">Mechanisms of Multidrug Resistance: The Potential Role of Microtubule-stabilizing Agents</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1093%2Fannonc%2Fmdm172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=17656560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A280%3ADC%252BD2sngs1SitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=3-8&author=T.+Fojoauthor=M.+Menefee&title=Mechanisms+of+Multidrug+Resistance%3A+The+Potential+Role+of+Microtubule-stabilizing+Agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents</span></div><div class="casAuthors">Fojo T; Menefee M</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology / ESMO</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18 Suppl 5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">v3-8</span>
        ISSN:<span class="NLM_cas:issn">0923-7534</span>.
    </div><div class="casAbstract">Antimitotic agents that target the dynamic equilibrium between the microtubule polymer and tubulin heterodimers are key components of chemotherapeutic regimens for various solid tumors.  These agents can be divided into two major classes based on their effect on microtubule polymerization and the mass of microtubule polymers: those that inhibit polymerization, such as the vinca alkaloids and those that stabilize microtubules, such as the taxanes and epothilones.  The taxanes paclitaxel (Taxol) and docetaxel (Taxotere) were the first antimicrotubule agents approved for use in solid tumors, but their usefulness is often limited by development of drug resistance.  The epothilones are distinguished from the taxanes structurally and functionally and have been shown in vitro and in preclinical models to have superior potency to the taxanes.  The epothilones are not susceptible to P-glycoprotein-mediated efflux and have shown activity against taxane-resistant tumors.  Other natural-product microtubule-stabilizing agents also have promising pharmacologic profiles.  This article discusses mechanisms of drug resistance and summarizes scientific and clinical data supporting the potential of novel microtubule-stabilizing agents for achieving broad antitumor efficacy without the emergence of drug resistance.  The ability to reduce the development of resistance with the epothilones and other microtubule-stabilizing agents may provide additional treatment options at the time of presentation and in the setting of taxane resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTF5uhi21MM5z0O18WR3iAofW6udTcc2ebgcrbIO3zLArntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sngs1SitA%253D%253D&md5=ddbd9ea289b1a1cb1f79d6be860f2bfa</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdm172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdm172%26sid%3Dliteratum%253Aachs%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DMenefee%26aufirst%3DM.%26atitle%3DMechanisms%2520of%2520Multidrug%2520Resistance%253A%2520The%2520Potential%2520Role%2520of%2520Microtubule-stabilizing%2520Agents%26jtitle%3DAnn.%2520Oncol.%26date%3D2007%26volume%3D18%26spage%3D3%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Rosell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scagliotti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danenberg, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, R. V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bepler, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novello, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooc, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Marinis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marangolo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozzelino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Costanzo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rinaldi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salonga, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, C.</span><span> </span><span class="NLM_article-title">Transcripts in Pretreatment Biopsies From A Three-Arm Randomized Trial In Metastatic Non-Small-Cell Lung Cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3548</span><span class="NLM_x">–</span> <span class="NLM_lpage">3553</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=3548-3553&author=R.+Rosellauthor=G.+Scagliottiauthor=K.+D.+Danenbergauthor=R.+V.+N.+Lordauthor=G.+Beplerauthor=S.+Novelloauthor=J.+Coocauthor=L.+Crinoauthor=J.+J.+Sanchezauthor=M.+Taronauthor=C.+Boniauthor=F.+De+Marinisauthor=M.+Tonatoauthor=M.+Marangoloauthor=F.+Gozzelinoauthor=F.+Di+Costanzoauthor=M.+Rinaldiauthor=D.+Salongaauthor=C.+Stephens&title=Transcripts+in+Pretreatment+Biopsies+From+A+Three-Arm+Randomized+Trial+In+Metastatic+Non-Small-Cell+Lung+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosell%26aufirst%3DR.%26aulast%3DScagliotti%26aufirst%3DG.%26aulast%3DDanenberg%26aufirst%3DK.%2BD.%26aulast%3DLord%26aufirst%3DR.%2BV.%2BN.%26aulast%3DBepler%26aufirst%3DG.%26aulast%3DNovello%26aufirst%3DS.%26aulast%3DCooc%26aufirst%3DJ.%26aulast%3DCrino%26aufirst%3DL.%26aulast%3DSanchez%26aufirst%3DJ.%2BJ.%26aulast%3DTaron%26aufirst%3DM.%26aulast%3DBoni%26aufirst%3DC.%26aulast%3DDe%2BMarinis%26aufirst%3DF.%26aulast%3DTonato%26aufirst%3DM.%26aulast%3DMarangolo%26aufirst%3DM.%26aulast%3DGozzelino%26aufirst%3DF.%26aulast%3DDi%2BCostanzo%26aufirst%3DF.%26aulast%3DRinaldi%26aufirst%3DM.%26aulast%3DSalonga%26aufirst%3DD.%26aulast%3DStephens%26aufirst%3DC.%26atitle%3DTranscripts%2520in%2520Pretreatment%2520Biopsies%2520From%2520A%2520Three-Arm%2520Randomized%2520Trial%2520In%2520Metastatic%2520Non-Small-Cell%2520Lung%2520Cancer%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D3548%26epage%3D3553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Dumontet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaac, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souquet, P.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bejui-Thivolet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacheco, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peloux, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frankfurter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luduena, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perol, M.</span><span> </span><span class="NLM_article-title">Expression of Class III Beta Tubulin In Non-Small Cell Lung Cancer Is Correlated With Resistance To Taxane Chemotherapy</span> <span class="citation_source-journal">Bull. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">E25</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2005&pages=E25-30&author=C.+Dumontetauthor=S.+Isaacauthor=P.-J.+Souquetauthor=F.+Bejui-Thivoletauthor=Y.+Pachecoauthor=N.+Pelouxauthor=A.+Frankfurterauthor=R.+Luduenaauthor=M.+Perol&title=Expression+of+Class+III+Beta+Tubulin+In+Non-Small+Cell+Lung+Cancer+Is+Correlated+With+Resistance+To+Taxane+Chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDumontet%26aufirst%3DC.%26aulast%3DIsaac%26aufirst%3DS.%26aulast%3DSouquet%26aufirst%3DP.-J.%26aulast%3DBejui-Thivolet%26aufirst%3DF.%26aulast%3DPacheco%26aufirst%3DY.%26aulast%3DPeloux%26aufirst%3DN.%26aulast%3DFrankfurter%26aufirst%3DA.%26aulast%3DLuduena%26aufirst%3DR.%26aulast%3DPerol%26aufirst%3DM.%26atitle%3DExpression%2520of%2520Class%2520III%2520Beta%2520Tubulin%2520In%2520Non-Small%2520Cell%2520Lung%2520Cancer%2520Is%2520Correlated%2520With%2520Resistance%2520To%2520Taxane%2520Chemotherapy%26jtitle%3DBull.%2520Cancer%26date%3D2005%26volume%3D92%26spage%3DE25%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Seve, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaac, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tredan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souquet, P.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacheco, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perol, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafanechere, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peiller, E.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumontet, C.</span><span> </span><span class="NLM_article-title">Expression of Class III β -Tubulin Is Predictive of Patient Outcome in Patients with Non-Small Cell Lung Cancer Receiving Vinorelbine-Based Chemotherapy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">5481</span><span class="NLM_x">–</span> <span class="NLM_lpage">5486</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1158%2F1078-0432.CCR-05-0285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=16061864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFSmtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=5481-5486&author=P.+Seveauthor=S.+Isaacauthor=O.+Tredanauthor=P.-J.+Souquetauthor=Y.+Pachecoauthor=M.+Perolauthor=L.+Lafanechereauthor=A.+Penetauthor=E.-L.+Peillerauthor=C.+Dumontet&title=Expression+of+Class+III+%CE%B2+-Tubulin+Is+Predictive+of+Patient+Outcome+in+Patients+with+Non-Small+Cell+Lung+Cancer+Receiving+Vinorelbine-Based+Chemotherapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of Class III β-Tubulin Is Predictive of Patient Outcome in Patients with Non-Small Cell Lung Cancer Receiving Vinorelbine-Based Chemotherapy</span></div><div class="casAuthors">Seve, Pascal; Isaac, Sylvie; Tredan, Olivier; Souquet, Pierre-Jean; Pacheco, Yves; Perol, Maurice; Lafanechere, Laurence; Penet, Aurelie; Peiller, Eva-Laure; Dumontet, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5481-5486</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: To det. the prevalence and the prognostic value of microtubule component expression in tumors of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).  Exptl. Design: Expression of microtubular components was immunohistochem. examd. in 93 tumor samples from untreated patients with stage III and IV NSCLC.  All patients received vinorelbine-based chemotherapy.  Response to chemotherapy, progression-free survival, and overall survival were correlated with the expression of microtubule proteins.  RESULTS: The response rate was 27.3% (21 partial responses among 77 valuable patients).  Although expression of microtubule components was not assocd. with the response rate, high class III {szligbeta}-tubulin expression was correlated with resistance to vinorelbine, defined as disease progression under treatment.  Patients whose tumors expressed high levels of class III β-tubulin isotype had shorter progression-free survival and overall survival (P = 0.002 and 0.001, resp.).  High Δ2 α-tubulin expression was assocd. with a shorter overall survival (P = 0.018).  Tubulin II levels were not found to be correlated with patient outcome.  A multivariate anal., taking into account sex, age, histol., stage, wt. loss, and class II β-tubulin, class III β-tubulin, and Δ2 α-tubulin levels, confirmed that class III {szligbeta}-tubulin expression was independently correlated with progression-free survival (P = 0.04) and overall survival (P = 0.012).  CONCLUSIONS: These findings suggest that a high level of expression of class III {szligbeta}-tubulin in tumor cells is assocd. with resistance to vinorelbine and a poor prognosis in patients with NSCLC receiving vinorelbine-based chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQLbZO_aEZCLVg90H21EOLACvtfcHk0ljidZZ1bTe6nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFSmtbc%253D&md5=144a54ce9966814240d86f5b92dbc2e6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-0285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-0285%26sid%3Dliteratum%253Aachs%26aulast%3DSeve%26aufirst%3DP.%26aulast%3DIsaac%26aufirst%3DS.%26aulast%3DTredan%26aufirst%3DO.%26aulast%3DSouquet%26aufirst%3DP.-J.%26aulast%3DPacheco%26aufirst%3DY.%26aulast%3DPerol%26aufirst%3DM.%26aulast%3DLafanechere%26aufirst%3DL.%26aulast%3DPenet%26aufirst%3DA.%26aulast%3DPeiller%26aufirst%3DE.-L.%26aulast%3DDumontet%26aufirst%3DC.%26atitle%3DExpression%2520of%2520Class%2520III%2520%25CE%25B2%2520-Tubulin%2520Is%2520Predictive%2520of%2520Patient%2520Outcome%2520in%2520Patients%2520with%2520Non-Small%2520Cell%2520Lung%2520Cancer%2520Receiving%2520Vinorelbine-Based%2520Chemotherapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D5481%26epage%3D5486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Tommasi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacalamita, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedele, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiriatti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomssen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendzierski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latorre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorusso, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schittulli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zito, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavallaris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paradiso, A.</span><span> </span><span class="NLM_article-title">Cytoskeleton and Paclitaxel Sensitivity In Breast Cancer: The Role Of Beta-Tubulins</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">2078</span><span class="NLM_x">–</span> <span class="NLM_lpage">2085</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1002%2Fijc.22557" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=17285590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1Oitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2007&pages=2078-2085&author=S.+Tommasiauthor=A.+Mangiaauthor=R.+Lacalamitaauthor=A.+Bellizziauthor=V.+Fedeleauthor=A.+Chiriattiauthor=C.+Thomssenauthor=N.+Kendzierskiauthor=A.+Latorreauthor=V.+Lorussoauthor=F.+Schittulliauthor=F.+Zitoauthor=M.+Kavallarisauthor=A.+Paradiso&title=Cytoskeleton+and+Paclitaxel+Sensitivity+In+Breast+Cancer%3A+The+Role+Of+Beta-Tubulins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of β-tubulins</span></div><div class="casAuthors">Tommasi, Stefania; Mangia, Anita; Lacalamita, Rosanna; Bellizzi, Antonia; Fedele, Vita; Chiriatti, Annalisa; Thomssen, Christopher; Kendzierski, Nancy; Latorre, Agnese; Lorusso, Vito; Schittulli, Francesco; Zito, Francesco; Kavallaris, Maria; Paradiso, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2078-2085</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The antineoplastic effect of paclitaxel is mainly related to its ability to bind the β subunit of tubulin, thus preventing tubulin chain depolarization and inducing apoptosis.  The relevance of the Class 1 β-tubulin characteristics have also been confirmed in the clin. setting where mutations of paclitaxel-binding site of β-tubulin Class I have been related to paclitaxel resistance in non small cell lung and ovarian cancers.  In the present study, we verified the hypothesis of a relationship between mol. alterations of β-tubulin Class I and paclitaxel sensitivity in a panel of breast cell lines with different drug IC50.  The Class I β-tubulin gene cDNA has been sequenced detecting heterozygous missense mutations (exon 1 and 4) only in MCF-7 and SK-BR-3 lines.  Furthermore, the expression (at both mRNA and protein level) of the different isotypes have been analyzed demonstrating an assocn. between low cell sensitivity to paclitaxel and Class III β-tubulin expression increasing.  Antisense oligonucleotide (ODN) expts. confirmed that the inhibition of Class III β-tubulin could at least partially increase paclitaxel-chemosensitivity.  The hypothesis of a relationship between β-tubulin tumor expression and paclitaxel clin. response has been finally verified in a series of 92 advanced breast cancer patients treated with a first line paclitaxel-based chemotherapy.  Thirty-five percent (95% CI: 45-31) of patients with high Class III β-tubulin expression showed a disease progression vs. only 7% of patients with low expression (35% vs. 7%, p < 0.002).  Our study suggests that Class III β-tubulin tumor expression could be considered a predictive biomarker of paclitaxel-clin. resistance for breast cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBTFhVq0oPHrVg90H21EOLACvtfcHk0lgXz9aI4eQkLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1Oitbo%253D&md5=efd1c3424ce6be7595069049392d016c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fijc.22557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.22557%26sid%3Dliteratum%253Aachs%26aulast%3DTommasi%26aufirst%3DS.%26aulast%3DMangia%26aufirst%3DA.%26aulast%3DLacalamita%26aufirst%3DR.%26aulast%3DBellizzi%26aufirst%3DA.%26aulast%3DFedele%26aufirst%3DV.%26aulast%3DChiriatti%26aufirst%3DA.%26aulast%3DThomssen%26aufirst%3DC.%26aulast%3DKendzierski%26aufirst%3DN.%26aulast%3DLatorre%26aufirst%3DA.%26aulast%3DLorusso%26aufirst%3DV.%26aulast%3DSchittulli%26aufirst%3DF.%26aulast%3DZito%26aufirst%3DF.%26aulast%3DKavallaris%26aufirst%3DM.%26aulast%3DParadiso%26aufirst%3DA.%26atitle%3DCytoskeleton%2520and%2520Paclitaxel%2520Sensitivity%2520In%2520Breast%2520Cancer%253A%2520The%2520Role%2520Of%2520Beta-Tubulins%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2007%26volume%3D120%26spage%3D2078%26epage%3D2085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Mozzetti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferlini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Concolino, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raspaglio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prislei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranelletti, F. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scambia, G.</span><span> </span><span class="NLM_article-title">Class III β-tubulin Overexpression Is A Prominent Mechanism Of Paclitaxel Resistance In Ovarian Cancer Patients</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">305</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=15671559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVegtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=298-305&author=S.+Mozzettiauthor=C.+Ferliniauthor=P.+Concolinoauthor=F.+Filippettiauthor=G.+Raspaglioauthor=S.+Prisleiauthor=D.+Galloauthor=E.+Martinelliauthor=F.+O.+Ranellettiauthor=G.+Ferrandinaauthor=G.+Scambia&title=Class+III+%CE%B2-tubulin+Overexpression+Is+A+Prominent+Mechanism+Of+Paclitaxel+Resistance+In+Ovarian+Cancer+Patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Class III β-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients</span></div><div class="casAuthors">Mozzetti, Simona; Ferlini, Cristiano; Concolino, Paola; Filippetti, Flavia; Raspaglio, Giuseppina; Prislei, Silvia; Gallo, Daniela; Martinelli, Enrica; Ranelletti, Franco Oreste; Ferrandina, Gabriella; Scambia, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">298-305</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The vast majority of women with advanced ovarian cancer will ultimately relapse and develop a drug-resistant disease with an overall 5-yr survival of <50%.  Unfortunately, the mechanisms of drug resistance actually operating in patients are still unknown.  To address this issue, in 41 patients affected by advanced ovarian cancer the three main mechanisms of paclitaxel resistance were investigated: overexpression of MDR-1 gene, point mutations at prominently expressed α-tubulin and β-tubulin genes and selective alterations in the expression of β-tubulin isotypes.  MDR-1 and the β-tubulin isotypes expression were evaluated by semiquant. and real-time PCR.  On the same specimens, quant. immunohistochem. was also done in the tumor area.  No statistically significant changes of MDR-1 expression were noticed between the sensitive and resistant patients either at the mRNA or protein level.  The tubulin mutations for the ubiquitous α-tubulin and β-tubulin genes were evaluated by automated DNA sequencing, and in all patients, no mutations were detected in both resistant and sensitive cases.  With regard to the expression of tubulin isoforms, a statistically significant up-regulation of class III β-tubulin was found in the resistant subset.  It is worth noting that this statistically significant increase of the expression of class III β-tubulin was detectable at the mRNA and protein level.  By a direct comparison of the three main known mechanisms of paclitaxel resistance, this study indicates that overexpression of class III β-tubulin is the most prominent mechanism of paclitaxel resistance in ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_j0ZXNlGPW7Vg90H21EOLACvtfcHk0ljbQK9MQcti0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVegtrg%253D&md5=861e1e01da277ff2f4d76b458ebe5e48</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMozzetti%26aufirst%3DS.%26aulast%3DFerlini%26aufirst%3DC.%26aulast%3DConcolino%26aufirst%3DP.%26aulast%3DFilippetti%26aufirst%3DF.%26aulast%3DRaspaglio%26aufirst%3DG.%26aulast%3DPrislei%26aufirst%3DS.%26aulast%3DGallo%26aufirst%3DD.%26aulast%3DMartinelli%26aufirst%3DE.%26aulast%3DRanelletti%26aufirst%3DF.%2BO.%26aulast%3DFerrandina%26aufirst%3DG.%26aulast%3DScambia%26aufirst%3DG.%26atitle%3DClass%2520III%2520%25CE%25B2-tubulin%2520Overexpression%2520Is%2520A%2520Prominent%2520Mechanism%2520Of%2520Paclitaxel%2520Resistance%2520In%2520Ovarian%2520Cancer%2520Patients%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D298%26epage%3D305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Ferrandina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zannoni, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paglia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallotta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mozzetti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scambia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferlini, C.</span><span> </span><span class="NLM_article-title">Class III β -Tubulin Overexpression Is A Marker Of Poor Clinical Outcome In Advanced Ovarian Cancer Patients</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2774</span><span class="NLM_x">–</span> <span class="NLM_lpage">2779</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1158%2F1078-0432.CCR-05-2715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=16675570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD28Xltlamsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=2774-2779&author=G.+Ferrandinaauthor=G.+F.+Zannoniauthor=E.+Martinelliauthor=A.+Pagliaauthor=V.+Gallottaauthor=S.+Mozzettiauthor=G.+Scambiaauthor=C.+Ferlini&title=Class+III+%CE%B2+-Tubulin+Overexpression+Is+A+Marker+Of+Poor+Clinical+Outcome+In+Advanced+Ovarian+Cancer+Patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Class III β-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients</span></div><div class="casAuthors">Ferrandina, Gabriella; Zannoni, Gian Franco; Martinelli, Enrica; Paglia, Amelia; Gallotta, Valerio; Mozzetti, Simona; Scambia, Giovanni; Ferlini, Cristiano</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2774-2779</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Overexpression of β III tubulin has been involved in paclitaxel resistance in several exptl. models.  We investigated the role of β III tubulin as predictor of clin. outcome in ovarian cancer patients given platinum/paclitaxel treatment.  We also investigated whether β III tubulin expression could be modified after the selective pressure represented by chemotherapy in vivo.  Exptl. Design: The study was designed to include a series of consecutive ovarian cancer patients with unresectable disease at time of first surgery, who underwent interval debulking surgery with pathol. assessment of response to treatment with platinum/paclitaxel chemotherapy.  Immunostaining was done on formalin-fixed, paraffin-embedded tissue sections from pretreatment and posttreatment tissue biopsies by using the polyclonal rabbit anti-class III β-tubulin antibody.  Results: β III Tubulin immunoreaction was obsd. in 51 of 62 (82.2%) cases.  β III Tubulin positivity was neither assocd. with clinicopathol. variables nor with pathol. response to chemotherapy.  Significantly lower percentages of β III tubulin positivity were obsd. in posttreatment (range, 5-80%; median, 20%) vs. pretreatment (range 10-100%; median, 40%) tissue biopsies (P = 0.0011).  Cases with high β III tubulin expression showed a worse overall survival with respect to cases with low β III tubulin expression (median overall survival, 25 vs. 46 mo; P = 0.002).  Multivariate anal. showed that high content of β III tubulin remains independently assocd. with a worse prognosis.  Conclusions: Assessment of β III tubulin could be useful to identify poor prognosis ovarian cancer patients candidates to more aggressive and/or targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkRULoF4-0uLVg90H21EOLACvtfcHk0ljbQK9MQcti0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xltlamsb0%253D&md5=569d52a398426b7b06eddeb7b0e98751</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-2715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-2715%26sid%3Dliteratum%253Aachs%26aulast%3DFerrandina%26aufirst%3DG.%26aulast%3DZannoni%26aufirst%3DG.%2BF.%26aulast%3DMartinelli%26aufirst%3DE.%26aulast%3DPaglia%26aufirst%3DA.%26aulast%3DGallotta%26aufirst%3DV.%26aulast%3DMozzetti%26aufirst%3DS.%26aulast%3DScambia%26aufirst%3DG.%26aulast%3DFerlini%26aufirst%3DC.%26atitle%3DClass%2520III%2520%25CE%25B2%2520-Tubulin%2520Overexpression%2520Is%2520A%2520Marker%2520Of%2520Poor%2520Clinical%2520Outcome%2520In%2520Advanced%2520Ovarian%2520Cancer%2520Patients%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D2774%26epage%3D2779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Seve, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumontet, C.</span><span> </span><span class="NLM_article-title">Is Class III β-Tubulin a Predictive Factor in Patients Receiving Tubulin-binding Agents?</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1016%2FS1470-2045%2808%2970029-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=18237851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=168-175&author=P.+Seveauthor=C.+Dumontet&title=Is+Class+III+%CE%B2-Tubulin+a+Predictive+Factor+in+Patients+Receiving+Tubulin-binding+Agents%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Is class III β-tubulin a predictive factor in patients receiving tubulin-binding agents?</span></div><div class="casAuthors">Seve, Pascal; Dumontet, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">168-175</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: On the basis of preclin. studies that show overexpression of class III β-tubulin is assocd. with resistance to tubulin-binding agents, several investigators have addressed the relation between class III β-tubulin and outcome in patients treated with such agents.  High expression of class III β-tubulin has been found to be correlated either with low response rates in patients treated with regimens contg. taxanes or vinorelbine or with reduced survival in patients with non-small-cell lung cancer, in breast, ovarian, and gastric cancers, and in cancers of unknown primary site.  Two studies have shown patients with advanced non-small-cell lung cancer receiving paclitaxel whose tumors expressed high levels of class III β-tubulin had a lower response to paclitaxel and shorter survival, whereas this variable was not found to be predictive in patients receiving regimens without tubulin-binding agents.  Conversely, anal. of samples from patients in the JBR-10 trial, which compared adjuvant chemotherapy to no further therapy in operable non-small-cell lung cancer, showed that chemotherapy seemed to overcome the neg. prognostic effect of high levels of expression of class III β-tubulin and the greatest benefit from cisplatin/vinorelbine was seen in patients with high levels of expression of class III β-tubulin.  Further analyses in operable and advanced non-small-cell lung cancer showed a relation between high expression of class III β-tubulin and baseline factors such as age under 60 years, adenocarcinoma and large-cell carcinoma histologies, and advanced stage of disease.  These results suggest that class III β-tubulin could be both a prognostic and a predictive factor.  Large randomized studies are warranted to det. the prognostic or predictive value of class III β-tubulin in different settings and tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopsXLbaFHm3LVg90H21EOLACvtfcHk0lh2FpaLaHCgSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOmsr8%253D&md5=4d4adaf4db80a5eb71c771c9f09d74b4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2808%2970029-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252808%252970029-9%26sid%3Dliteratum%253Aachs%26aulast%3DSeve%26aufirst%3DP.%26aulast%3DDumontet%26aufirst%3DC.%26atitle%3DIs%2520Class%2520III%2520%25CE%25B2-Tubulin%2520a%2520Predictive%2520Factor%2520in%2520Patients%2520Receiving%2520Tubulin-binding%2520Agents%253F%26jtitle%3DLancet%2520Oncol.%26date%3D2008%26volume%3D9%26spage%3D168%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Strengel, C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesse, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">Class III Beta- Tubulin Expression and in vitro Resistance To Microtubule Targeting Agents</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1038%2Fsj.bjc.6605489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=20029418" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2010&pages=316-324&author=C+Strengelauthor=S.+P.+Newmanauthor=M.+P.+Lesseauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohit&title=Class+III+Beta-+Tubulin+Expression+and+in+vitro+Resistance+To+Microtubule+Targeting+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6605489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6605489%26sid%3Dliteratum%253Aachs%26aulast%3DStrengel%26aufirst%3DC%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DLesse%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3DClass%2520III%2520Beta-%2520Tubulin%2520Expression%2520and%2520in%2520vitro%2520Resistance%2520To%2520Microtubule%2520Targeting%2520Agents%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2010%26volume%3D102%26spage%3D316%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risinger, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooberry, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Biological Evaluations of 2,5-Diaryl-2,3-dihydro-1,3,4-oxadiazoline Analogs of Combretastatin-A4</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901268n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=325-334&author=L.+Leeauthor=L.+M.+Robbauthor=M.+Leeauthor=R.+Davisauthor=H.+Mackayauthor=S.+Chavdaauthor=E.+L.+O%E2%80%99Brienauthor=A.+L.+Risingerauthor=S.+L.+Mooberryauthor=M.+Lee&title=Design%2C+Synthesis+and+Biological+Evaluations+of+2%2C5-Diaryl-2%2C3-dihydro-1%2C3%2C4-oxadiazoline+Analogs+of+Combretastatin-A4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm901268n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901268n%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DL.%26aulast%3DRobb%26aufirst%3DL.%2BM.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DMackay%26aufirst%3DH.%26aulast%3DChavda%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DE.%2BL.%26aulast%3DRisinger%26aufirst%3DA.%2BL.%26aulast%3DMooberry%26aufirst%3DS.%2BL.%26aulast%3DLee%26aufirst%3DM.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biological%2520Evaluations%2520of%25202%252C5-Diaryl-2%252C3-dihydro-1%252C3%252C4-oxadiazoline%2520Analogs%2520of%2520Combretastatin-A4%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D325%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Dumontet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. F. Y.</span><span> </span><span class="NLM_article-title">Ixabepilone: Targeting βIII-Tubulin Expression in Taxane-resistant Malignancies</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1158%2F1535-7163.MCT-08-0986" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=19139109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFSmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=17-25&author=C.+Dumontetauthor=M.+A.+Jordanauthor=F.+F.+Y.+Lee&title=Ixabepilone%3A+Targeting+%CE%B2III-Tubulin+Expression+in+Taxane-resistant+Malignancies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Ixabepilone: targeting βIII-tubulin expression in taxane-resistant malignancies</span></div><div class="casAuthors">Dumontet, Charles; Jordan, Mary Ann; Lee, Francis F. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-25</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Microtubule-targeting agents, such as taxanes and epothilones, block mitosis and cell proliferation by targeting the dynamics of the cytoskeleton.  The taxanes are widely used for treatment of various malignancies, but primary and acquired resistance to chemotherapy remains a significant clin. concern.  Class I, II, III, IV, and V β-tubulin isotypes are expressed in human tumors.  Overexpression of the βIII-tubulin isotype is one mechanism that can render tumor cells resistant to taxanes.  The relative expression of βIII-tubulin correlates with clin. outcomes in several tumor types, including breast cancer, non-small cell lung cancer, and ovarian cancer.  A novel analog of epothilone B, ixabepilone, has recently been approved in combination with capecitabine for the treatment of patients with anthracycline- and taxane-resistant locally advanced or metastatic breast cancer and as monotherapy in patients whose tumors are resistant or refractory to an anthracycline, a taxane, and capecitabine.  The significant antitumor activity of ixabepilone in taxane-resistant tumors may be related to its preferential suppression of the dynamic instability of α/βIII-microtubules in cells expressing high levels of βIII-tubulin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDIBa1OKa6abVg90H21EOLACvtfcHk0ljO29Hme5yXQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFSmtA%253D%253D&md5=0073f077c14f0cefbc034f6f5bafa0b5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0986%26sid%3Dliteratum%253Aachs%26aulast%3DDumontet%26aufirst%3DC.%26aulast%3DJordan%26aufirst%3DM.%2BA.%26aulast%3DLee%26aufirst%3DF.%2BF.%2BY.%26atitle%3DIxabepilone%253A%2520Targeting%2520%25CE%25B2III-Tubulin%2520Expression%2520in%2520Taxane-resistant%2520Malignancies%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D17%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Speicher, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barone, L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tew, K. D.</span><span> </span><span class="NLM_article-title">Combined Antimicrotubule Activity of Estramustine and Taxol in Human Prostate Carcinoam Cell lines</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4433</span><span class="NLM_x">–</span> <span class="NLM_lpage">4440</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1992&pages=4433-4440&author=L.+A.+Speicherauthor=L+Baroneauthor=K.+D.+Tew&title=Combined+Antimicrotubule+Activity+of+Estramustine+and+Taxol+in+Human+Prostate+Carcinoam+Cell+lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpeicher%26aufirst%3DL.%2BA.%26aulast%3DBarone%26aufirst%3DL%26aulast%3DTew%26aufirst%3DK.%2BD.%26atitle%3DCombined%2520Antimicrotubule%2520Activity%2520of%2520Estramustine%2520and%2520Taxol%2520in%2520Human%2520Prostate%2520Carcinoam%2520Cell%2520lines%26jtitle%3DCancer%2520Res.%26date%3D1992%26volume%3D52%26spage%3D4433%26epage%3D4440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Giannakakou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalba, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poruchynsky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span> </span><span class="NLM_article-title">Combinations of Paclitaxel and Vinblastine and Their Effects on Tubulin Polymerization and Cellular Cytotoxicity: Characterization of a Synergistic Schedule</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1002%2F%28SICI%291097-0215%2819980105%2975%3A1%3C57%3A%3AAID-IJC10%3E3.0.CO%3B2-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=9426691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADyaK1cXjsFKqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1998&pages=57-63&author=P.+Giannakakouauthor=L.+Villalbaauthor=H.+Liauthor=M.+Poruchynskyauthor=T.+Fojo&title=Combinations+of+Paclitaxel+and+Vinblastine+and+Their+Effects+on+Tubulin+Polymerization+and+Cellular+Cytotoxicity%3A+Characterization+of+a+Synergistic+Schedule"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Combinations of paclitaxel and vinblastine and their effects on tubulin polymerization and cellular cytotoxicity: characterization of a synergistic schedule</span></div><div class="casAuthors">Giannakakou, Paraskevi; Villalba, Lourdes; Li, Hang; Poruchynsky, Marianne; Fojo, Tito</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-63</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Paclitaxel (PTX) and vinblastine (VBL) represent 2 classes of drugs that target tubulin but have sep. binding properties and opposing mechanisms of action.  To evaluate the potential use of these agents together in a chemotherapeutic regimen, their effects on the dynamics of tubulin polymn. and cellular cytotoxicity, when administered singly or in combination, were investigated.  In human epidermoid carcinoma KB cells and MCF-7 breast carcinoma cells, there was a time- and concn.-dependent effect of both PTX and VBL on cytoskeletal dynamics.  Tubulin polymn. induced by PTX was stable for >24 h.  When PTX was followed by addn. of VBL, a time- and concn.-dependent reversal of tubulin polymn. was obsd.  In contrast, rapid tubulin polymn. occurred when VBL was followed by PTX.  When both agents were added simultaneously, a diminution of PTX-induced tubulin polymn. occurred with increasing concns. of VBL; a max. redn. was achieved when equal concns. were used.  Examn. of the tubulin pattern by immunofluorescence in MCF-7 breast cancer cells confirmed and extended these findings.  Bundle formation followed treatment with PTX.  Addn. of increasing concns. of VBL prevented bundling; however, the normal cytoskeletal architecture was not restored.  Cytotoxicity studies carried out by using median concn. effect principles and combination index anal. showed synergism when VBL and PTX were added sequentially, and antagonism for simultaneous addn.  The results demonstrate changes in tubulin dynamics following drug treatment and provide a rationale for combined PTX/VBL therapy after careful evaluation of the schedule of administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqROGtMFC6SabVg90H21EOLACvtfcHk0ljO29Hme5yXQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjsFKqsA%253D%253D&md5=976a9cebba0e2d6899762f532c8df8bd</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2819980105%2975%3A1%3C57%3A%3AAID-IJC10%3E3.0.CO%3B2-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252819980105%252975%253A1%253C57%253A%253AAID-IJC10%253E3.0.CO%253B2-A%26sid%3Dliteratum%253Aachs%26aulast%3DGiannakakou%26aufirst%3DP.%26aulast%3DVillalba%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DPoruchynsky%26aufirst%3DM.%26aulast%3DFojo%26aufirst%3DT.%26atitle%3DCombinations%2520of%2520Paclitaxel%2520and%2520Vinblastine%2520and%2520Their%2520Effects%2520on%2520Tubulin%2520Polymerization%2520and%2520Cellular%2520Cytotoxicity%253A%2520Characterization%2520of%2520a%2520Synergistic%2520Schedule%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1998%26volume%3D75%26spage%3D57%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Shi, W.; Horsman, M. R.; Siemann, D. W.</span><span> </span><span class="NLM_article-title">Combined Modality Approaches Using Vasculature-disrupting Agents</span>. In  <span class="citation_source-book">Vascular-Targeted Therapies in Oncology</span>; <span class="NLM_contrib-group">Siemann, D. W.</span>, Ed.; <span class="NLM_publisher-name">J. Wiley & Sons, Ltd.</span>: <span class="NLM_publisher-loc">West Sussex, England</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">123</span>− <span class="NLM_lpage">136</span> and other chapters in the text.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1002%2F0470035439.ch7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=123-136&author=W.+Shi&author=M.+R.+Horsman&author=D.+W.+Siemannauthor=D.+W.+Siemann&title=Vascular-Targeted+Therapies+in+Oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2F0470035439.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0470035439.ch7%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DW.%26atitle%3DCombined%2520Modality%2520Approaches%2520Using%2520Vasculature-disrupting%2520Agents%26btitle%3DVascular-Targeted%2520Therapies%2520in%2520Oncology%26aulast%3DSiemann%26aufirst%3DD.%2BW.%26pub%3DJ.%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26date%3D2006%26spage%3D123%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Gangjee, A.; Zhao, Y.; Ihnat, M. A.; Green, D.; Miller, W. T.</span><span> </span><span class="NLM_article-title">Synthesis of 2-Amino-4-<i>m</i>-bromoanilino-6-arylmethyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidines as Tyrosine Kinase Inhibitors and Antiangiogenic Agents</span>. Presented at the 96th American Association for Cancer Research (AACR) Annual Meeting, Anaheim, CA, April 16−20,<span class="NLM_x"> </span><span class="NLM_year">2005</span>. Poster No. 3946.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=A.+Gangjee&author=Y.+Zhao&author=M.+A.+Ihnat&author=D.+Green&author=W.+T.+Miller&title=Synthesis+of+2-Amino-4-m-bromoanilino-6-arylmethyl-7H-pyrrolo%5B2%2C3-d%5Dpyrimidines+as+Tyrosine+Kinase+Inhibitors+and+Antiangiogenic+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGangjee%26aufirst%3DA.%26atitle%3DSynthesis%2520of%25202-Amino-4-m-bromoanilino-6-arylmethyl-7H-pyrrolo%255B2%252C3-d%255Dpyrimidines%2520as%2520Tyrosine%2520Kinase%2520Inhibitors%2520and%2520Antiangiogenic%2520Agents%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Gangjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raghavan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihnat, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Disch, B. C.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Evaluation of 2-Amino-4-<i>m</i>-bromoanilino-6-arylmethyl-<i>7H</i>-pyrrolo[2,3-<i>d</i>]pyrimidines as Tyrosine Kinase Inhibitors and Antiangiogenic Agents</span> <span class="citation_source-journal">Bioorg. Med . Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5261</span><span class="NLM_x">–</span> <span class="NLM_lpage">5273</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=5261-5273&author=A.+Gangjeeauthor=Y.+Zhaoauthor=S.+Raghavanauthor=M.+A.+Ihnatauthor=B.+C.+Disch&title=Design%2C+Synthesis+and+Evaluation+of+2-Amino-4-m-bromoanilino-6-arylmethyl-7H-pyrrolo%5B2%2C3-d%5Dpyrimidines+as+Tyrosine+Kinase+Inhibitors+and+Antiangiogenic+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGangjee%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DRaghavan%26aufirst%3DS.%26aulast%3DIhnat%26aufirst%3DM.%2BA.%26aulast%3DDisch%26aufirst%3DB.%2BC.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Evaluation%2520of%25202-Amino-4-m-bromoanilino-6-arylmethyl-7H-pyrrolo%255B2%252C3-d%255Dpyrimidines%2520as%2520Tyrosine%2520Kinase%2520Inhibitors%2520and%2520Antiangiogenic%2520Agents%26jtitle%3DBioorg.%2520Med%2520.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D5261%26epage%3D5273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Bai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paull, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herald, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettit, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span> </span><span class="NLM_article-title">Halichondrin B and Homohalichondrin B, Marine Natural Products Binding in the Vinca Domain of Tubulin. Discovery of Tubulin-based Mechanism of Action by Analysis of Differential Cytotoxicity Data</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">266</span><span class="NLM_x">, </span> <span class="NLM_fpage">15882</span><span class="NLM_x">–</span> <span class="NLM_lpage">15889</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=1874739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADyaK3MXmsVOls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1991&pages=15882-15889&author=R.+Baiauthor=K.+D.+Paullauthor=C.+L.+Heraldauthor=G.+R.+Pettitauthor=E.+Hamel&title=Halichondrin+B+and+Homohalichondrin+B%2C+Marine+Natural+Products+Binding+in+the+Vinca+Domain+of+Tubulin.+Discovery+of+Tubulin-based+Mechanism+of+Action+by+Analysis+of+Differential+Cytotoxicity+Data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin.  Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data</span></div><div class="casAuthors">Bai, Ruoli; Paull, Kenneth D.; Herald, Cherry L.; Malspeis, Louis; Pettit, George R.; Hamel, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">266</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">15882-9</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Data generated in the new National Cancer Institute drug evaluation program, which is based on inhibition of cell growth in 60 human tumor cell lines, were used to compare new compds. with agents of known mechanism of action in terms of their differential cytotoxicity.  Two marine natural products, halichondrin B (I) and homohalichondrin B (II), appeared repeatedly when the data base was probed with known antimitotic agents.  The authors confirmed that both compds. were highly cytotoxic (IC50 values for L1210 murine leukemia cells of 0.3 and 1 nM, resp.), with accumulation of cells arrested in mitosis at toxic concns., that both inhibited the polymn. of purified tubulin, and that both inhibited microtubule assembly dependent on microtubule-assocd. proteins.  Limited amts. of II, the less active agent, were available, so only I was studied in detail.  I did not interfere with colchicine binding to tubulin, but it was a noncompetitive inhibitor of the binding of vinblastine to tubulin (apparent Ki, 5.0 μM).  I was therefore compared with other agents which interfere with the binding of vinca alkaloids to tubulin (vinblastine, maytansine, dolastatin 10, phomopsin A, rhizoxin) in terms of its effects on tubulin polymn., inhibition of GTP hydrolysis, inhibition of nucleotide exchange, and stabilization of tubulin, as well as the quant. assessment of its effects on vinca alkaloid binding and inhibition of cell growth.  Since I was originally isolated from the same organism as the phosphatase inhibitor okadaic acid, and since it is about 50-fold more effective than okadaic acid as an inhibitor of L1210 cell growth, perturbations of cellular microtubules obsd. following treatment with okadaic acid should be interpreted cautiously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHQ_94iRSg7rVg90H21EOLACvtfcHk0lh4mTUODovQKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmsVOls74%253D&md5=292cdeb1c3c262dac15d6af5bf2f100c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DR.%26aulast%3DPaull%26aufirst%3DK.%2BD.%26aulast%3DHerald%26aufirst%3DC.%2BL.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DHalichondrin%2520B%2520and%2520Homohalichondrin%2520B%252C%2520Marine%2520Natural%2520Products%2520Binding%2520in%2520the%2520Vinca%2520Domain%2520of%2520Tubulin.%2520Discovery%2520of%2520Tubulin-based%2520Mechanism%2520of%2520Action%2520by%2520Analysis%2520of%2520Differential%2520Cytotoxicity%2520Data%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1991%26volume%3D266%26spage%3D15882%26epage%3D15889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Paull, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malspeis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span> </span><span class="NLM_article-title">Identification of Novel Antimitotic Agents Acting at the Tubulin Level by Computer-assisted Evaluation of Differential Cytotoxicity Data</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3892</span><span class="NLM_x">–</span> <span class="NLM_lpage">3900</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=1617665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADyaK38XmtVClt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1992&pages=3892-3900&author=K.+D.+Paullauthor=C.+M.+Linauthor=L.+Malspeisauthor=E.+Hamel&title=Identification+of+Novel+Antimitotic+Agents+Acting+at+the+Tubulin+Level+by+Computer-assisted+Evaluation+of+Differential+Cytotoxicity+Data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel antimitotic agents acting at the tubulin level by computer-assisted evaluation of differential cytotoxicity data</span></div><div class="casAuthors">Paull, Kenneth D.; Lin, Chii M.; Malspeis, Louis; Hamel, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3892-900</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Data generated in the new National Cancer Institute drug evaluation program, which are based on inhibition of cell growth in 60 human tumor cells lines, were probed with nine known antimitotic agents using the COMPARE algorithm.  Cytotoxicity data were available on approx. 7000 compds. at the time of anal., and, based on the criteria used, 82 compds. were selected as pos. by the computer search.  Nine were the probe compds. themselves, and 41 were analogs of known antimitotic agents.  Among the remaining 32 compds. there were 19 distinct chem. species.  Agents in ten of these groups (contg. 20 compds.) were effective inhibitors of in vitro tubulin polymn. and caused the mitotic arrest of cells grown in culture.  Two compds. were related natural products binding in the Vinca domain of tubulin, and the others were synthetic agents which interfered with colchicine binding.  The remaining 12 agents (one natural product, the remainder synthetic) fell into several groups: two compds. were weak inhibitors of tubulin polymn., inhibited colchicine binding, and caused mitotic arrest; one compd. weakly inhibited tubulin polymn. but did not cause an increase in the no. of cells arrested in mitosis; two compds. caused mitotic arrest at micromolar concns., but thus far no in vitro interaction with tubulin has been obsd.; the remainder neither inhibited tubulin polymn. nor caused a rise in the no. of cultured cells arrested in mitosis.  Tubulin-dependent GTP hydrolysis was stimulated or inhibited by all agents which inhibited tubulin polymn. with the exception of one compd.  The anal. of differential cytotoxicity data thus appears to have great promise for the identification of new antimitotic agents with antineoplastic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS4q-eezqocbVg90H21EOLACvtfcHk0linLjTZvPdjrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XmtVClt74%253D&md5=d53ce5e4e91048c340c10069ec71f2bb</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaull%26aufirst%3DK.%2BD.%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DMalspeis%26aufirst%3DL.%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DIdentification%2520of%2520Novel%2520Antimitotic%2520Agents%2520Acting%2520at%2520the%2520Tubulin%2520Level%2520by%2520Computer-assisted%2520Evaluation%2520of%2520Differential%2520Cytotoxicity%2520Data%26jtitle%3DCancer%2520Res.%26date%3D1992%26volume%3D52%26spage%3D3892%26epage%3D3900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Paull, K. D.; Hamel, E.; Malspeis, L.</span><span> </span><span class="NLM_article-title">The Prediction of Biochemical Mechanism of Action From the in vivo Antitumor Screen of the National Cancer Institute</span>. In  <span class="citation_source-book">Cancer Chemotherapeutic Agents</span>; <span class="NLM_contrib-group">Foye, W. O.</span>, Ed.; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">1995</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">9</span>− <span class="NLM_lpage">45</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=9-45&author=K.+D.+Paull&author=E.+Hamel&author=L.+Malspeisauthor=W.+O.+Foye&title=Cancer+Chemotherapeutic+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPaull%26aufirst%3DK.%2BD.%26atitle%3DThe%2520Prediction%2520of%2520Biochemical%2520Mechanism%2520of%2520Action%2520From%2520the%2520in%2520vivo%2520Antitumor%2520Screen%2520of%2520the%2520National%2520Cancer%2520Institute%26btitle%3DCancer%2520Chemotherapeutic%2520Agents%26aulast%3DFoye%26aufirst%3DW.%2BO.%26pub%3DAmerican%2520Chemical%2520Society%26date%3D1995%26spage%3D9%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">West, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauchamp, L.</span><span> </span><span class="NLM_article-title">2-Alkyl(aryl)- and 2,7-Dimethyl-4-substituted Aminopyrrolo [2,3-<i>d</i>] pyrimidines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">3809</span><span class="NLM_x">–</span> <span class="NLM_lpage">3812</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01068a044" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1961&pages=3809-3812&author=R.+A.+Westauthor=L.+Beauchamp&title=2-Alkyl%28aryl%29-+and+2%2C7-Dimethyl-4-substituted+Aminopyrrolo+%5B2%2C3-d%5D+pyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjo01068a044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01068a044%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DR.%2BA.%26aulast%3DBeauchamp%26aufirst%3DL.%26atitle%3D2-Alkyl%2528aryl%2529-%2520and%25202%252C7-Dimethyl-4-substituted%2520Aminopyrrolo%2520%255B2%252C3-d%255D%2520pyrimidines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1961%26volume%3D26%26spage%3D3809%26epage%3D3812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Ohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukoshi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagasaka, M.</span><span> </span><span class="NLM_article-title">Synthesis and Hypoglycemic Activity of 7,8-Dihydro-6H-thiopyrano[3,2-<i>d</i>]pyrimidine Derivatives and Related Compounds</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">4150</span><span class="NLM_x">–</span> <span class="NLM_lpage">4165</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1986&pages=4150-4165&author=S.+Ohnoauthor=K.+Mizukoshiauthor=O.+Komatsuauthor=Y.+Kunoauthor=Y.+Nakamuraauthor=E.+Katoauthor=M.+Nagasaka&title=Synthesis+and+Hypoglycemic+Activity+of+7%2C8-Dihydro-6H-thiopyrano%5B3%2C2-d%5Dpyrimidine+Derivatives+and+Related+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhno%26aufirst%3DS.%26aulast%3DMizukoshi%26aufirst%3DK.%26aulast%3DKomatsu%26aufirst%3DO.%26aulast%3DKuno%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DKato%26aufirst%3DE.%26aulast%3DNagasaka%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Hypoglycemic%2520Activity%2520of%25207%252C8-Dihydro-6H-thiopyrano%255B3%252C2-d%255Dpyrimidine%2520Derivatives%2520and%2520Related%2520Compounds%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1986%26volume%3D34%26spage%3D4150%26epage%3D4165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Skehan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storeng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vistica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bokesch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span> </span><span class="NLM_article-title">New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1093%2Fjnci%2F82.13.1107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=2359136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADyaK3cXltVylsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1990&pages=1107-1112&author=P.+Skehanauthor=R.+Storengauthor=D.+Scudieroauthor=A.+Monksauthor=J.+McMahonauthor=D.+Visticaauthor=J.+T.+Warrenauthor=H.+Bokeschauthor=S.+Kenneyauthor=M.+R.+Boyd&title=New+Colorimetric+Cytotoxicity+Assay+for+Anticancer-Drug+Screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">New colorimetric cytotoxicity assay for anticancer-drug screening</span></div><div class="casAuthors">Skehan, Philip; Storeng, Ritsa; Scudiero, Dominic; Monks, Anne; McMahon, James; Vistica, David; Warren, Jonathan T.; Bokesch, Heidi; Kenney, Susan; Boyd, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1107-12</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">A rapid, sensitive, and inexpensive method was developed for measuring the cellular protein content of adherent and suspension cultures in 96-well microtiter plates.  The method is suitable for ordinary lab. purposes and for very large-scale applications, such as the National Cancer Institute's disease-oriented in vitro anticancer-drug discovery screen, which requires the use of several million culture wells per yr.  Cultures fixed with trichloroacetic acid were stained for 30 min with 0.4% (wt/vol) sulforhodamine B (SRB) dissolved in 1% acetic acid.  Unbound dye was removed by four washes with 1% acetic acid, and protein-bound dye was extd. with 10 mM unbuffered Tris base [tris(hydroxymethyl)aminomethane] for detn. of optical d. in a computer-interfaced, 96-well microtiter plate reader.  The SRB assay results were linear with the no. of cells and with values for cellular protein measured by both the Lowry and Bradford assays at densities ranging from sparse subconfluence to multilayered supraconfluence.  The signal-to-noise ratio at 564 nm was approx. 1.5 with 1,000 cells per well.  The sensitivity of the SRB assay compared favorably with sensitivities of several fluorescence assays and was superior to those of both the Lowry and Bradford assays and to those of 20 other visible dyes.  The SRB assay provides a colorimetric end point that is nondestructive, indefinitely stable, and visible to the naked eye.  It provides a sensitive measure of drug-induced cytotoxicity, is useful in quantitating clonogenicity, and is well suited to high-vol., automated drug screening.  SRB fluoresces strongly with laser excitation at 488 nm and can be measured quant. at the single-cell level by static fluorescence cytometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA1MIZ3rkcqLVg90H21EOLACvtfcHk0liqpOMlUuLIJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXltVylsL8%253D&md5=d7bc1784a1f181842d2999efa7fa870c</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F82.13.1107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F82.13.1107%26sid%3Dliteratum%253Aachs%26aulast%3DSkehan%26aufirst%3DP.%26aulast%3DStoreng%26aufirst%3DR.%26aulast%3DScudiero%26aufirst%3DD.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DMcMahon%26aufirst%3DJ.%26aulast%3DVistica%26aufirst%3DD.%26aulast%3DWarren%26aufirst%3DJ.%2BT.%26aulast%3DBokesch%26aufirst%3DH.%26aulast%3DKenney%26aufirst%3DS.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DNew%2520Colorimetric%2520Cytotoxicity%2520Assay%2520for%2520Anticancer-Drug%2520Screening%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1990%26volume%3D82%26spage%3D1107%26epage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Boyd, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paull, K. D.</span><span> </span><span class="NLM_article-title">Some Practical Considerations and Applications of the National Cancer Institute <i>in vitro</i> Anticancer Discovery Screen</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=91-109&author=M.+R.+Boydauthor=K.+D.+Paull&title=Some+Practical+Considerations+and+Applications+of+the+National+Cancer+Institute+in+vitro+Anticancer+Discovery+Screen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26aulast%3DPaull%26aufirst%3DK.%2BD.%26atitle%3DSome%2520Practical%2520Considerations%2520and%2520Applications%2520of%2520the%2520National%2520Cancer%2520Institute%2520in%2520vitro%2520Anticancer%2520Discovery%2520Screen%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1995%26volume%3D34%26spage%3D91%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Risinger, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polin, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helms, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeBoeuf, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joe, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopper-Borge, E</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludueña, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruh, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooberry, S. L.</span><span> </span><span class="NLM_article-title">The Taccalonolides: Microtubule Stabilizers that Circumvent Clinically Relevant Taxane Resistance Mechanisms</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">8881</span><span class="NLM_x">–</span> <span class="NLM_lpage">8888</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=8881-8888&author=A.+L.+Risingerauthor=E.+M.+Jacksonauthor=L.+A.+Polinauthor=G.+L.+Helmsauthor=D.+A.+LeBoeufauthor=P.+A.+Joeauthor=E+Hopper-Borgeauthor=R.+F.+Ludue%C3%B1aauthor=G.+D.+Kruhauthor=S.+L.+Mooberry&title=The+Taccalonolides%3A+Microtubule+Stabilizers+that+Circumvent+Clinically+Relevant+Taxane+Resistance+Mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRisinger%26aufirst%3DA.%2BL.%26aulast%3DJackson%26aufirst%3DE.%2BM.%26aulast%3DPolin%26aufirst%3DL.%2BA.%26aulast%3DHelms%26aufirst%3DG.%2BL.%26aulast%3DLeBoeuf%26aufirst%3DD.%2BA.%26aulast%3DJoe%26aufirst%3DP.%2BA.%26aulast%3DHopper-Borge%26aufirst%3DE%26aulast%3DLudue%25C3%25B1a%26aufirst%3DR.%2BF.%26aulast%3DKruh%26aufirst%3DG.%2BD.%26aulast%3DMooberry%26aufirst%3DS.%2BL.%26atitle%3DThe%2520Taccalonolides%253A%2520Microtubule%2520Stabilizers%2520that%2520Circumvent%2520Clinically%2520Relevant%2520Taxane%2520Resistance%2520Mechanisms%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D8881%26epage%3D8888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Ravelli, R. B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigant, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curmi, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knossow, M.</span><span> </span><span class="NLM_article-title">Insight into Tubulin Regulation from a Complex with Colchicine and a Stathmin-like Domain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">428</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1038%2Fnature02393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=15014504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFCls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=428&publication_year=2004&pages=198-202&author=R.+B.+G.+Ravelliauthor=B.+Gigantauthor=P.+A.+Curmiauthor=I.+Jourdainauthor=S.+Lachkarauthor=A.+Sobelauthor=M.+Knossow&title=Insight+into+Tubulin+Regulation+from+a+Complex+with+Colchicine+and+a+Stathmin-like+Domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain</span></div><div class="casAuthors">Ravelli, Raimond B. G.; Gigant, Benoit; Curmi, Patrick A.; Jourdain, Isabelle; Lachkar, Sylvie; Sobel, Andre; Knossow, Marcel</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">428</span>
        (<span class="NLM_cas:issue">6979</span>),
    <span class="NLM_cas:pages">198-202</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Microtubules are cytoskeletal polymers of tubulin involved in many cellular functions.  Their dynamic instability is controlled by numerous compds. and proteins, including colchicine and stathmin family proteins.  The way in which microtubule instability is regulated at the mol. level has remained elusive, mainly because of the lack of appropriate structural data.  Here, the authors present the structure, at 3.5 Å resoln., of tubulin in complex with colchicine (I) and with the stathmin-like domain (SLD) of RB3.  It showed the interaction of RB3-SLD with 2 tubulin heterodimers in a curved complex capped by the SLD N-terminal domain, which prevented the incorporation of the complexed tubulin into microtubules.  A comparison with the structure of tubulin in protofilaments showed changes in the subunits of tubulin as it switched from its straight conformation to a curved one.  These changes correlated with the loss of lateral contacts and provided a rationale for the rapid microtubule depolymn. characteristic of dynamic instability.  Moreover, the tubulin-I complex shed light on the mechanism of I activity; it was shown that I binds at a location where it prevents curved tubulin from adopting a straight structure, which inhibits assembly.  Thus, the results establish a relation between the onset and speed of microtubule disassembly and the changes in tubulin subunits when tubulin switches from its straight to its curved conformation.  The results further provide a mol. description of the interaction of RB3-SLD and I with tubulin, and may be useful for the development of novel therapeutic I analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx2vePjtf347Vg90H21EOLACvtfcHk0li3B8rIaQyUYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFCls7g%253D&md5=9fbb1edfc64239638a3c2eac879bffe9</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnature02393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02393%26sid%3Dliteratum%253Aachs%26aulast%3DRavelli%26aufirst%3DR.%2BB.%2BG.%26aulast%3DGigant%26aufirst%3DB.%26aulast%3DCurmi%26aufirst%3DP.%2BA.%26aulast%3DJourdain%26aufirst%3DI.%26aulast%3DLachkar%26aufirst%3DS.%26aulast%3DSobel%26aufirst%3DA.%26aulast%3DKnossow%26aufirst%3DM.%26atitle%3DInsight%2520into%2520Tubulin%2520Regulation%2520from%2520a%2520Complex%2520with%2520Colchicine%2520and%2520a%2520Stathmin-like%2520Domain%26jtitle%3DNature%26date%3D2004%26volume%3D428%26spage%3D198%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Nguyen, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermone, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaharevitz, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wipf, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gussio, R.</span><span> </span><span class="NLM_article-title">A Common Pharmacophore for a Diverse Set of Colchicine Site Inhibitors Using a Structure-based Approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6107</span><span class="NLM_x">–</span> <span class="NLM_lpage">6116</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050502t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpt1WitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6107-6116&author=T.+L.+Nguyenauthor=C.+McGrathauthor=A.+R.+Hermoneauthor=J.+C.+Burnettauthor=D.+W.+Zaharevitzauthor=B.+W.+Dayauthor=P.+Wipfauthor=E.+Hamelauthor=R.+Gussio&title=A+Common+Pharmacophore+for+a+Diverse+Set+of+Colchicine+Site+Inhibitors+Using+a+Structure-based+Approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach</span></div><div class="casAuthors">Nguyen, Tam Luong; McGrath, Connor; Hermone, Ann R.; Burnett, James C.; Zaharevitz, Daniel W.; Day, Billy W.; Wipf, Peter; Hamel, Ernest; Gussio, Rick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6107-6116</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Modulating the structure and function of tubulin and microtubules is an important route to anticancer therapeutics, and therefore, small mols. that bind to tubulin and cause mitotic arrest are of immense interest.  A large no. of synthetic and natural compds. with diverse structures have been shown to bind at the colchicine site, one of the major binding sites on tubulin, and inhibit tubulin assembly.  Using the recently detd. x-ray structure of the tubulin:colchicinoid complex as the template, we employed docking studies to det. the binding modes of a set of structurally diverse colchicine site inhibitors.  These binding models were subsequently used to construct a comprehensive, structure-based pharmacophore that in combination with mol. dynamics simulations confirms and extends our understanding of binding interactions at the colchicine site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp40uoXQZMHULVg90H21EOLACvtfcHk0li3B8rIaQyUYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpt1WitL8%253D&md5=443f25ca9212b379813d91ccdf820c5a</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm050502t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050502t%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DT.%2BL.%26aulast%3DMcGrath%26aufirst%3DC.%26aulast%3DHermone%26aufirst%3DA.%2BR.%26aulast%3DBurnett%26aufirst%3DJ.%2BC.%26aulast%3DZaharevitz%26aufirst%3DD.%2BW.%26aulast%3DDay%26aufirst%3DB.%2BW.%26aulast%3DWipf%26aufirst%3DP.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DGussio%26aufirst%3DR.%26atitle%3DA%2520Common%2520Pharmacophore%2520for%2520a%2520Diverse%2520Set%2520of%2520Colchicine%2520Site%2520Inhibitors%2520Using%2520a%2520Structure-based%2520Approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6107%26epage%3D6116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Bhattacharyya, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, M.</span><span> </span><span class="NLM_article-title">Anti-Mitotic Activity of Colchicine and the Structural Basis for its Interaction with Tubulin</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1002%2Fmed.20097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=17464966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVSjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=155-183&author=B.+Bhattacharyyaauthor=D.+Pandaauthor=S.+Guptaauthor=M.+Banerjee&title=Anti-Mitotic+Activity+of+Colchicine+and+the+Structural+Basis+for+its+Interaction+with+Tubulin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin</span></div><div class="casAuthors">Bhattacharyya, Bhabatarak; Panda, Dulal; Gupta, Suvroma; Banerjee, Mithu</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">155-183</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">In this review, an attempt has been made to throw light on the mechanism of action of colchicine and its different analogs as anti-cancer agents.  Colchicine interacts with tubulin and perturbs the assembly dynamics of microtubules.  Though its use has been limited because of its toxicity, colchicine can still be used as a lead compd. for the generation of potent anti-cancer drugs.  Colchicine binds to tubulin in a poorly reversible manner with high activation energy.  The binding interaction is favored entropically.  In contrast, binding of its simple analogs AC or DAAC is enthalpically favored and commences with comparatively low activation energy.  Colchicine-tubulin interaction, which is normally pH dependent, has been found to be independent of pH in the presence of microtubule-assocd. proteins, salts or upon cleavage of carboxy termini of tubulin.  Biphasic kinetics of colchicines-tubulin interaction has been explained in light of the variation in the residues around the drug-binding site on β-tubulin.  Using the crystal structure of the tubulin-DAMAcolchicine complex, a detailed discussion on the pharmacophore concept that explains the variation of affinity for different colchicine site inhibitors (CSI) has been discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9F4KA4GVMr7Vg90H21EOLACvtfcHk0li3B8rIaQyUYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVSjsA%253D%253D&md5=720f26c98a40dd91634dbe558d982e98</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fmed.20097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20097%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharyya%26aufirst%3DB.%26aulast%3DPanda%26aufirst%3DD.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DBanerjee%26aufirst%3DM.%26atitle%3DAnti-Mitotic%2520Activity%2520of%2520Colchicine%2520and%2520the%2520Structural%2520Basis%2520for%2520its%2520Interaction%2520with%2520Tubulin%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2008%26volume%3D28%26spage%3D155%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span>Molecular Operating Environment (MOE 2008.10); <span class="NLM_publisher-name">Chemical Computing Group, Inc.</span>: <span class="NLM_publisher-loc">Montreal, Quebec, Canada</span>, 2008; <a href="http://www.chemcomp.com" class="extLink">www.chemcomp.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Molecular+Operating+Environment+%28MOE+2008.10%29%3B+Chemical+Computing+Group%2C+Inc.%3A+Montreal%2C+Quebec%2C+Canada%2C+2008%3B+www.chemcomp.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Operating%2520Environment%2520%2528MOE%25202008.10%2529%26pub%3DChemical%2520Computing%2520Group%252C%2520Inc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">De Martino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Regina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coluccia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edler, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbera, M. C.</span><span> </span><span class="NLM_article-title">Arylthioindoles, Potent Inhibitors of Tubulin Polymerization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6120</span><span class="NLM_x">–</span> <span class="NLM_lpage">6123</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049360d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6120-6123&author=G.+De+Martinoauthor=G.+La+Reginaauthor=A.+Colucciaauthor=M.+C.+Edlerauthor=M.+C.+Barbera&title=Arylthioindoles%2C+Potent+Inhibitors+of+Tubulin+Polymerization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm049360d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049360d%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BMartino%26aufirst%3DG.%26aulast%3DLa%2BRegina%26aufirst%3DG.%26aulast%3DColuccia%26aufirst%3DA.%26aulast%3DEdler%26aufirst%3DM.%2BC.%26aulast%3DBarbera%26aufirst%3DM.%2BC.%26atitle%3DArylthioindoles%252C%2520Potent%2520Inhibitors%2520of%2520Tubulin%2520Polymerization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6120%26epage%3D6123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Gangjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisliuk, R. L.</span><span> </span><span class="NLM_article-title">5-Arylthio Substituted 2-Amino-4-oxo-6-methylpyrrolo[2,3-<i>d</i>]pyrimidine Antifolates as Thymidylate Synthase Inhibitors and Antitumor Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">4495</span><span class="NLM_x">–</span> <span class="NLM_lpage">4502</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00022a015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=4495-4502&author=A.+Gangjeeauthor=R.+Devrajauthor=J.+J.+McGuireauthor=R.+L.+Kisliuk&title=5-Arylthio+Substituted+2-Amino-4-oxo-6-methylpyrrolo%5B2%2C3-d%5Dpyrimidine+Antifolates+as+Thymidylate+Synthase+Inhibitors+and+Antitumor+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm00022a015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00022a015%26sid%3Dliteratum%253Aachs%26aulast%3DGangjee%26aufirst%3DA.%26aulast%3DDevraj%26aufirst%3DR.%26aulast%3DMcGuire%26aufirst%3DJ.%2BJ.%26aulast%3DKisliuk%26aufirst%3DR.%2BL.%26atitle%3D5-Arylthio%2520Substituted%25202-Amino-4-oxo-6-methylpyrrolo%255B2%252C3-d%255Dpyrimidine%2520Antifolates%2520as%2520Thymidylate%2520Synthase%2520Inhibitors%2520and%2520Antitumor%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D4495%26epage%3D4502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Gangjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasudevan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisliuk, R. L.</span><span> </span><span class="NLM_article-title">Nonclassical 5-Substituted Tetrahydroquinazolines as Potential Inhibitors of Thymidylate Synthase</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1669</span><span class="NLM_x">–</span> <span class="NLM_lpage">1676</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1997&pages=1669-1676&author=A.+Gangjeeauthor=A.+Vasudevanauthor=R.+L.+Kisliuk&title=Nonclassical+5-Substituted+Tetrahydroquinazolines+as+Potential+Inhibitors+of+Thymidylate+Synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGangjee%26aufirst%3DA.%26aulast%3DVasudevan%26aufirst%3DA.%26aulast%3DKisliuk%26aufirst%3DR.%2BL.%26atitle%3DNonclassical%25205-Substituted%2520Tetrahydroquinazolines%2520as%2520Potential%2520Inhibitors%2520of%2520Thymidylate%2520Synthase%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1997%26volume%3D34%26spage%3D1669%26epage%3D1676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Gangjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mavandadi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisliuk, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Queener, S. F.</span><span> </span><span class="NLM_article-title">Synthesis of Classical and a Nonclassical 2-Amino-4-oxo-6-methyl-5-substituted Pyrrolo[2,3-<i>d</i>]pyrimidine Antifolate Inhibitors of Thymidylate Synthase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2272</span><span class="NLM_x">–</span> <span class="NLM_lpage">2279</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980586o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=2272-2279&author=A.+Gangjeeauthor=F.+Mavandadiauthor=R.+L.+Kisliukauthor=S.+F.+Queener&title=Synthesis+of+Classical+and+a+Nonclassical+2-Amino-4-oxo-6-methyl-5-substituted+Pyrrolo%5B2%2C3-d%5Dpyrimidine+Antifolate+Inhibitors+of+Thymidylate+Synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm980586o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980586o%26sid%3Dliteratum%253Aachs%26aulast%3DGangjee%26aufirst%3DA.%26aulast%3DMavandadi%26aufirst%3DF.%26aulast%3DKisliuk%26aufirst%3DR.%2BL.%26aulast%3DQueener%26aufirst%3DS.%2BF.%26atitle%3DSynthesis%2520of%2520Classical%2520and%2520a%2520Nonclassical%25202-Amino-4-oxo-6-methyl-5-substituted%2520Pyrrolo%255B2%252C3-d%255Dpyrimidine%2520Antifolate%2520Inhibitors%2520of%2520Thymidylate%2520Synthase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D2272%26epage%3D2279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Gangjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisliuk, R. L.</span><span> </span><span class="NLM_article-title">Benzoyl Ring Halogenated Classical 2-Amino-6-methyl-3,4-dihydro-4-oxo-5-substituted Thiobenzoyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine Antifolates as Inhibitors of Thymidylate Synthase and as Antitumor Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6730</span><span class="NLM_x">–</span> <span class="NLM_lpage">6739</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040144e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6730-6739&author=A.+Gangjeeauthor=H.+D.+Jainauthor=J.+J.+McGuireauthor=R.+L.+Kisliuk&title=Benzoyl+Ring+Halogenated+Classical+2-Amino-6-methyl-3%2C4-dihydro-4-oxo-5-substituted+Thiobenzoyl-7H-pyrrolo%5B2%2C3-d%5Dpyrimidine+Antifolates+as+Inhibitors+of+Thymidylate+Synthase+and+as+Antitumor+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm040144e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040144e%26sid%3Dliteratum%253Aachs%26aulast%3DGangjee%26aufirst%3DA.%26aulast%3DJain%26aufirst%3DH.%2BD.%26aulast%3DMcGuire%26aufirst%3DJ.%2BJ.%26aulast%3DKisliuk%26aufirst%3DR.%2BL.%26atitle%3DBenzoyl%2520Ring%2520Halogenated%2520Classical%25202-Amino-6-methyl-3%252C4-dihydro-4-oxo-5-substituted%2520Thiobenzoyl-7H-pyrrolo%255B2%252C3-d%255Dpyrimidine%2520Antifolates%2520as%2520Inhibitors%2520of%2520Thymidylate%2520Synthase%2520and%2520as%2520Antitumor%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6730%26epage%3D6739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Gangjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisliuk, R. L.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of Classical and Nonclassical 2-Amino-4-oxo-5-substituted-6-methylpyrrolo[3,2-<i>d</i>]pyrimidines as Dual Thymidylate Synthase and Dihydrofolate Reductase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701052u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=68-76&author=A.+Gangjeeauthor=W.+Liauthor=J.+Yangauthor=R.+L.+Kisliuk&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Classical+and+Nonclassical+2-Amino-4-oxo-5-substituted-6-methylpyrrolo%5B3%2C2-d%5Dpyrimidines+as+Dual+Thymidylate+Synthase+and+Dihydrofolate+Reductase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm701052u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701052u%26sid%3Dliteratum%253Aachs%26aulast%3DGangjee%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DKisliuk%26aufirst%3DR.%2BL.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Classical%2520and%2520Nonclassical%25202-Amino-4-oxo-5-substituted-6-methylpyrrolo%255B3%252C2-d%255Dpyrimidines%2520as%2520Dual%2520Thymidylate%2520Synthase%2520and%2520Dihydrofolate%2520Reductase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D68%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Webber, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleckman, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deal, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kathardekar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsh, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, D. A.</span><span> </span><span class="NLM_article-title">Design of Thymidylate Synthase Inhibitors Using Protein Crystal Structures: The Synthesis and Biological Evaluation of a Novel Class of 5-Substituted Quinazolinones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00058a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=733-746&author=S.+J.+Webberauthor=T.+M.+Bleckmanauthor=J.+Attardauthor=J.+G.+Dealauthor=V.+Kathardekarauthor=K.+M.+Welshauthor=S.+Webberauthor=C.+A.+Jansonauthor=D.+A.+Matthews&title=Design+of+Thymidylate+Synthase+Inhibitors+Using+Protein+Crystal+Structures%3A+The+Synthesis+and+Biological+Evaluation+of+a+Novel+Class+of+5-Substituted+Quinazolinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm00058a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00058a010%26sid%3Dliteratum%253Aachs%26aulast%3DWebber%26aufirst%3DS.%2BJ.%26aulast%3DBleckman%26aufirst%3DT.%2BM.%26aulast%3DAttard%26aufirst%3DJ.%26aulast%3DDeal%26aufirst%3DJ.%2BG.%26aulast%3DKathardekar%26aufirst%3DV.%26aulast%3DWelsh%26aufirst%3DK.%2BM.%26aulast%3DWebber%26aufirst%3DS.%26aulast%3DJanson%26aufirst%3DC.%2BA.%26aulast%3DMatthews%26aufirst%3DD.%2BA.%26atitle%3DDesign%2520of%2520Thymidylate%2520Synthase%2520Inhibitors%2520Using%2520Protein%2520Crystal%2520Structures%253A%2520The%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520a%2520Novel%2520Class%2520of%25205-Substituted%2520Quinazolinones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D733%26epage%3D746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span>Sybyl X 1.1; <span class="NLM_publisher-name">Tripos, Inc.</span>: <span class="NLM_publisher-loc">St. Louis, MO</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sybyl+X+1.1%3B+Tripos%2C+Inc.%3A+St.+Louis%2C+MO%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSybyl%2520X%25201.1%26pub%3DTripos%252C%2520Inc%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baichwal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skvortsova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skvortsov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">English, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirisoma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pervin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiman, C. M.</span><span> </span><span class="NLM_article-title">MPC-6827: A Small Molecule Inhibitor of Microtubule Formation that is not a Substrate for Multidrug Resistance Pumps</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">5865</span><span class="NLM_x">–</span> <span class="NLM_lpage">5871</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=5865-5871&author=S.+Kasibhatlaauthor=V.+Baichwalauthor=S.+X.+Caiauthor=B.+Rothauthor=I.+Skvortsovaauthor=S.+Skvortsovauthor=P.+Lukasauthor=N.+M.+Englishauthor=N.+Sirisomaauthor=J.+Dreweauthor=A.+Pervinauthor=B.+Tsengauthor=R.+O.+Carlsonauthor=C.+M.+Pleiman&title=MPC-6827%3A+A+Small+Molecule+Inhibitor+of+Microtubule+Formation+that+is+not+a+Substrate+for+Multidrug+Resistance+Pumps"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DBaichwal%26aufirst%3DV.%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DRoth%26aufirst%3DB.%26aulast%3DSkvortsova%26aufirst%3DI.%26aulast%3DSkvortsov%26aufirst%3DS.%26aulast%3DLukas%26aufirst%3DP.%26aulast%3DEnglish%26aufirst%3DN.%2BM.%26aulast%3DSirisoma%26aufirst%3DN.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DPervin%26aufirst%3DA.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DCarlson%26aufirst%3DR.%2BO.%26aulast%3DPleiman%26aufirst%3DC.%2BM.%26atitle%3DMPC-6827%253A%2520A%2520Small%2520Molecule%2520Inhibitor%2520of%2520Microtubule%2520Formation%2520that%2520is%2520not%2520a%2520Substrate%2520for%2520Multidrug%2520Resistance%2520Pumps%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D5865%26epage%3D5871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Sirisoma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pervin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willardsen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baichwal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessing, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiman, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery of 2-Chloro-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (EP128265, MPI-0441138) as a Potent Inducer of Apoptosis with High In Vivo Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4771</span><span class="NLM_x">–</span> <span class="NLM_lpage">4779</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8003653" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4771-4779&author=N.+Sirisomaauthor=S.+Kasibhatlaauthor=A.+Pervinauthor=H.+Zhangauthor=S.+Jiangauthor=J.+A.+Willardsenauthor=M.+Andersonauthor=V.+Baichwalauthor=G.+G.+Matherauthor=K.+Jessingauthor=R.+Hussainauthor=K.+Hoangauthor=C.+M.+Pleimanauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery+of+2-Chloro-N-%284-methoxyphenyl%29-N-methylquinazolin-4-amine+%28EP128265%2C+MPI-0441138%29+as+a+Potent+Inducer+of+Apoptosis+with+High+In+Vivo+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm8003653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8003653%26sid%3Dliteratum%253Aachs%26aulast%3DSirisoma%26aufirst%3DN.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DPervin%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26aulast%3DAnderson%26aufirst%3DM.%26aulast%3DBaichwal%26aufirst%3DV.%26aulast%3DMather%26aufirst%3DG.%2BG.%26aulast%3DJessing%26aufirst%3DK.%26aulast%3DHussain%26aufirst%3DR.%26aulast%3DHoang%26aufirst%3DK.%26aulast%3DPleiman%26aufirst%3DC.%2BM.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%25202-Chloro-N-%25284-methoxyphenyl%2529-N-methylquinazolin-4-amine%2520%2528EP128265%252C%2520MPI-0441138%2529%2520as%2520a%2520Potent%2520Inducer%2520of%2520Apoptosis%2520with%2520High%2520In%2520Vivo%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4771%26epage%3D4779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Sirisoma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pervin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willardsen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiman, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-(4-Methoxyphenyl)-<i>N</i>,2-dimethylquinazolin-4-amine, a Potent Apoptosis Inducer and Efficacious Anticancer Agent with High Blood Brain Barrier Penetration</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2341</span><span class="NLM_x">–</span> <span class="NLM_lpage">2351</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801315b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2341-2351&author=N.+Sirisomaauthor=A.+Pervinauthor=H.+Zhangauthor=S.+Jiangauthor=J.+A.+Willardsenauthor=M.+Andersonauthor=G.+G.+Matherauthor=C.+M.+Pleimanauthor=S.+Kasibhatlaauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery+of+N-%284-Methoxyphenyl%29-N%2C2-dimethylquinazolin-4-amine%2C+a+Potent+Apoptosis+Inducer+and+Efficacious+Anticancer+Agent+with+High+Blood+Brain+Barrier+Penetration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm801315b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801315b%26sid%3Dliteratum%253Aachs%26aulast%3DSirisoma%26aufirst%3DN.%26aulast%3DPervin%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26aulast%3DAnderson%26aufirst%3DM.%26aulast%3DMather%26aufirst%3DG.%2BG.%26aulast%3DPleiman%26aufirst%3DC.%2BM.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%2520N-%25284-Methoxyphenyl%2529-N%252C2-dimethylquinazolin-4-amine%252C%2520a%2520Potent%2520Apoptosis%2520Inducer%2520and%2520Efficacious%2520Anticancer%2520Agent%2520with%2520High%2520Blood%2520Brain%2520Barrier%2520Penetration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2341%26epage%3D2351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Sirisoma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pervin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willardsen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiman, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-methyl-4-(4-methoxyanilino) quinazolines as Potent Apoptosis Inducers. Structure−Activity Relationship of the Quinazoline Ring</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2030</span><span class="NLM_x">–</span> <span class="NLM_lpage">2334</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2030-2334&author=N.+Sirisomaauthor=A.+Pervinauthor=H.+Zhangauthor=S.+Jiangauthor=J.+A.+Willardsenauthor=M.+Andersonauthor=G.+G.+Matherauthor=C.+M.+Pleimanauthor=S.+Kasibhatlaauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery+of+N-methyl-4-%284-methoxyanilino%29+quinazolines+as+Potent+Apoptosis+Inducers.+Structure%E2%88%92Activity+Relationship+of+the+Quinazoline+Ring"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSirisoma%26aufirst%3DN.%26aulast%3DPervin%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26aulast%3DAnderson%26aufirst%3DM.%26aulast%3DMather%26aufirst%3DG.%2BG.%26aulast%3DPleiman%26aufirst%3DC.%2BM.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%2520N-methyl-4-%25284-methoxyanilino%2529%2520quinazolines%2520as%2520Potent%2520Apoptosis%2520Inducers.%2520Structure%25E2%2588%2592Activity%2520Relationship%2520of%2520the%2520Quinazoline%2520Ring%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2030%26epage%3D2334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Kemnitzer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirisoma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery of 4-Anilino-N-methylthieno[3,2-<i>d</i>]pyrimidines and 4-Anilino-N-methylthieno[2,3-d]pyrimidines as Potent Apoptosis Inducers</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3536</span><span class="NLM_x">–</span> <span class="NLM_lpage">3540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3536-3540&author=W.+Kemnitzerauthor=N.+Sirisomaauthor=C.+Mayauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery+of+4-Anilino-N-methylthieno%5B3%2C2-d%5Dpyrimidines+and+4-Anilino-N-methylthieno%5B2%2C3-d%5Dpyrimidines+as+Potent+Apoptosis+Inducers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKemnitzer%26aufirst%3DW.%26aulast%3DSirisoma%26aufirst%3DN.%26aulast%3DMay%26aufirst%3DC.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%25204-Anilino-N-methylthieno%255B3%252C2-d%255Dpyrimidines%2520and%25204-Anilino-N-methylthieno%255B2%252C3-d%255Dpyrimidines%2520as%2520Potent%2520Apoptosis%2520Inducers%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3536%26epage%3D3540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span> </span><span class="NLM_article-title">Separation of Active Tubulin and Microtubule-associated Proteins by Ultracentrifugation and Isolation of a Component Causing the Formation of Microtubule bundles</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4173</span><span class="NLM_x">–</span> <span class="NLM_lpage">4184</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00313a026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1984&pages=4173-4184&author=E.+Hamelauthor=C.+M.+Lin&title=Separation+of+Active+Tubulin+and+Microtubule-associated+Proteins+by+Ultracentrifugation+and+Isolation+of+a+Component+Causing+the+Formation+of+Microtubule+bundles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fbi00313a026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00313a026%26sid%3Dliteratum%253Aachs%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DC.%2BM.%26atitle%3DSeparation%2520of%2520Active%2520Tubulin%2520and%2520Microtubule-associated%2520Proteins%2520by%2520Ultracentrifugation%2520and%2520Isolation%2520of%2520a%2520Component%2520Causing%2520the%2520Formation%2520of%2520Microtubule%2520bundles%26jtitle%3DBiochemistry%26date%3D1984%26volume%3D23%26spage%3D4173%26epage%3D4184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Hamel, E.</span><span> </span><span class="NLM_article-title">Evaluation of Antimitotic Agents by Quantitative Comparisons of Their Effects on the Polymerization of Purified Tubulin</span> <span class="citation_source-journal">Cell Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm101010n&amp;key=10.1385%2FCBB%3A38%3A1%3A1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm101010n&amp;key=12663938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm101010n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtVaisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=1-22&author=E.+Hamel&title=Evaluation+of+Antimitotic+Agents+by+Quantitative+Comparisons+of+Their+Effects+on+the+Polymerization+of+Purified+Tubulin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin</span></div><div class="casAuthors">Hamel, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-21</span>CODEN:
                <span class="NLM_cas:coden">CBBIFV</span>;
        ISSN:<span class="NLM_cas:issn">1085-9195</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Most antimitotic compds. have highly specific interactions with tubulin, the major protein component of microtubules.  It is, therefore, often desirable to characterize interactions of these agents with tubulin.  In particular, quant. comparisons between new and old ("std.") agents, between different classes of agent, and between structural analogs (e.g., for a structure-activity relationship study) are important.  Because antimitotic drugs have a variety of effects on tubulin and bind at multiple distinct sites on the protein, the tubulin assembly reaction is probably the only universally applicable reaction that can be analyzed.  In my lab., we use the assembly of purified tubulin induced by higher concns. of monosodium glutamate as our basic assay system.  This report presents a detailed description of our current routine assay, including the effects of a variety of reaction components on the reaction.  In addn., the variety of effects that reaction components can have on the quant. results obtained with drugs, using the colchicine site drug combretastatin A-4 as a model compd., is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLvDICXLUiYbVg90H21EOLACvtfcHk0lhPHRA1baCBsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtVaisLY%253D&md5=c37c365cc707e237f43feffca64d706b</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1385%2FCBB%3A38%3A1%3A1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FCBB%253A38%253A1%253A1%26sid%3Dliteratum%253Aachs%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DEvaluation%2520of%2520Antimitotic%2520Agents%2520by%2520Quantitative%2520Comparisons%2520of%2520Their%2520Effects%2520on%2520the%2520Polymerization%2520of%2520Purified%2520Tubulin%26jtitle%3DCell%2520Biochem.%2520Biophys.%26date%3D2003%26volume%3D38%26spage%3D1%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Verdier-Pinard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, H.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Márquez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagle, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falck, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerwick, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span> </span><span class="NLM_article-title">Structure-Activity Analysis of the Interaction of Curacin a, the Potent Colchicine Site Antimitotic Agent, with Tubulin and Effects of Analogs on the Growth of MCF-7 Breast Cancer Cells</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1998&pages=62-76&author=P.+Verdier-Pinardauthor=J.-Y.+Laiauthor=H.-D.+Yooauthor=J.+Yuauthor=B.+M%C3%A1rquezauthor=D.+G.+Nagleauthor=M.+Nambuauthor=J.+D.+Whiteauthor=J.+R.+Falckauthor=W.+H.+Gerwickauthor=B.+W.+Dayauthor=E.+Hamel&title=Structure-Activity+Analysis+of+the+Interaction+of+Curacin+a%2C+the+Potent+Colchicine+Site+Antimitotic+Agent%2C+with+Tubulin+and+Effects+of+Analogs+on+the+Growth+of+MCF-7+Breast+Cancer+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerdier-Pinard%26aufirst%3DP.%26aulast%3DLai%26aufirst%3DJ.-Y.%26aulast%3DYoo%26aufirst%3DH.-D.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DM%25C3%25A1rquez%26aufirst%3DB.%26aulast%3DNagle%26aufirst%3DD.%2BG.%26aulast%3DNambu%26aufirst%3DM.%26aulast%3DWhite%26aufirst%3DJ.%2BD.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DGerwick%26aufirst%3DW.%2BH.%26aulast%3DDay%26aufirst%3DB.%2BW.%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DStructure-Activity%2520Analysis%2520of%2520the%2520Interaction%2520of%2520Curacin%2520a%252C%2520the%2520Potent%2520Colchicine%2520Site%2520Antimitotic%2520Agent%252C%2520with%2520Tubulin%2520and%2520Effects%2520of%2520Analogs%2520on%2520the%2520Growth%2520of%2520MCF-7%2520Breast%2520Cancer%2520Cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D1998%26volume%3D53%26spage%3D62%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SA0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SA0','PDB','1SA0'); return false;">PDB: 1SA0</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i39"><a href="/doi/suppl/10.1021/jm101010n">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_26182"></div></div></div></div></div><hr /></hr><p class="last">Results from elemental analysis: high resolution mass spectra (HRMS) (EI); high resolution mass spectra (HRMS) (ESI); and representation of cell cycle distribution data (Figure <a id="rightTab-" class=" internalNav" href="#fig4">4</a>). This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm101010n/suppl_file/jm101010n_si_001.pdf">jm101010n_si_001.pdf (39.57 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm101010n&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-22%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Fjm101010n%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm101010n" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677aecc5dc1d3d66","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
